Propeller protein containing a FYVE domain, ProF : an adaptor for kinases involved in glucose uptake in adipocytes by Fritzius, Thorsten
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2006
Propeller protein containing a FYVE domain, ProF : an adaptor for kinases
involved in glucose uptake in adipocytes
Fritzius, Thorsten
Abstract: Adapterproteine sind wesentliche Bestandteile zahlreicher Signalwege. Obwohl selbst nicht
enzymatisch aktiv, können sie wichtige Proteine wie zum Beispiel Proteinkinasen nach deren Aktivation zu
Proteinkomplexen oder zu bestimmten subzellulären Bereichen rekrutieren. Um diese Aufgabe zu erfüllen,
besitzen Adapterproteine oftmals viele verschiedene Proteindomänen zur koordinierten Interaktion mit
Proteinen, Lipiden oder Nukleinsäuren. Diese Arbeit behandelt die Identifizierung und ausführliche
Beschreibung eines potentiellen Adapterproteins. Das Protein beinhaltet zwei Domänen, einen WD-
repeat Propeller und eine FYVE Domäne, und wurde daher als ProF bezeichnet. Die FYVE Domäne
ermöglicht die Bindung von ProF an interne Vesikel, während die WD-repeats für die Wechselwirkung mit
anderen Proteinen verantwortlich sind. ProF interagiert mit verschiedenen Proteinen, was in Adipozyten
(Fettzellen) und anderen Zellsystemen demonstriert werden konnte. Unter diesen Interaktionspartnern
sind zwei Kinasen, Akt und PKC￿, und VAMP2, ein Protein, welches an der Fusion von Vesikeln mit
ihren Zielmembranen beteiligt ist. Überexpression und Knockdown von ProF zeigten, dass das Protein
die Differenzierung von Präadipozyten und Glukoseaufnahme in Adipozyten reguliert. Des Weiteren
mag ProF eine allgemeinere Rolle in einer Vielzahl von Vesikeltransport- Prozessen - in Adipozyten wie
auch in anderen Zellsystemen - spielen und mit zahlreichen anderen Proteinen interagieren. Adaptor
proteins are essential components of many signal transduction pathways. Although not enzymatically
active themselves, they can recruit important signaling components such as protein kinases to protein
complexes or to specific subcellular locations in response to an activating signal. To perform this task,
adaptor proteins often contain several different domains for coordinated protein-protein, protein-lipid,
or protein-nucleic acid interaction. In this thesis the identification and extensive characterization of one
potential adaptor protein is described. The protein contains two domains, a WD-repeat propeller and
a FYVE domain, designated as ProF. The FYVE domain allows the interaction of ProF with internal
vesicles, whereas the WD-repeats provide a protein- protein interaction platform. ProF interacts with
several proteins as demonstrated in adipocytes (fat cells) and other cellular systems. Among these
interaction partners are two protein kinases, Akt and PKC￿, and VAMP2, a protein involved in fusion of
vesicles with their target membranes. Overexpression and knock down of ProF showed that the protein
regulates differentiation of pre-adipocytes and glucose uptake in adipocytes. Furthermore, ProF may be
more generally involved in a variety of vesicular trafficking processes in adipocytes or other tissues and
may bind to numerous other signaling proteins.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-163395
Dissertation
Published Version
Originally published at:
Fritzius, Thorsten. Propeller protein containing a FYVE domain, ProF : an adaptor for kinases involved
in glucose uptake in adipocytes. 2006, University of Zurich, Faculty of Science.
2
Propeller Protein Containing a FYVE Domain, ProF:
 An Adaptor for Kinases Involved in Glucose Uptake in
Adipocytes
Dissertation
zur
Erlangung der naturwissenschaftlichen Doktorwürde
(Dr. sc. nat.)
vorgelegt der
Mathematisch-naturwissenschaftlichen Fakultät
der
Universität Zürich
von
Thorsten Fritzius
aus
Deutschland
Promotionskomitee
Prof. Dr. Karin Moelling, Zürich (Leitung der Dissertation)
Prof. Dr. Ernst Hafen, Zürich
Zürich, 2006
2Table of contents
1 Summary ........................................................................................................... 3
2 Zusammenfassung ............................................................................................. 5
3 Introduction ....................................................................................................... 8
3.1 Signal transduction and adaptor proteins .................................................... 8
3.2 WD-repeat proteins .................................................................................. 10
3.2.1 Distribution and structure of WD-repeats.......................................... 10
3.2.2 Function of WD-repeat proteins........................................................ 13
3.2.3 WD-repeat proteins and signal transduction...................................... 14
3.2.4 Additional functional domains of WD-repeat proteins ...................... 15
3.3 FYVE domains......................................................................................... 16
3.3.1 Sequence and structure of FYVE domains ........................................ 16
3.3.2 FYVE binding to phosphoinositides ................................................. 18
3.3.3 The functions of FYVE proteins ....................................................... 18
3.4 The serine-threonine kinases Akt and PKCζ/λ ......................................... 21
3.4.1 Akt ................................................................................................... 21
3.4.2 Atypical PKC (aPKC)....................................................................... 30
3.4.3 Akt and aPKC- regulating proteins ................................................... 35
3.5 Insulin-dependent GLUT4 translocation and glucose uptake .................... 37
3.5.1 Structure and function of the glucose transporter 4, GLUT4 ............. 37
3.5.2 The intracellular GLUT4 storage compartment ................................. 38
3.5.3 Activation of GLUT4 translocation................................................... 39
3.5.4 The role of Akt and PKCζ/λ in insulin-dependent glucose uptake..... 40
3.5.5 Fusion of GLUT4 with the plasma membrane................................... 42
3.6 Aim of this thesis ..................................................................................... 45
4 Results ............................................................................................................. 47
4.1 WD-FYVE protein binds the kinases Akt and PKCζ/λ and regulates glucose
uptake in adipocytes............................................................................................. 48
4.2 WD-FYVE protein binds VAMP2 and PKCζ and increases PKCζ-
dependent phosphorylation of VAMP2 ................................................................ 70
4.3 WD-FYVE protein regulates differentiation of preadipocytes and glucose
uptake in adipocytes............................................................................................. 87
5 Discussion ..................................................................................................... 107
6 References ..................................................................................................... 120
7 Appendix ....................................................................................................... 142
7.1 Abbreviations......................................................................................... 142
7.2 Acknowledgements ................................................................................ 145
7.3 Curriculum vitae .................................................................................... 146
7.4 Statement of contribution ....................................................................... 148
31 Summary
Adaptor proteins are essential components of many signal transduction pathways.
Although not enzymatically active themselves, they can recruit important signaling
components such as protein kinases to protein complexes or to specific subcellular
locations in response to an activating signal. To perform this task, adaptor proteins
often contain several different domains for coordinated protein-protein, protein-lipid,
or protein-nucleic acid interaction.
In the first part of my thesis we identified and extensively characterized one potential
adaptor protein. It contains two domains, a WD-repeat propeller and a FYVE domain,
designated as ProF. We found that WD-repeats provided a protein- protein interaction
platform, whereas the FYVE domain allowed interaction of ProF with internal
vesicles. Two interaction partners of ProF were identified and investigated, the serine-
threonine kinases Akt and PKCζ. ProF was found to preferentially interact with the
activated kinases upon growth factor stimulation. We further demonstrated the
interaction with ectopically expressed and endogenous proteins. Because activated
Akt and the protein kinase C ζ, PKCζ, play an important role in insulin-stimulated
translocation of the glucose transporter GLUT4 in adipocytes, we used adipocytes as
a model system to study the function of ProF. We found that ProF translocated to the
plasma membrane upon insulin stimulation, parallel to the kinases Akt2 and PKCζ/λ,
and GLUT4. Overexpression of ProF led to increased glucose uptake, while
knockdown of ProF by siRNA caused reduced glucose uptake. In summary, we
concluded that ProF acts as an interaction partner of kinases and regulates glucose
uptake into adipocytes.
Because ProF interacted with several proteins, we assumed that it could
simultaneously bind to additional proteins. In that way, adaptor proteins can bring
together kinases and their substrates. We searched for such substrate candidates and
found in the second part of my thesis the membrane protein VAMP2 as interaction
partner of ProF in vitro and in vivo. We further investigated the interaction of ProF,
VAMP2, and PKCζ. We were able to show that these proteins colocalized on
vesicular structures and demonstrated that ProF, VAMP2, and PKCζ form a ternary
complex, in which ProF increases the binding of VAMP2 to PKCζ. Furthermore, we
4found an IGF-1 stimulation- and PKCζ-dependent phosphorylation of VAMP2.
Finally, we showed that ProF could recruit activated PKCζ to VAMP2 to increase
phosphorylation of VAMP2 as substrate in vitro. These results further strengthened
our hypothesis, that ProF can act as adaptor protein to integrate a kinase with its
substrate. It further corroborated the assumption that ProF is involved in vesicle
cycling, since VAMP2 is known to regulate vesicle docking and fusion.
The third part of my thesis focused on the question whether ProF, which plays a role
in stimulation-dependent glucose uptake in adipocytes, also influences the generation
of new adipocytes from undifferentiated pre-adipocytes, a process designated as
adipogenesis. We found that knock down of ProF also influenced adipocyte
differentiation, because protein and lipid droplet accumulation were delayed in
adipocyte precursor cells. The effects of ProF knock down on protein accumulation
and glucose uptake were limited to the first days of differentiation. ProF did not
influence the growth rate of the cells, but influenced the expression of several
adipocyte differentiation-related marker proteins. By using two different siRNAs
targeted against ProF mRNA we found that complete downregulation of ProF
strongly influenced glucose uptake and adipogenesis, whereas partial downregulation
had much weaker effects. Together, these data indicate that ProF influences both,
adipogenesis of pre-adipocytes and glucose uptake of adipocytes.
In conclusion, we characterized a new adaptor protein, which interacts with several
proteins as demonstrated in pre-adipocytes and other cellular systems, such as brain
tissue. Among these interaction partners are two kinases, Akt and PKCζ, and the
protein VAMP2, which is involved in fusion of vesicles with their target membranes.
Overexpression and knock down of ProF showed that it regulates differentiation of
pre-adipocytes and glucose uptake in adipocytes. Furthermore, ProF may be more
generally involved in a variety of vesicular trafficking processes, not only in
adipocytes but also in other tissues and may bind to numerous other signaling
proteins. Further research will shed light on the additional functions and interaction
partners of this protein.
52 Zusammenfassung
Adapterproteine sind wesentliche Bestandteile zahlreicher Signalwege. Obwohl selbst
nicht enzymatisch aktiv, können sie wichtige Proteine wie zum Beispiel
Proteinkinasen nach deren Aktivation zu Proteinkomplexen oder zu bestimmten
subzellulären Bereichen rekrutieren. Um diese Aufgabe zu erfüllen, besitzen
Adapterproteine oftmals viele verschiedene Proteindomänen zur koordinierten
Interaktion mit Proteinen, Lipiden oder Nukleinsäuren.
Der erste Teil meiner Arbeit behandelt die Identifizierung und ausführliche
Beschreibung eines potentiellen Adapterproteins. Es beinhaltet zwei Proteindomänen,
einen WD-repeat Propeller und eine FYVE Domäne, und wurde daher als ProF
bezeichnet. Wir stellten fest, dass die WD-repeats für die Wechselwirkung mit
anderen Proteinen verantwortlich sind, während die FYVE Domäne die Bindung von
ProF an interne Vesikel ermöglicht. Zwei Bindungspartner von ProF, die Serin-
Threonin Kinasen Akt und PKCζ  wurden identifiziert und untersucht. Hierbei
interagiert ProF bevorzugt mit den aktivierten Kinasen nach Wachstumsfaktor-
Stimulation. Wir zeigten diese Bindung mit ektopisch überexprimierten und mit
endogenen Proteinen. Da die aktivierten Kinasen Akt und PKCζ eine bedeutende
Rolle  in der insulinabhängigen  Translokation des Glukosetransporters GLUT4 in
Adipozyten spielen, benutzten wir Adipozyten als ein Modellsystem, um die
biologische Funktion von ProF zu untersuchen.  Wir stellten fest, dass ProF nach
Insulin-Stimulation an die Plasmamembran translozierte, parallel mit den Kinasen Akt
2 und PKCζ/λ und mit GLUT4. Überexpression von ProF bewirkte eine erhöhte
Glukoseaufnahme, während der Knockdown von ProF durch siRNA zu einer
verminderten Glukoseaufnahme führte. Wir folgern daher, dass ProF die
Glukoseaufnahme in Adipozyten reguliert und als Interaktionspartner von Kinasen
fungiert.
Weil ProF mit verschiedenen Proteinen interagiert, vermuteten wir, dass es
gleichzeitig mit weiteren Molekülen interagieren kann. Auf diese Weise können
Adapterproteine Kinasen und deren Substrate zusammenführen. Im zweiten Teil
meiner Arbeit suchten wir nach solchen potentiellen Substraten und entdeckten das
Membranprotein VAMP2 als Interaktionspartner von ProF in vitro und in vivo. Wir
6untersuchten die Interaktion zwischen ProF, VAMP2 und PKCζ genauer und konnten
zeigen, dass diese drei Proteine auf vesikulären Strukturen kolokalisierten. Wir
wiesen nach, dass ProF, VAMP2 und PKCζ einen Dreifach-Komplex ausbilden und
dass ProF die Bindung von VAMP2 an PKCζ verstärkt. Des Weiteren stellten wir
eine Phosphorylierung von VAMP2 fest, welche abhängig von IGF-1 Stimulation und
PKCζ ist. Schliesslich zeigten wir, dass ProF aktiviertes PKCζ mit VAMP2
zusammenführen kann, um die VAMP2- Substratphosphorylierung in vitro zu
verstärken. Diese Resultate bestätigten unsere Vermutung, dass ProF als
Adapterprotein agiert, um eine Kinase und ihr Substrat zusammenzubringen. Zudem
bekräftigten sie unsere Hypothese, dass ProF an vesikulären Prozessen beteiligt ist, da
VAMP2 als ein Regulator solcher Prozesse gilt.
Der dritte Teil meiner Arbeit konzentrierte sich auf die Frage ob das Protein ProF,
welches eine Rolle in der Insulin-abhängigen Glukoseaufnahme in Adipozyten spielt,
auch einen Einfluss auf die Erzeugung neuer Adipozyten aus undifferenzierten
Präadipozyten hat – ein Vorgang, der als Adipogenese bezeichnet wird. Wir stellten
fest, dass der Knockdown von ProF in der Tat die Differenzierung der Adipozyten
beeinflusst, da die Akkumulation von Protein und Fetttröpfchen in Zellen mit ProF
Knockdown verzögert war. Die Auswirkungen von ProF Knockdown auf die
Akkumulation von Protein und Fetttröpfchen waren auf die ersten Tage der
Differenzierung beschränkt. Der Knockdown von ProF hatte keinen Einfluss auf die
Wachstumsgeschwindigkeit der Zellen, sondern beeinflusste die Expression
verschiedener für die Adipozyten-Differenzierung verantwortlicher Proteine. Indem
wir zwei verschiedene siRNAs benutzten, die unterschiedliche Sequenzbereiche der
ProF mRNA angriffen, stellten wir fest, dass eine vollständige Repression der ProF-
Expression Glukoseaufnahme und Adipozyten- Differenzierung stark beeinflusste,
während eine teilweise Repression viel geringere Effekte erzielte.  Gesamthaft deuten
diese Daten darauf hin, dass ProF sowohl den Prozess der Adipogenese von
Präadipozyten als auch die Glukoseaufnahme in Adipozyten beeinflusst.
Zusammenfassend lässt sich sagen, dass ein neu entdecktes Adapterprotein
charakterisiert wurde, dessen Interaktion mit verschiedenen Proteinen in
Präadipozyten und anderen Zellsystemen wie Gehirngewebe demonstriert werden
konnte. Unter diesen Interaktionspartnern sind zwei Kinasen, Akt und PKCζ, und das
Protein VAMP2, welches an der Fusion von Vesikeln mit ihren Zielmembranen
7beteiligt ist. Überexpression und Knockdown von ProF zeigten, dass das Protein die
Differenzierung von Präadipozyten und Glukoseaufnahme in Adipozyten reguliert.
Des Weiteren mag ProF eine allgemeinere Rolle in einer Vielzahl von
Vesikeltransport- Prozessen haben – in Adipozyten wie auch in anderen Zellsystemen
spielen und mit zahlreichen anderen Proteinen interagieren. Weitere Untersuchungen
werden Aufschluss geben über die zusätzlichen Funktionen und Interaktionspartner
von ProF.
83 Introduction
3.1 Signal transduction and adaptor proteins
A fundamental quest in biology is to understand the dynamic nature of the cell. The
activity and subcellular localization of proteins within a cell is constantly modified in
response to internal cues or external signals. These adjustments are performed by
signaling molecules such as kinases and phosphatases. The regulation of these
molecules strongly depends on interacting proteins and their binding to numerous
signaling enzymes (Du and Tsichlis, 2005).
Protein-protein interaction can induce conformational changes to stabilize, destabilize,
or alter the enzymatic properties of a signaling enzyme (Goh et al., 2004). Interacting
proteins can also contribute to the formation of large protein complexes and thus
allowing the coordinate response of multiple molecules to incoming signals (Stagljar,
2003). Finally, some proteins function as cellular anchors to recruit their binding
partners to specific cellular structures. They may also facilitate the transport of their
partners between cellular compartments (Fowler and Alarid, 2004).
To accomplish these diverse functions “adaptor proteins” have evolved. Adaptor
proteins allow the formation of signaling complexes by binding their partner proteins
either constitutively or in a signal-dependent manner (Kuriyan and Cowburn, 1997;
Pawson and Scott, 1997).
Such adaptor proteins are important components of many signal transduction
pathways. They usually are devoid of any intrinsic enzymatic activity themselves, but
instead mediate specific protein-protein interactions, to relay important signaling
events. Much of the specificity and effectiveness of signal transduction depends on
the recruitment of signaling components such as protein kinases into short-lived
active complexes in response to an activating signal such as binding of a growth
factor to its receptor. A multitude of diverse interaction domains is found within
adaptor proteins. These domains facilitate a rich diversity of specific and coordinated
protein-protein, protein-lipid, or protein-nucleic acid interactions to occur within the
cell during signal transduction. For example, while WD-repeats allow either stable or
reversible binding to proteins and in some cases can also serve in phospho-peptide
recognition of activated kinases, FYVE domains binds to phospholipids, present on
9cellular membranes. Of special importance are so called “multidomain proteins”, in
which several different modules cooperate to integrate diverse external or internal
signals. In that way, they contribute to cellular responses such as changes in enzyme
activity, gene expression or other activities.
One putative adaptor protein is a newly identified protein that was found by members
of our institute as interacting protein of Akt - a serine-threonine kinase, which plays a
key role in multiple signaling pathways. This newly identified protein contains seven
WD-repeats, folding into a β-propeller, and a FYVE domain, and was designated as
ProF. The multidomain structure of ProF with a protein-interacting module and a
membrane-localization domain makes it an ideal adaptor protein- candidate. Thus,
ProF may regulate external signals by recruiting key signaling molecules to distinct
cellular locations. The characterization of ProF will be the topic of this thesis. Its
structure, its interaction partners and the model system, in which a possible
physiological role of ProF was studied, will be addressed in this introduction.
In the first part, the domains of ProF - WD-repeats and FYVE domain - will be
discussed in more detail. I will describe their structure and function with special
emphasis on signal transduction.
In the second part, I will introduce the interacting partners of ProF, the serine-
threonine kinase Akt, as well as the atypical protein kinase C isoform PKCζ, which
was also found as a binding partner of ProF and further investigated during this thesis.
In the third part, the insulin-dependent glucose uptake in adipocytes will be applied as
a model system in which the two interaction partners of ProF, Akt and PKCζ, play a
key role.
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3.2 WD-repeat proteins
3.2.1 Distribution and structure of WD-repeats
WD-repeat proteins, also known as WD40-repeat or Trp-Asp repeat proteins, form a
large and structurally highly conserved protein family in eukaryotes. Only recently,
WD-repeat proteins have been found in prokaryotes (Stoytcheva et al., 2000), in
which, however, they appear to be extremely rare (Madrona and Wilson, 2004). WD-
repeats are widely distributed in many hundreds of eukaryotic proteins, comprising a
significant percentage of their proteome. Each WD-repeat contains about 40 amino
acids, hence the synonym WD40-repeat, but the total number of amino acids can rise
up to 60 amino acids per repeat (Anderson and Parker, 1998). The name WD-repeat is
derived from a weakly conserved Trp (W)-Asp (D) dipeptide found at the C-terminal
end of the consensus sequence. Typically, a Gly (G)-His (H) dipeptide is found
between the N-terminus and the WD-dipeptide. However, neither the GH nor the WD
motif is absolutely conserved, and the whole WD-motif shows very limited amino
acid sequence conservation (Neer et al., 1994). WD-repeats within a polypeptide are
usually not more similar to each other than they are to repeats in other WD-repeat
proteins. Furthermore, the sequences can contain large insertions, which complicate
their identification on the basis of sequence information alone.
Known WD-repeat proteins range in size from small proteins (ca. 33 kDa) such as the
pleiotropic plant developmental regulator VIP3 (Zhang et al., 2003) to large (>400-
kDa) proteins such as the mammalian protein trafficking factor Lyst (van Nocker and
Ludwig, 2003). WD-repeat containing proteins mostly have four – eight copies of the
WD-repeat motif, but up to 16 copies can be found in a single protein (Smith et al.,
1999): see GenBank D63999).
The WD-repeat propeller structure creates a stable and probably very rigid platform
for protein interactions. Up to date (2006) seven WD-repeat containing proteins were
analyzed by X-ray crystallization and structure determination:
• The β-subunit of the cell-signaling G protein transducin (Sondek et al., 1996; Wall
et al., 1995).
• A fragment of the Tup1p corepressor protein (Sprague et al., 2000),
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• The p40 subunit of the Arp2/3 complex (Robinson et al., 2001),
• A domain of the Groucho/TLE1 corepressor protein (Pickles et al., 2002)
•  The actin-interacting protein Aip1p, a regulator of depolymerization of actin
filaments (Voegtli et al., 2003),
• The small protein Ski8p, a regulator of degradation of damaged mRNA (Cheng et
al., 2004; Madrona and Wilson, 2004),
• Sif2p, a component of the Set9 complex (SET3C), responsible for the repression
of a set of meiotic genes (Cerna and Wilson, 2005).
Taken together, these data allow several conclusions about the general structure and
function of WD-repeat proteins. Seven WD-repeats form a highly symmetric β-
propeller structure. The only exception known to date is the structure of Sif2p, which
revealed an eight-bladed propeller (Cerna and Wilson, 2005). It has been speculated
for a long time whether proteins with more than eight WD domains will form one big
propeller or two small ones. In the case of Aip1p, a WD-repeat protein that regulates
cofilin-mediated depolymerization of actin filaments (Konzok et al., 1999; Ono,
2001) X-ray crystallization and structure analysis was performed and the protein was
found to contain 14 WD-repeats, which fold into two connected seven-bladed β-
propellers (Voegtli et al., 2003).
Each WD-repeat is made up of a small antiparallel β-sheet consisting of four short β-
strands (Fig.1). These strands are labeled A, B, C and D by convention, beginning
with the strand closest to the center and ending with the outside strand. However, one
repeat in the amino acid sequence does not coincide with one structural WD-repeat
propeller blade. The order of the strands in the WD-repeat amino acid sequence is D-
A-B-C, such that one sequence repeat composes the D strand of one blade and the A,
B, C strand of the succeeding blade, causing an overlapping structure (Fig.1). This
structural feature is conserved among all β-propeller proteins and is believed to be
very important for protein stability (Jawad and Paoli, 2002; Neer et al., 1994).
The loops connecting the individual strands are designated by the two strands they
connect (e.g. the A-B loop connects strands A and B). By convention, the “top” of the
protein is defined by the surface that contains the D-A and B-C loop. In general, the
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existence of well-ordered blades with large or disordered D-A loops and C-D turns
suggest that it is possible to maintain the blade structure despite large variations in the
traditional WD-repeat pattern. Protein-protein interactions with WD-repeat proteins
are often mediated by contacts with the variable regions composed of the “top”,
“bottom” and, to a lesser extend, sides of the protein. It is assumed that the binding of
interacting proteins to exposed loop- like regions of WD-repeat proteins would allow
modulation of protein-binding properties without significant perturbation of the core
structure.
Structures of the Gβ protein (Loew et al., 1998; Wall et al., 1995), p40 (Robinson et
al., 2001), and Cdc4 (Orlicky et al., 2003) in complex with partner proteins or
peptides demonstrate full or partial involvement of the loops in binding. In the case of
the WD-repeat protein β-TrCP1 is has been shown that all seven WD-repeats
Fig. 1A: Schematic model of a WD-repeat propeller, containing seven propeller blades. Each of the
blades (numbered 1 – 7 in the central circle) is formed by a small anti-parallel β-sheet consisting of
four short β-strands, indicated as arrows. The strands are labeled A, B, C, and D, beginning with the
strand, which is closest to the center of the propeller. Note that a single WD-sequence repeat
(indicated in the structure as arrows of identical color) comprises the D strand of one blade and A, B,
and C strand of the following blade. Therefore, one repeat in sequence does not coincide with one
structural repeat or blade. For further details see text.
Fig. 1B: Crystal structure of the yeast protein Ski8p, a regulator of mRNA degradation, as determined
by (Cheng et al., 2004). Ski8p shows the characteristical seven-bladed β-propeller structure of a WD-
repeat protein, as depicted in a ribbon diagram. Each blade consists of a four-stranded β-sheet (labeled
A–D to the right). The view is looking down the central axis of the propeller onto the "top" surface,
defined by the presence of the D–A loops connecting sequential blades. The N- and C-terminus of the
protein are denoted to the left. For further details see text.
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contribute to contacts to β-catenin. Two thirds of the contacts involve the A strand
and the rest involves B-C loops (Wu et al., 2003).
3.2.2 Function of WD-repeat proteins
WD-repeats do not possess any catalytic activity (Neer et al., 1994). Instead, WD-
repeat proteins form a recognition module for linking partner proteins in intracellular
networks of signaling and sorting. The common function of all WD-repeat proteins is
the coordination of complex multiprotein assembly in an multitude of cellular systems
(Li and Roberts, 2001; Smith et al., 1999) by specifically binding to one or more
partner proteins. This is often done to present a protein substrate molecule to an
enzyme such as a kinase or ubiquitin ligase.
WD-repeat proteins are involved in a diverse range of physiological processes, which
can be roughly categorized into ten groups (modified after (Neer et al., 1994; van
Nocker and Ludwig, 2003; Yu et al., 2000)):
• Signal transduction (Clapham and Neer, 1997; McCahill et al., 2002)
•  RNA synthesis, degradation and processing such as splicing and export
(Harnpicharnchai et al., 2001; Ohnacker et al., 2000; Saveanu et al., 2003)
• Chromosomal modifications such as chromatin assembly (Martinez-Balbas et al.,
1998; Tyler et al., 1996).
• Vesicular trafficking (Rybakin and Clemen, 2005).
• Transcriptional regulation and repression (Chen and Courey, 2000).
• Protein degradation (Brunson et al., 2005).
• Cytoskeletal assembly and dynamics (Voegtli et al., 2003).
•  Cell cycle control and regulation, such as mitotic spindle formation (Li and
Roberts, 2001; Smith et al., 1999).
• Apoptosis (Benedict et al., 2000; Lauber et al., 2001).
• Unknown functions
Because mediation of signal transduction is an important aspect of the function of
WD-repeat proteins in general and of the protein characterized in this thesis in
particular, I will now focus mainly on the role of WD-repeat proteins in signal
transduction.
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3.2.3 WD-repeat proteins and signal transduction
A growing number of WD-repeat proteins is known to be involved in signal
transduction. For brevity, I will restrict this introduction to the best characterized
proteins, the receptors for activated C kinases (RACKs).
3.2.3.1 RACK proteins
RACK proteins, which are entirely made up of WD-repeats are required for the
function of protein kinase C (PKC). Up to now, two RACK proteins have been
identified, RACK1, a binding partner for activated PKCβII and RACK2, a binding
partner for activated PKCε.
3.2.3.1.1 RACK1
RACK1 is a cytosolic 36-kDa protein, which is highly conserved in animals and
plants (McCahill et al., 2002). As member of the WD-repeat family of proteins,
RACK1 is predicted to fold into a β-propeller-like structure, comprising seven WD-
repeats (Ron et al., 1994). These findings are in agreement with data recently obtained
from cryo-electron microscopy (Sengupta et al., 2004).
RACK1 has several independent protein-binding sites and can simultaneously interact
with a number of signaling molecules (Rodriguez et al., 1999). This allows RACK1 to
integrate inputs from distinct signaling pathways.
RACK1 interacts selectively and saturable with activated PKCβII (Ron et al., 1994)
by binding to the C2 domain of PKCβII. RACK1 also shuttles activated PKCβII to its
correct cellular localization (Ron et al., 1999). The antagonist peptide βC2-4, which
corresponds to amino acids 218 –226 of PKCβII, can compete with PKCβII for
binding and inhibits phorbol ester-induced translocation of PKCβII in cardiac
myocytes, and insulin-induced PKCβII translocation and function in Xenopus oocytes
(Ron et al., 1995). RACK1 does not appear to be a PKC substrate itself, but facilitates
the interaction of PKCβII with its substrates and thus increases PKCβII substrate
phosphorylation by several-fold (Schechtman and Mochly-Rosen, 2001).
Recently it has been found that RACK1 also binds to activated PKCδ (Rosdahl et al.,
2002) and PKCµ (Hermanto et al., 2002). Besides activated isozymes of PKC
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RACK1 has many other binding partners, including β1, β2, β3, and β5 integrins
(Buensuceso et al., 2001; Liliental and Chang, 1998), the common β-chain of the
interleukin-5 (IL-5) receptor (Geijsen et al., 1999), phospholipase C-γ (Chang et al.,
2001), β-spectrin and dynamin (Rodriguez et al., 1999); the protein tyrosine
phosphatase PTPµ (Mourton et al., 2001), the Src- kinase  (Chang et al., 2001; Chang
et al., 1998; Chang et al., 2002a; Miller et al., 2004), and a phosphodiesterase isoform
(Yarwood et al., 1999). Some of these interactions are mutually exclusive and some
are concurrent. This suggests that RACK1 may act as a scaffolding protein, recruiting
proteins to various transmembrane receptors and providing a platform for
protein–protein interactions. Much remains unknown concerning the functional role
of RACK1; however, in vivo studies have indicated that RACK1 is upregulated in
human carcinomas and during tissue regeneration after ischemic renal injury (Berns et
al., 2000; Padanilam and Hammerman, 1997), suggesting a role of RACK1 in proto-
oncogenic signaling events.
3.2.3.1.2 RACK2
RACK2, also known as β’-coatomer protein (COP), is a part of the coatomer complex
(Harrison-Lavoie et al., 1993; Stenbeck et al., 1993). It binds to activated PKCε
selectively and saturable (Csukai et al., 1997a; Csukai et al., 1997b). It is not a PKC
substrate itself, but increases PKCε substrate phosphorylation by several-fold and is
likely to be involved in vesicular release and cell- cell communication.
These findings of a second receptor for activated C kinases led to the assumption that
PKC isoform specificity is guided by interactions with a family of RACK proteins.
Those proteins display specific and saturable binding only to the activated
conformation of PKC isoforms and act as targeting signals (Mochly-Rosen and
Gordon, 1998). More generally, other WD-repeat proteins could, by preferentially
binding to activated kinases, play a key role in signal transduction.
3.2.4 Additional functional domains of WD-repeat proteins
WD-repeat containing proteins often have additional functional domains. Some of
these additional motifs are zinc-binding motifs, actin-binding motifs, F-boxes, leucine
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zippers, (Src homology-3) SH3 domains binding to proline rich sequences, BROMO
domains as found in chromatin-associated proteins, or the catalytic domains of
kinases. Such associated protein domains can determine the subcellular localization of
the protein by binding to specific compartments. There the WD-repeats can bring
together interacting partners at their correct site of action.
3.3 FYVE domains
Numerous cellular processes such as signal transduction, vesicle trafficking, and
cytoskeletal rearrangement require the targeting of proteins to subcellular membranes.
Membrane targeting is largely achieved by specific recognition of particular
membrane lipids by proteins. A diverse group of such membrane-targeting domains,
which specifically recognize different types of membrane lipids, have been identified.
One of these motifs is the FYVE domain, which shows high specificity and affinity
exclusively for phosphatidylinositol 3-phosphate (PI3P) and will be discussed in
detail.
3.3.1 Sequence and structure of FYVE domains
FYVE domains are short (70-80 residues long) sequence motifs named after the four
proteins Fab1p, YOTB, Vac1p, and EEA1, in which this domain was originally
observed (Stenmark et al., 1996). Database searches revealed that the human
proteome contains 27 FYVE proteins (Stenmark et al., 2002). For Caenorhabditis
elegans 13 FYVE proteins were reported, while in Saccharomyces cerevisiae 5 FYVE
domains were identified (Stenmark et al., 1996).
FYVE domains contain eight conserved zinc-coordinating cysteines (Stenmark et al.,
2002) to form a zinc-finger like structure (Misra and Hurley, 1999) and a highly
conserved, basic (R/K)-(R/K)-H-H-C-R sequence surrounding their third cysteine
(Fig. 2). The crystal structures of FYVE domains revealed their great similarity to the
C1 domain of PKC and the cysteine-rich region of rabphilin 3A (Kutateladze et al.,
1999; Misra and Hurley, 1999). FYVE domains additionally contain a long loop at the
N-terminus, two short antiparallel ß-sheets (ß-2 and ß-3) and a C-terminal α-helix, α-
1, as seen in Fig. 2. The PI3P-binding site is formed by the basic residues in the
conserved (R/K)-(R/K)-H-H-C-R sequence, which fold into a shallow, positively
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charged pocket that dominates the surface of the FYVE domain. Side-chains from this
motif largely account for the binding between the PI3P head group and the FYVE
domain as demonstrated in the case of the FYVE-protein EEA1 crystallized in
complex with phosphoinositide (Dumas et al., 2001). Importantly, the structure
furthermore contains a prominent hydrophobic protrusion (Fig. 2) that allows the
domain to penetrate the membrane bilayer (Misra and Hurley, 1999).
It is important to note that, because of the relatively shallow PI3P-binding pocket and
a single phosphate interaction, isolated FYVE domains are in the most cases
insufficient for membrane localization and require adjacent sequences that interact
with other proteins or allow dimerization for efficient membrane recruitment (Dumas
et al., 2001; Lawe et al., 2000). However, there is a small number of FYVE-
containing proteins that have been reported to autonomously translocate to endosomal
membranes when expressed ectopically (Ridley et al., 2001; Seet and Hong, 2001;
Tsukazaki et al., 1998). The increased endosomal targeting properties of these
proteins can be partly attributed to their unique structure. The FYVE domain of
endofin has a strongly positively charged membrane-binding surface, which greatly
enhances its affinity for PI3P-containing vesicles (Blatner et al., 2004). Another
highly interesting FYVE-containing protein, which will be dealt with in greater detail
below, is the FYVE-domain containing protein localized to endosomes-1 (FENS-1).
The structural feature that determines the high membrane affinity of the FYVE
*  = hydrophobic protrusion
* Fig. 2: The crystal structure of the FYVE domain
of the yeast protein vsp27p is depicted, as
determined by (Misra and Hurley, 1999) and
discussed by (Corvera, 2000). The cysteine
residues and a single histidine residue involved in
the coordination of two Zn++ atoms (Zn1 and Zn2
in light green) are highlighted in green. The highly
conserved positive residues in the ß1 strand,
involved in PI3P binding, are depicted in blue. The
amino acids that comprise the other three ß-sheets
(ß2 - ß-4) and the C-terminal α1-helix are depicted
by red arrows and a red helix (left). The
hydrophobic protrusion that allows membrane
penetration is indicated to the top right. For further
details see text.
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domain of FENS-1 is a unique 11-amino acid insertion next to the conserved (R/K)-
(R/K-)H-H-C-R sequence. This motif forms an extended turret loop rich in aromatic
side chains, resulting in a high membrane penetration power (Blatner et al., 2004).
3.3.2 FYVE binding to phosphoinositides
FYVE domains localize several proteins that participate in vacuolar sorting or
endocytosis to membranes by interacting with PI3P (Burd and Emr, 1998; Simonsen
et al., 1998; Stenmark et al., 1996). PI3P are generated from phosphatidylinositol by
specific isoforms of phosphatidylinositol 3-kinase (PI3K). Even though the levels of
PI3P within the cell are low, they play a key role in eukaryotic membrane trafficking
and are found in specific subcellular localizations, including the cytoplasmic face of
early endosomes and internal vesicles of multivesicular bodies (Stenmark and
Gillooly, 2001). A large body of work has shown that PI3P is involved in the
regulation of trafficking in the early endocytic pathway (Corvera, 2000) as well as in
Golgi/ vacuole sorting (Odorizzi et al., 1998) and appears to serve as a specific
marker for a subset of endosomes, the “early endosomes”. Only recently, it has been
found that PI3P is also generated in a stimulus-dependent fashion (Razzini et al.,
2000; Vieira et al., 2001; Zhang et al., 1998), including insulin-mediated formation of
PI3P at lipid raft subdomains of the plasma membrane (Maffucci et al., 2003).
3.3.3 The functions of FYVE proteins
3.3.3.1 FYVE domain proteins involved in membrane trafficking
The most extensively studied FYVE domain protein is the early endosome antigen 1
(EEA1), which serves as a good example for the main function of FYVE proteins, the
regulation of membrane trafficking.
EEA1 is a large coiled-coiled protein with a C-terminal FYVE domain (Mu et al.,
1995). This protein also contains two binding domains for the early-endosomal Rab5
in its active, GTP-bound state (Simonsen et al., 1998). Endosomal targeting of EEA1
requires both binding to PI3P and to Rab5-GTP. It has been proposed that this dual
binding requirement enables the very specific and regulated recruitment of EEA1 to
early endosomes (Lawe et al., 2000; Patki et al., 1997; Simonsen et al., 1998).
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EEA1 plays a key role in endosome fusion, since depletion of EEA1 inhibits, and
excess of EEA1 stimulates, this process in vitro (Christoforidis et al., 1999; Simonsen
et al., 1998). Endosome fusion also requires Rab5-GTP, which has to be present on
both membranes (Barbieri et al., 1998). Thus, EEA1 likely acts as a tether for two
Rab5-positive membranes (Rothman, 1994), and thereby drives membrane fusion.
The role of the FYVE domain and its interaction with PI3P is probably to concentrate
EEA1 at the correct subcellular location to participate in this process.
Another FYVE-domain-containing protein, which has been implicated in vesicular
trafficking, is Fab1p from yeast. This protein is a PI3P 5-kinase, i.e. it phosphorylates
PI3P to form phosphatidylinositol-(3,4)-biphosphate (PI(3,5)P2) (McEwen et al.,
1999). PI(3,5)P2 is a comparatively recently discovered phosphoinositide (Cooke et
al., 1998), for which there is at present no known effector. fab1 mutants have
morphological defects such as expanded vacuoles, indicating a role for PI(3,5)P2 in
vacuolar homoeostasis in yeast (Odorizzi et al., 1998). A mammalian ortholog of
Fab1p, termed PI3P 5-kinase containing a FYVE domain (PIKfyve) has been
identified (Sbrissa et al., 1999). This protein is able to produce both PtdIns5P and
PI(3,5)P2 in vitro and has been reported to play a role in the trafficking between the
late endosome and the lysosome (Ikonomov et al., 2001; Shisheva, 2001). More
recently it has been shown to be phosphorylated in 3T3-L1 adipocytes by the serine-
threonine kinase Akt in response to insulin (Berwick et al., 2004).
3.3.3.2 FYVE domain proteins involved in signal transduction
An example of a FYVE finger protein that is involved in a signaling cascade is the
Smad anchor for receptor activation, (SARA). This protein is responsible for the
recruitment of Smad2 and Smad3 to the transforming growth factor (TGF)-β receptor
upon receptor stimulation (Tsukazaki et al., 1998). These Smad proteins are then
phosphorylated and activated by the activated receptor kinase. The phosphorylation of
Smad2 and Smad3 enables them to bind Smad4 and to translocate to the nucleus,
where the complex controls the transcription of target genes. Since SARA is located
on early endosomes by binding to PI3P the role of SARA in the TGF-β signaling
cascade is probably to recruit molecules to early endosomes, to which the
receptor–ligand complex localizes upon endocytosis. SARA thus provides a potential
example of signaling not from the plasma membrane but from the endosomal
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membrane (Ceresa and Schmid, 2000). It also represents an example of a role for a
FYVE domain containing protein in a cell-signaling cascade.
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3.4  The serine-threonine kinases Akt and PKCζ/λ 
3.4.1 Akt
3.4.1.1 History of Akt
The serine-threonine Akt was initially identified as an oncogene transduced by the
AKT8 acute transforming retrovirus, which was isolated from an AKR mouse
thymoma in 1977, hence its name. This virus induced malignant transformation in the
mink lung epithelial cell line CCL-64 and tumor formation, specifically thymic
lymphoma, in nude mice (Staal et al., 1977). A decade later, its defective retrovirus
was identified from mink lung epithelial cells infected with AKT8 virus, and was
shown to contain a cell-derived protooncogenic sequence, which was termed Akt
(Staal and Hartley, 1988; Staal et al., 1988).
In the early 1990’s, sequence analysis of the Akt viral oncogene and its cellular
homolog revealed that it encodes a serine-threonine protein kinase, composed of a N-
terminal pleckstrin homology (PH) domain and a C-terminal kinase domain very
similar to that of PKC and PKA (Bellacosa et al., 1991). At the same time, Akt was
also cloned based on its homology with PKC or PKA by two additional groups, who
named it RAC (protein related to protein kinase A and protein kinase C) or PKB
(protein kinase B) (Coffer and Woodgett, 1991; Jones et al., 1991). To date, the
protein is most commonly named Akt/PKB, and will be referred to as Akt here.
3.4.1.2 Conservation of Akt
The Akt family of kinases is evolutionarily conserved in eukaryotes. Orthologs of Akt
were found in and cloned from a number of species including Drosophila and C.
elegans, demonstrating a wide evolutionary conservation (Franke et al., 1994).
Homologs were also found in the slime mould Dictyostelium (Meili et al., 1999) and a
protein isoform lacking the N-terminal PH domain was identified in Saccharomyces
cerevisiae (Jorgensen et al., 2004). The amino acid identity between C. elegans and
human Akt is around 60%, whereas that between mouse, rat and human it is more
than 95%. Akt shares a similarity in its catalytic domain with a group of kinases from
the large PKA, PKG, and PKC (AGC) superfamily of serine-threonine kinases that
consists of more than 80 kinases.
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3.4.1.3 Isoforms of Akt
Three major isoforms of Akt, encoded by three separate genes, have been identified in
mammalian cells (Fig. 3). Akt1 and Akt2 were the first isolated isoforms (Bellacosa et
al., 1991; Cheng et al., 1992; Coffer and Woodgett, 1991; Jones et al., 1991). Akt3
was subsequently cloned through homology screening (Konishi et al., 1995). While
Akt1 is the true human homolog of the v-akt, originally identified by Staal and
coworkers (98% identity at the amino acid level), Akt2 and Akt3 are v-akt closely
related kinases (Cheng et al., 1992; Nakatani et al., 1999a). The overall sequence
identity between these three Akt- isoforms is >85%. They share a very similar
structure and possess conserved threonine and serine residues (T308/S473 in Akt1,
T309/S474 in Akt2 and T305/S472 in Akt3) that together with the PH domain are
critical for Akt activation (Fig.3).
  
Fig. 3: The three mammalian Akt isoforms Akt1, Akt2, and Akt3 are depicted. All isoforms share a
highly similar structure with a N-terminal PH domain for binding to PIP3, a central kinase domain
(KINASE) and a C-terminal regulatory domain (RD). The essential threonine and serine residues
necessary for activation are indicated. For further details see text.
Although Akt1, Akt2, and Akt3 display high sequence homology, there are clear
differences between them in terms of biological and physiological function: First,
overexpression of wild type-Akt2, but not Akt1 and Akt3, transforms NIH 3T3 cells
and induces invasion and metastasis in human breast and ovarian cancer cells
(Arboleda et al., 2003; Cheng et al., 1997); second, the gene Akt2, but not Akt1 and
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Akt3, is frequently amplified in certain types of human cancer even though alterations
of all three isoforms of Akt have been detected in human malignancies (Bellacosa et
al., 1995; Cheng et al., 1992; Cheng et al., 1996; Miwa et al., 1996; Nakatani et al.,
1999b; Ruggeri et al., 1998; Yuan et al., 2000); third, Akt1 expression is relatively
uniform in various normal organs. High levels of Akt2 mRNA are also detected in
various tissues, usually at a lower level than Akt1 except in insulin- responsive
tissues, such as fat cells, liver and skeletal muscles. Akt3 is expressed at the lowest
level in most adult tissues except testes and brain (Brodbeck et al., 1999; Nakatani et
al., 1999a). Forth, Akt2, but not Akt1, plays an unique role in muscle differentiation
(Kaneko et al., 2002) and fifth, Akt1-, Akt2- and Akt3-deficient mice displayed
different phenotypes. Shortly, Akt1-/- knockout mice were found to be small and had
increased spontaneous apoptosis in the thymus (Chen et al., 2001; Cho et al., 2001b).
Furthermore,  it was found that Akt1 knockout restricted the development of the
placenta, leading to an impaired nutrient supply of the embryo. This may partially
explain the reduced size of Akt1-/- knockout mice (Cho et al., 2001b; Yang et al.,
2003). The phenotype of Akt2-/- knockout mice was more striking (Cho et al., 2001a;
Garofalo et al., 2003). Consistent with the high expression levels of Akt2 in insulin-
responsive organs and tissues, Akt2-/- knockout mice developed severe diabetes.
Insulin action was blocked in the absence of Akt2 and the mice were insulin resistant,
with hyperglycaemia, hyperinsulinaemia and glucose intolerance (Cho et al., 2001a).
Akt3-/- mutant mice did not show a growth retardation syndrome. In adult Akt3-/-
knockout mice, brain size and weight were dramatically reduced, which is caused, at
least partially, by a significant reduction in both cell size and cell number (Tschopp et
al., 2005), suggesting a critical role of Akt3 in the postnatal development of the
mammalian brain. Finally, double knockout mice of Akt1/2 died shortly after birth,
showing more obvious phenotypes than single knockout mice (Peng et al., 2003). The
mutant mice were much smaller than wild type, with impaired skin development,
skeletal muscle atrophy and abnormal bone development. Furthermore, the
differentiation of double knockout mouse embryonic fibroblasts into adipocytes was
blocked. This underscores the hypothesis that adipogenesis, the generation of new
adipocytes, is under the control of Akt (Peng et al., 2003).
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3.4.1.4 Domain structure of Akt
All three Akt isoforms consist of a conserved domain structure: an N-terminal PH
domain, a central kinase domain and a C-terminal serine-threonine rich regulatory
domain (RD) with a conserved hydrophobic motif (Fig. 3). The PH domain was
originally found in pleckstrin, the major phosphorylation substrate for PKC in
platelets (Tyers et al., 1988). The PH domain interacts with membrane lipid products
such as phosphatidylinositol-(3,4,5)-trisphosphate (PIP3), which is produced by class
I PI3K. Biochemical analysis revealed that the PH domain of Akt binds to both, PIP3
and phosphatidylinositol-(3,4)-bisphosphate (PIP2), with similar affinity (Frech et al.,
1997; James et al., 1996).
The kinase domain of Akt, located in the central region of the molecule, shares a high
similarity with other AGC kinases such as PKA, PKC, p70 S6 kinase (p70S6K) and
p90 ribosomal S6 kinase (p90RSK) (Peterson and Schreiber, 1999). A conserved
threonine residue (T308 in Akt1), whose phosphorylation is required for enzymatic
activation, is located in the activation loop of the kinase domain (Peterson and
Schreiber, 1999). The RD domain is  a C-terminal extension of around 40 amino
acids, in which the C-terminal serine (S473 in Akt1) resides. The RD domain
possesses the F-X-X-F/Y-S/T-Y/F hydrophobic motif (where X is any amino acid)
that is characteristic of the AGC kinase family (Peterson and Schreiber, 1999). For all
AGC family kinases, phosphorylation of the S or T residue in this hydrophobic motif
is necessary for full activation of the kinase. Deletion of this motif completely
abolishes enzymatic activity (Andjelkovic et al., 1997).
3.4.1.5 Activation of Akt
Akt is activated by a variety of stimuli, including growth factors such as platelet
derived growth factor (PDGF), insulin, epidermal growth factor (EGF), basic
fibroblast growth factor (bFGF) and insulin-like growth factor I (IGF-I), but also
protein phosphatase inhibitors and cellular stress (Burgering and Coffer, 1995; Franke
et al., 1995; Liu et al., 1998; Meier et al., 1997). Activation of Akt by these ligands is
PI3K-dependent (Burgering and Coffer, 1995; Cross et al., 1995; Franke et al., 1995;
Kohn et al., 1995) and blocked by the PI3K inhibitors wortmannin and LY294002, or
by the dominant negative form of class I PI3K (reviewed in (Chan et al., 1999)). This
class of PI3K forms heterodimeric enzymes consisting of a catalytic subunit and a
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regulatory subunit. The regulatory subunit contains Src homology 2 (SH2) domains in
their N- and C-terminal region to bind phosphotyrosine motifs of receptor tyrosine
kinases and their substrates, such as insulin receptor substrate-1 (IRS-1). Thereby
PI3K is targeted to the plasma membrane to access its substrates – the
phosphoinositides, which are anchored in the plasma membrane.
The production of phosphoinositides by PI3K is reversed by phosphoinositide
phosphatases. The phosphatase and tensin homolog deleted on chromosome 10
(PTEN) possesses 3’-phosphoinositide phosphatase activity, and activation of PTEN
results in inactivation of Akt (Maehama and Dixon, 1999; Stambolic et al., 1998).
Genetic alteration of the gene encoding PTEN has been found in nearly all types of
human cancers examined so far (Li et al., 1997; Risinger et al., 1997; Steck et al.,
1997; Tashiro et al., 1997), underscoring the role of PTEN as tumor suppressor, but
also of Akt as protooncogene.
Phosphorylation site mapping of Akt from quiescent cells and IGF-I stimulated cells
revealed a complex pattern (Alessi et al., 1996a). S124 and T450 in Akt1 are
constitutively phosphorylated and seem to contribute to the stabilization of Akt
protein. Phosphorylation of T308 and S473 in Akt1 is detected when cells are
stimulated, and can be completely blocked by the PI3K inhibitor wortmannin (Alessi
et al., 1996a). Point mutations at these sites with alanine (T308A and S473A for
Akt1) show little activity, even after insulin or IGF-I stimulation, and the
phosphorylation-mimicking mutant (T308D/S473D) shows constitutive kinase
activation. There, these two sites are necessary and sufficient for full activation of
Akt. The significance of the phosphorylation of these two sites was recently clarified
by solving the crystal structure of the kinase (Auguin et al., 2004; Milburn et al.,
2003; Thomas et al., 2002; Thomas et al., 2001).
The kinase responsible for T308 phosphorylation was purified by two groups (Alessi
et al., 1997; Stephens et al., 1998) and identified as phosphoinositide-dependent
kinase 1 (PDK1), a 63-kDa serine-threonine kinase. The primary structure of this
kinase is similar to other AGC kinase family members, and it has a high-affinity PH
domain at its C-terminal (Mora et al., 2004). For both proteins, Akt and PDK1,
translocation to the plasma membrane for binding of PIP3 is necessary for full
activation (Anderson et al., 1998; Andjelkovic et al., 1997). The role of PDK1 for
26
T308 phosphorylation was confirmed by gene targeting in mouse embryonic stem
(ES) cells. The deletion of PDK1 in ES cells resulted in inhibition of Akt, p70S6K,
and p90RSK activation, with complete inhibition of phosphorylation on the threonine
residue in their activation loops. Other AGC kinases were only partially inactivated in
PDK1-/- cells (Williams et al., 2000), demonstrating the in vivo role and substrate
specificity of PDK1.
The identity of S473 kinase is much more complicated and highly controversial. Since
S473, as well as T308, phosphorylation is dependent on PI3K activity, PDK1 was
initially assumed to be the kinase for S473 (Balendran et al., 1999). However, in
PDK1-/- knockout ES cells S473 was phosphorylated similar to wild-type cells,
whereas T308 phosphorylation was completely abolished (Williams et al., 2000).
There are few reports describing Akt itself as a S473 kinase under certain conditions
(Toker and Newton, 2000). However, as in PDK1-/- cells, T308 phosphorylation and
Akt activity are completely abolished, but the S473 residue is still phosphorylated in
response to IGF-I stimulation (Williams et al., 2000). Therefore, autophosphorylation
is unlikely to play an important role for S473 phosphorylation.
Up to now ten kinases have been tested as Akt- S473 kinases (Dong and Liu, 2005).
One candidate, mitogen-activated protein kinase-activated protein kinase 2
(MAPKAP-K2) possesses the potential for Akt S473 phosphorylation (Alessi et al.,
1996b), but its activation is not induced by Akt-activating stimuli, such as IGF-I, and
is not dependent on PI3K activation, suggesting that this protein is not a major kinase
for Akt S473 (Shaw et al., 1998). Integrin-linked kinase (ILK) 1, which possesses a
phosphoinositide-binding motif, is activated by insulin in a PI3K-dependent manner.
It can phosphorylate Akt on S473 in vitro (Delcommenne et al., 1998) and interacts
with Akt in response to serum stimulation in vivo (Persad et al., 2001). However, as
ILK1 kinase dead mutants can induce phosphorylation of S473 (Lynch et al., 1999)
and fibroblasts from ILK1-/- knockout mice exhibit the same extent of Akt
phosphorylation on S473 as wild-type mouse (Sakai et al., 2003), ILK1 is probably
not important for S473 phosphorylation. Other proteins, which have been suggested to
act as S473 kinase are, among others, PKCα, PKCβ, and mammalian target of
rapamycin (mTOR) (reviewed in (Dong and Liu, 2005)) with mTOR being one of the
most promising candidates for S473 phosphorylation so far (Hresko and Mueckler,
2005), at least in 3T3-L1 adipocytes. Therefore, it has been hypothesized that, unlike
T308 phosphorylation, the S473 phosphorylation is mediated by more than one kinase
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(Dong and Liu, 2005) and also might be cell type- and stimulus- specific (Fayard et
al., 2005).
3.4.1.6 Cellular functions of Akt
After activation, Akt phosphorylates numerous proteins in both the cytoplasm and the
nucleus. The minimum motif in a peptide enabling Akt phosphorylation is R-X-R-
Sma-Sma-S/T-Hyd, where X is any amino acid, Sma is preferably a small residue
other than glycine, and Hyd is a bulky hydrophobic residue, such as phenylalanine or
leucine (Alessi et al., 1996b). For clarity, I will group the cellular functions of Akt in
six categories: anti-apoptosis, cell cycle progression, protein synthesis, cellular
proliferation, angiogenesis, and glycogen synthesis. A seventh category, the insulin-
dependent glucose uptake will be dealt with in detail later.
3.4.1.6.1 Anti-apoptosis
In numerous cell types, it has been shown that Akt induces cell survival and
suppresses apoptosis induced by various stimuli. One major target of Akt is the
proapoptotic protein BAD, the Bcl-2/Bcl-XL-antagonist, causing cell death. By
binding to Bcl-2 and Bcl-XL, BAD inhibits their anti-apoptotic potential (Datta et al.,
1997). BAD phosphorylation by Akt inactivates BAD. It has also been shown that
Akt activates p21 activated kinase 1 (PAK1), which in turn phosphorylates BAD
resulting in its release from Bcl-XL complex (Datta et al., 2000; Tang et al., 2000).
Akt also promotes anti-apoptosis by phosphorylation and inactivation of the protein
Bcl-2-associated X protein (BAX) (Gardai et al., 2004), a promoter of cell death
(Eskes et al., 1998; Granville et al., 1999; Murphy et al., 2000; Shinoura et al., 1999).
Akt furthermore inhibits apoptosis at the postmitochondrial level (Zhou et al., 2000)
by phosphorylating the protein X-linked inhibitor of apoptosis protein (XIAP) (Dan et
al., 2004). Activated XIAP prevents apoptosis by direct interaction and inhibition of
activated caspases 9, 3, and 7 at postmitochondrial level (Deveraux et al., 1999;
Deveraux et al., 1998; Roy et al., 1997).
Akt can also interfere with apoptosis by phosphorylation, and thus activation, of
various cell survival related molecules. Phosphorylation of apoptosis signal-regulating
kinase1 (ASK1) by Akt inhibits ASK1-dependent stimulation of c-Jun N-terminal
kinase (JNK) (Kim et al., 2001; Yoon et al., 2002; Yuan et al., 2003), which plays an
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essential role in anti-tumor reagents-induced programmed cell death (Benhar et al.,
2001; Sanchez-Perez et al., 1998).
Furthermore, Akt phosphorylates the forkhead transcription factor Forkhead box,
class O (FoxO) (Biggs et al., 1999; Brunet et al., 1999; Kops et al., 1999), an
important inducer of apoptosis (Lin et al., 1997). Akt phosphorylation of FoxO results
in translocation of the transcription factor out of the nucleus and consequently its
inactivation (Brunet et al., 1999; Kops et al., 1999). Similarly, Akt can phosphorylate
the pro-apoptotic transcription factor Yes-associated protein (YAP). As in the case for
FoxO, this results in the cytosolic localization and therefore inactivation of YAP
(Basu et al., 2003).
3.4.1.6.2 Cell cycle progression, protein synthesis and cell differentiation
Akt targets several key cell cycle regulators including p21cip1/waf1 (Li et al., 2002;
Rossig et al., 2001; Zhou et al., 2001a), p27kip1 (Liang et al., 2002; Shin et al., 2002;
Viglietto et al., 2002), and mouse double minute 2 (MDM2) (Ashcroft et al., 2002;
Zhou et al., 2001b). In the case of p21cip1/waf1 and human p27kip1, which are both
major inhibitors of cyclin-dependent cell cycle progression, phosphorylation by Akt
causes the exclusion of these proteins from the nucleus.
An interesting target of Akt is the serine-threonine kinase mTOR, a regulator of cell
cycle progression and cell proliferation by integrating signals from nutrients – such as
amino acids and growth factors (Heitman et al., 1991; Helliwell et al., 1994; Kunz et
al., 1993). mTOR regulates protein synthesis by initiation of mRNA translation
leading to increased cell growth and subsequently increased proliferation (Hay and
Sonenberg, 2004). Akt can directly phosphorylate mTOR (Bolster et al., 2003; Nave
et al., 1999; Reynolds et al., 2002; Sekulic et al., 2000), but most likely acts on mTOR
indirectly. Akt phosphorylation of the tumor suppressor protein tuberous sclerosis
complex 2 (TSC2) leads to degradation of the TSC1/TCS2 complex and thus release
of mTOR from TSC1/2-dependent inhibition (Dan et al., 2002; Hay and Sonenberg,
2004; Inoki et al., 2002; Manning et al., 2002; Plas and Thompson, 2003; Potter et al.,
2002; Tee et al., 2003).
Furthermore, a crosstalk between Akt- and Raf- mediated signal transduction has been
recently described in our laboratory (Moelling et al., 2002; Rommel et al., 1999;
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Zimmermann and Moelling, 1999). This Akt- Raf1 crosstalk was found to regulate the
decision whether a cell will differentiate or proliferate.
3.4.1.6.3 Angiogenesis
Accumulated evidence shows that Akt plays a central role in angiogenesis, the
sprouting of new blood vessels. Akt mediates many angiogenic growth factors and
regulates downstream target molecules involved in blood vessel growth, as recently
demonstrated in Akt1-/- knockout mice (Chen et al., 2005). One of these target
molecules is the vascular endothelial growth factor (VEGF), the primary inducer of
angiogenesis, whose mRNA expression is induced by stabilization (Zhong et al.,
2000) and enhanced translation (Laughner et al., 2001) through regulation of the
mTOR pathway. Moreover, Akt phosphorylates and activates endothelial nitric
oxide synthase (eNOS) (Dimmeler et al., 1999), which leads to production of NO
and angiogenesis.
3.4.1.6.4 Glycogen synthesis
In humans, skeletal muscle store large parts of insulin-stimulated whole-body glucose
uptake as glycogen (Shulman et al., 1990). Insulin promotes glycogen synthesis both
by increasing rates of glucose transport (see below) and by activating glycogen
synthase (GS), which catalyzes the final step in glycogen synthesis. Akt-mediated
inactivation of glycogen synthase kinase-3β  (GSK-3β )  leads to reduced
phosphorylation of GS, and therefore increased glycogen synthesis as demonstrated
by overexpression of an Akt insensitive mutant of GSK-3β, which caused decreased
insulin-stimulated GS activity (Summers et al., 1999a; Takata et al., 1999; Ueki et al.,
1998). Nonetheless, the absolute contribution of Akt to the regulation of glycogen
synthesis remains uncertain because several other signaling molecules also modulate
this process.
30
3.4.2 Atypical PKC (aPKC)
3.4.2.1 Isoforms of  the aPKC family
Protein kinase Cζ (PKCζ) was originally discovered as a unique PKC isotype (Ono et
al., 1989). In the beginning of the 1990’s, the PKCλ/ι isotype was cloned as the tenth
member of the PKC family based on the amino acid sequence similarity of its kinase
domain with those of other PKC members. Note that human PKCι (Selbie et al.,
1993) and mouse PKCλ (Akimoto et al., 1994) are orthologs with 98% overall amino
acid sequence identity and thus will be referred to as PKCλ/ι, hereafter. Comparison
of the amino acid sequence supports the notion that PKCλ/ι is a close relative of
PKCζ: the kinase domain of PKCλ/ι shows 86% identity with PKCζ and 45–55%
with other PKCs (Akimoto et al., 1994). The cysteine-rich sequence of PKCλ/ι also
displays higher amino acid sequence identity with PKCζ (69%) than with other PKCs
(30–40%) (Akimoto et al., 1994). Based on these results, PKCλ/ι and PKCζ were
categorized into a third subgroup of the PKC family, the atypical PKCs (aPKCs). The
other two subgroups of the PKC family are the conventional PKC (cPKC) isoforms
PKCα, PKCßI, its splice variant PKCßII (Coussens et al., 1987), and PKCγ, and the
novel PKC (nPKC) isoforms PKCδ, PKCε, PKCη, and PKCφ. Together they form the
PKC family of S/T protein kinases (Ohno and Nishizuka, 2002). The cPKC isoforms
have functional C1 domains, which bind phosphatidylserine and diacylglycerol
(DAG) as well as phorbol esters. Furthermore, they possess a C2 domain, which binds
anionic lipids and Ca2+. Activation of cPKCs occurs by DAG in a Ca2+- and
phospholipid-dependent manner. Novel nPKC isoforms exhibit a functional C1
domain and a novel C2 domain, which does not bind Ca2+. As a consequence, nPKCs
are also activated by DAG and phospholipids, but are Ca2+-insensitive. The atypical
PKC isoforms only possess an atypical C1 and no C2 domain, and are insensitive to
both DAG and Ca2+ (Mellor and Parker, 1998; Nishizuka, 1984).
3.4.2.2 Domain structure of aPKC 
Proteins of the aPKC subfamily consist of four functional domains and motifs,
including a Phox and Bem-1 (PB1) domain in the N-terminus, a pseudosubstrate (PS)
sequence, a C1 domain and a kinase domain in the C-terminus. The structure of aPKC
is depicted in Fig. 4.
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The PB1 domain has been found, up to now, in more than 200 signaling molecules
(Hirano et al., 2005) on the SMART database (Schultz et al., 1998). The PB1 domain
of PKCι, which contains an OPR/PC/AID (OPCA) motif with conserved acidic and
hydrophobic residues, has recently been crystallized (Hirano et al., 2005). It serves as
binding motif to the OPCA motifs of a number of aPKC- interacting proteins, such as
the proteins partitioning defective-6 (PAR-6), PKC zeta-interacting protein (ZIP), and
mitogen activated protein kinase kinase 5 (MEK5) (Hirano et al., 2005; Ponting et al.,
2002) through PB1- mediated heterodimerization or homo-oligomerization.
The PS domain is a short stretch of amino acids, which resembles the PKC substrate
sequence except for A occupying the position of S or T as a phospho-group acceptor,
and is assumed to block the substrate-binding cavity of the kinase domain as an
autoinhibition mechanism (House and Kemp, 1987; Pears et al., 1990).
The C1 domain of aPKC is different in terms of a repeat structure from that of cPKC
and nPKC that contain two repeated zinc-finger motifs, C1A and C1B, both of which
are essential for interaction with and activation by the second messengers DAG and
Fig. 4: At the top, the modular nature of the protein kinase C (PKC) isoforms is depicted. All PKC
isoforms contain a conserved kinase domain (KINASE) that is autoinhibited by the pseudosubstrate
(PS) domain, which blocks the active site in the unstimulated state.
The conventional isoforms (cPKC) contain a C1 domain to bind DAG or phorbol esters, and a C2
domain that binds the headgroup of phosphatidylserine in a calcium-dependent manner.
The novel PKC isoforms (nPKC) contain a functional C1 domain and a novel, nonfunctional C2-like
domain, which does not contain the amino acids required for calcium-binding and thus renders
nPKC calcium-independent.
The atypical PKC isoforms (aPKC) contain a PB1 domain for hetero- and homodimerization and a
non-functional C1 domain, but do not contain a C2 domain and are thus DAG and calcium-
independent.
At the bottom, the structure of PKCζ/λ, two members of the aPKC subfamily, is depicted. The
essential threonine and serine residues necessary for activation are indicated. For further details see
text.
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phorbol ester. Although aPKC possesses a atypical C1 domain, it does not respond to
DAG and phorbol esters (Ways et al., 1992). Thus, the function of the C1 zinc finger
in aPKC is unkown (Mellor and Parker, 1998).
The kinase domain of aPKC, as well as other members of the AGC group, includes an
ATP-binding region, an activation loop, a turn motif, and a hydrophobic motif. Recent
analysis of the crystal structure of PKCι demonstrated that the conformation of active
aPKC is strikingly similar to the kinase domain of Akt after activation
(Messerschmidt et al., 2005). The ATP-binding region contains a lysine residue,
which is crucial for its kinase activity. Important threonine residues for activation of
aPKC are found in the activation loop (T410 of PKCζ and T403 of PKCλ/ι,
respectively) and in the turn motif (T560 of PKCζ, and T554/T555 of PKCλ/ι,
respectively) and are phosphorylated upon activation (see below).
3.4.2.3 Activation of aPKC
Beside activation by PIP3 (Nakanishi et al., 1993), which is essentially identical with
activation of Akt described above aPKC can also be activated by other lipid
components, such as phosphatidic acid (Limatola et al., 1994), arachidonic acid
(Muller and Sorrell, 1995), and ceramide (Muller et al., 1995).
Unlike Akt, aPKC does not possess a PH domain, but the hydrophobic motifs of
aPKC include a short sequence, F-E-G-F-E-Y, which is very similar to that of the
PDK1-binding sites of PKC-related protein kinases, F-X-X-F-D-Y, where X is any
amino acid (Parekh et al., 2000). In the activation loop of PKCζ, T410 is
phosphorylated by PDK1 (Chou et al., 1998; Le Good et al., 1998). In ES cells
lacking PDK1 as a result of genetic manipulation, PKCζ is not phosphorylated at
T410, suggesting that PKCζ is a physiological substrate of PDK1 (Balendran et al.,
2000b). While an alanine mutant of PKCζ, T410A,  loses enzymatic activity, a
glutamic acid–mutant, T410E, mimicking a phosphorylated threonine, retains its
activity (Balendran et al., 2000b; Chou et al., 1998; Standaert et al., 1999), suggesting
that T410 phosphorylation is essential for PKC activation.
Following the T410 phosphorylation, PKCζ presumably exposes the kinase domain
for further phosphorylation. T560 in the turn motif of PKCζ is a key residue for
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activation (Le Good et al., 1998). In PKCα and PKCßII, the phosphorylation of T638
and T641, respectively, corresponding to T560 in PKCζ is required for their catalytic
functions and for locking these kinases in a catalytically competent state (Bornancin
and Parker, 1996; Edwards et al., 1999). The T410E active mutant of PKCζ shows
autophosphorylation in vitro, while T560A and T560E mutants do not, indicating that
T560 is the only autophosphorylation site in PKCζ (Standaert et al., 2001). In living
cells, whether T560 of PKCζ is phosphorylated by itself, by another PKCζ
intermolecularly, or by other protein kinases including other PKC isotypes, remains to
be resolved.
Numerous studies found that PKCζ and PKCλ / ι are activated and function
interchangeably, at least in certain cellular processes such as the translocation of
GLUT4 vesicles to the plasma membrane (Bandyopadhyay et al., 1999a; Standaert et
al., 1999). For example kinase-inactive forms of both, PKCζ and PKCλ, inhibited
translocation of the glucose transporter 4 comparably. Moreover, inhibitory effects of
each of these kinase-inactive aPKC isoforms on the translocation process can be
reversed by the wild type form of either atypical PKC, ζ or λ (Bandyopadhyay et al.,
1999a).
3.4.2.4 Cellular functions of aPKC
A large number of studies have been performed in the last years to determine the
physiological functions of aPKC. At present, most enzymatic and cell biological
features revealed were found to be essentially common to PKCζ and PKCλ/ι. In many
studies the high sequence identity between the aPKC isoforms hampered the
investigation of the isoform specific effect of small interfering RNA (siRNA),
dominant-negative mutants or pseudosubstrate peptides. Finally, all aPKC-binding
proteins investigated so far, were reported to bind both isoforms. Therefore, I will
restrict the following descriptions on the physiological role of atypical PKC isoforms
on PKCζ, which has been better covered up to now.
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3.4.2.4.1 Involvement of aPKC in the NF-κB pathway
In signaling for cell growth and survival, extracellular ligands often act through
regulation of signaling pathways by transcription factors, such as the nuclear factor
κB (NF-κB) (Luo et al., 2005). Kinase dead PKCζ blocks the response of NF-κB to
these stimuli. This indicates that PKCζ is involved in NF-κB activation in signal
transduction of tumor necrosis factor-α (TNF-α) and IL-1 (Sanz et al., 2000; Sanz et
al., 1999). Furthermore, the PKC zeta-interacting protein ZIP and its homologs link
aPKC to the TNF-α receptor signaling complex (Sanz et al., 1999) as well as to the
IL-1- and the nerve growth factor (NGF)- receptor complexes (Sanz et al., 2000;
Wooten et al., 2001a). ZIP is potentially also involved in the regulation of PKCζ
activity (Chang et al., 2002b). PKCζ  also regulates the NF-κB pathway by
phosphorylating the ß-subunit of IκB kinase (IKK) (Lallena et al., 1999, Rahman,
2000 #1106; Savkovic et al., 2003), an essential component of the NF-κB pathway
(Karin, 1999).
Collectively, aPKCs transduce signals from the receptors of TNF, IL-1, and NGF to
the activation sites of NF-κB in vivo. Furthermore, they may be involved in a variety
of signaling pathways from receptor complexes to the expression of their target genes
by activation of transcription factors.
3.4.2.4.2 p70S6 kinase signaling cascade
aPKC directly associates with p70S6K in vivo, and dominant negative PKCζ
suppresses the serum-induced activation of p70S6K (Akimoto et al., 1998; Romanelli
et al., 1999), while constitutive active PKCζ synergistically enhances PDK1-induced
phosphorylations and induces prolonged activation of p70S6K (Romanelli et al.,
2002). Thus, aPKC apparently plays a role in p70S6K activation, although multiple
signals, such as mTOR and Akt, are required for full p70S6K activation (Akimoto et
al., 1998; Romanelli et al., 2002; Romanelli et al., 1999).
3.4.2.4.3 Cell polarity
Cell polarity is essential not only for cell functions but also for development and
tissue maintenance. Recent studies have clearly demonstrated the importance of the
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ternary complex of the proteins partitioning defective 3 homolog (PAR-3), PAR-6,
and aPKC in cell polarity (Hurd et al., 2003; Joberty et al., 2000; Lin et al., 2000;
Ohno, 2001; Plant et al., 2003). A PAR-3-PAR-6-PKCζ complex controls the
formation of tight junctions in epithelial cells (Suzuki et al., 2001). Overexpression of
dominant negative aPKC (Suzuki et al., 2001) or the N-terminal regulatory domain of
PKCζ (Gao et al., 2002) interferes with the establishment of cell polarity. In addition
to epithelial cells, PKCζ also controls polarity in different neuronal cells (Etienne-
Manneville and Hall, 2001; Kuroda et al., 1999). Furthermore, aPKC is crucial for
anterior-posterior polarity in Caenorhabditis elegans and the apical-basal polarity of
epithelial cells and neuroblasts in Drosophila melanogaster (Cox et al., 2001; Drubin
and Nelson, 1996).
3.4.3 Akt and aPKC- regulating proteins
Accessory proteins that bind kinases and thereby regulate their kinase activity or
subcellular localization play a key role in many signal transduction cascades. In the
case of Akt, several proteins have been reported to be interaction partners of the
kinase (Brazil et al., 2002). Many of them are substrates for Akt and, in most cases do
not affect Akt kinase activity. However, a number of proteins have been found to
regulate Akt activity. These proteins include the carboxy-terminal modulator protein
(CTMP) (Maira et al., 2001), which probably keeps Akt in an unphosphorylated and
inactivated state by physical protein–protein interaction, heat-shock proteins, which
bind Akt isoforms after stress treatment (Konishi et al., 1997), causing Akt activation
and inhibition of apoptosis (Rane et al., 2003), and growth factor receptor-binding
protein 10 (Grb10), which is assumed to recruit Akt to the plasma membrane in
response to cellular activation (Jahn et al., 2002). Furthermore, the binding of keratin-
10 to Akt leads to translocation of the kinase to the cytoskeleton and thus to
inactivation of its kinase activity and inhibition of cell proliferation (Paramio et al.,
2001), while binding of the protein T-cell leukemia 1 (Tcl1) to Akt (Laine et al.,
2000; Pekarsky et al., 1999) has been speculated to facilitate activation of Akt
(Sarbassov et al., 2005).
aPKC interacting proteins were mostly found to bind to the N-terminal PB1 domain
and some of them have been implicated in the regulation of aPKC activity (Suzuki et
al., 2003). The interaction partner PAR-6 links aPKC to small GTPases (Joberty et al.,
2000; Lin et al., 2000; Noda et al., 2001; Qiu et al., 2000; Suzuki et al., 2001) and
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enhances its kinase activity (Yamanaka et al., 2001) in a GTP-dependent manner,
while Src binding to aPKC upon stimulation leads to Y256- phosphorylation
(Seibenhener et al., 1999; Vandenplas et al., 2002; Wooten et al., 2001b) and nuclear
import (White et al., 2002) of aPKC.
In summary, the serine-threonine kinases Akt and aPKC are involved in a large
variety of signal transduction pathways. However, there is little data so far on
signaling events where both kinases act additively or synergistically to modulate the
signal transduction cascade.
Both proteins appear to be involved in p70S6K-activation and therefore cell growth
by inducing protein synthesis, but the exact contribution of each individual kinase is
far from resolved (see above). There have also been reports on the role of Akt and
PKCζ in stress signaling via ceramides, but it appears that the two proteins have
opposite effects in this cascade (Bourbon et al., 2002; Powell et al., 2003; Zhou et al.,
1998).
The only system in which the two ProF-interacting proteins were clearly and
unambiguously found to play key roles and additively act on signaling events is the
insulin-dependent translocation of the glucose transporter GLUT4 to the plasma
membrane of adipose and muscle cells. In the last part of the introduction I will
discuss this system in detail with special emphasis on the role of Akt and aPKC.
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3.5 Insulin-dependent GLUT4 translocation and glucose uptake
3.5.1 Structure and function of the glucose transporter 4, GLUT4
Glucose is the primary energy source used in the animal kingdom, and numerous
transporters have evolved to move glucose and other sugars across lipid bilayers
(Tetaud et al., 1997; Walmsley et al., 1998). In mammals, glucose is cleared from the
bloodstream by facilitative glucose transporters (GLUTs), which comprise a family of
highly conserved transmembrane domain-containing proteins.
 Fig. 5A: A schematic representation of the glucose transporter (GLUT) family of proteins is shown.
They comprise 13 members at present, which are predicted to span the membrane twelve times with
both N- and C-termini located in the cytosol. The diagram shows a homology plot between GLUT1 and
GLUT4. Residues that are unique to GLUT4 are shown in red. For further details see text.
Fig. 5B: (Left) A ribbon representation (side view) of GLUT4 3D structure is depicted as model
(Strobel et al., 2005). C- and N-terminal regions are shown as a coil due to lack of a suitable template.
GLUT4 is depicted in a way that the extracellular or intravesicular region of GLUT4 is at the top.
(Right) The extracellular or intravesicular region of GLUT4 is shown in top view in ribbon
representation. Amino acids that are assumed to be important for glucose transport are shown in pink.
The transmembrane helices of GLUT4 are colored: helix 2 is orange, helix 5 is yellow, helix 7 is red,
helix 10 is green, and helix 11 is cyan. As can be seen, the transmembrane helices of GLUT4 fold into
a a-helix barrel to form an aqueous pore for glucose transport across the plasma membrane.
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The GLUT protein spans the membrane twelve- times with both, the N- and the C-
terminus, located in the cytosol. It is assumed that this transmembrane structure forms
an aqueous pore to transport glucose across the plasma membrane in an energy-
independent manner (Fig. 5) (Joost and Thorens, 2001). Although the structural
determination of GLUT membrane proteins by X-ray crystallography or nuclear
magnetic resonance has been unsuccessful up to now (Alvarez et al., 1987), 3D-
modeling approaches indicate that the glucose transporter isoform 4 (GLUT4) forms a
right-handed α-helix barrel with twelve- transmembrane α- helix segments
surrounding a central pore (Strobel et al., 2005), as can be seen in Fig. 5. Typically
glucose transporters are localized in the plasma membrane. However, the glucose
transporter isoform GLUT4, which is expressed primarily in adipose and striated
muscle tissue, is unique among all GLUTs, by being sequestered in specialized
intracellular membrane compartments under basal conditions and by being
translocated to the plasma membrane after insulin stimulation (Bryant et al., 2002).
Thereby, insulin stimulates the uptake of glucose into fat and muscle cells to promote
the storage of sugar as intracellular triglycerides in fat and glycogen in muscle cells
(Khan and Pessin, 2002).
3.5.2 The intracellular GLUT4 storage compartment
Under basal conditions, the majority of GLUT4 (more than 95%) is excluded from the
plasma membrane of fat and muscle cells due to efficient endocytosis and intracellular
sequestration (Holman and Cushman, 1994; Tanner and Lienhard, 1987). Insulin
dramatically increases the exocytosis of GLUT4 (Bryant et al., 2002) and slightly
inhibits its endocytosis (Czech and Buxton, 1993; Huang et al., 2001; Jhun et al.,
1992; Yang and Holman, 1993), resulting in a rapid and strong increase in GLUT4
transporter levels at the plasma membrane. Interestingly, the increase in glucose
transport activity due to insulin stimulation is approximately in the same range,
indicating that GLUT4 translocation mediated most or all of the effect of insulin on
this process (Thong et al., 2005; Zhou et al., 2004). There may also be to some degree
a regulation of the GLUT4 catalytic activity (Harrison et al., 1992), but direct data on
potential mechanisms involved are contradictory (Antonescu et al., 2005).
During the last decade considerable attention has been paid to the identification and
characterization of the insulin-regulated GLUT4 storage compartment. The work of
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several groups (Barr et al., 1997; Bogan and Lodish, 1999; Millar et al., 2000; Rea
and James, 1997; Roh et al., 2001) led to the finding that GLUT4 is localized to a
special membrane compartment that is separate from those occupied by other insulin-
responsive secretory proteins, such as adipsin and leptin. This specialized insulin-
responsive GLUT4 storage compartment will from now on be referred to as GLUT4
storage vesicles (GSVs).
The characterization of this GSV compartment has been very difficult, because at
steady state GLUT4 is distributed throughout most of the endomembrane system
(Kandror and Pilch, 1998). However, in the last years subcellular fractionation,
vesicle immunoabsorption, membrane compartment ablation, and immunoelectron
microscopy have revealed that around 50% of GLUT4 is localized to compartments of
the general endocytic pathway. These compartments include endocytic markers, but
are only weakly insulin-responsive and exclude the vesicle-associated membrane
protein 2 (VAMP2), which will be discussed later (Hah et al., 2002; Martin et al.,
1996; Ramm et al., 2000; Zeigerer et al., 2002). The rest of GLUT4 is found in the
unique GSV compartment that is largely devoid of general endosomal markers
(Livingstone et al., 1996; Robinson and James, 1992; Zorzano et al., 1989) and
constitutively recycling proteins (Kupriyanova et al., 2002; Malide et al., 2000), but is
highly insulin responsive (Birnbaum, 1992; Rea and James, 1997; Simpson et al.,
2001). Electron microscopy revealed the GSVs as comparatively small (50 – 80 nm in
diameter) tubulo-vesicular structures, which are distributed throughout the cytoplasm,
rather than in typical endosomes (Malide et al., 2000; Slot et al., 1991).
3.5.3 Activation of GLUT4 translocation
The insulin-induced translocation of GLUT4 vesicles to the plasma membrane and the
subsequent glucose entry is initiated by insulin binding to the insulin receptor, leading
to activation of its tyrosine kinase activity and autophosphorylation (White and Kahn,
1994). Activated IR, in turn, phosphorylates tyrosyl residues in two subsets of
phosphorylated substrates, involved in insulin action on GLUT4 vesicle translocation:
the IRS proteins (White, 1998) and adaptor containing PH and SH2 domains (APS)
proteins (Moodie et al., 1999; Ribon and Saltiel, 1997). The first subset of substrates
initiates a signaling cascade that depends on class IA PI3Ks, whereas the second
subset initiates a PI3K-independent signaling pathway. Activation of the PI3K-
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dependent pathway is caused by tyrosine phosphorylation of IRS proteins that recruit
and activate class IA PI3K through binding to the SH2 domain of the p85 regulatory
subunit of PI3K. As discussed earlier, activation of the PI3K-dependent pathway
increases cell surface production of PIP3 (Yang et al., 2000), and perhaps PIP2, which,
in turn, recruits and activates downstream targets including serine-threonine kinase
PDK1, and its substrate kinases Akt and PKCζ/λ.
The second pathway, which includes APS and the Rho family GTPase TC10 (Chiang
et al., 2001), has been speculated to act in parallel with the PI3K-dependent pathway
to allow GLUT4 translocation to the plasma membrane and glucose uptake membrane
(Egawa et al., 2002; Frevert and Kahn, 1997; Guilherme and Czech, 1998; Isakoff et
al., 1995; Jiang et al., 1998; Krook et al., 1997; Staubs et al., 1998), but has been
questioned by recent siRNA studies (Mitra et al., 2004).
3.5.4 The role of Akt and PKCζ/λ in insulin-dependent glucose uptake
3.5.4.1 Akt
Insulin rapidly activates the serine-threonine kinase Akt (Funaki et al., 2004). Results
from cell culture systems have generally supported the role of Akt in insulin-
stimulated GLUT4 translocation (Ueki et al., 1998). Expression of constitutively
active Akt increased glucose uptake and GLUT4 translocation to the plasma
membrane, while dominant-negative Akt resulted in inhibition of glucose uptake
(Czech and Corvera, 1999; Kohn et al., 1998; Kohn et al., 1996).
Among the Akt isoforms, Akt2 is assumed to preferentially mediate GLUT4
translocation, because Akt2 levels increase during differentiation of adipocytes (Hill
et al., 1999; Summers et al., 1999b). Furthermore Akt2, but not Akt1, partially resides
in GLUT4- positive membrane fractions (Calera et al., 1998) and has been recently
shown to translocate to the plasma membrane upon insulin stimulation (Hanada et al.,
2004), whereas Akt1 was reported to undergo nuclear localization after growth factor
stimulation (Pekarsky et al., 2000). As mentioned earlier, knockout of Akt2, but not
Akt1, resulted in mild glucose intolerance, impaired glucose uptake in skeletal
muscle, and the failure of insulin to suppress hepatic glucose production (Bae et al.,
2003; Cho et al., 2001a). These results, as well as recent studies with Akt gene
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silencing in 3T3-L1 adipocytes (Jiang et al., 2003; Katome et al., 2003) strongly
support the role for Akt2 in insulin-dependent glucose uptake.
3.5.4.2 aPKC
In addition to Akt, the aPKC isoforms PKCζ and PKCλ/ι have also been implicated
in insulin-dependent GLUT4 translocation. Insulin stimulation results in an increase
in PKCζ phosphorylation (Kanzaki et al., 2004; Kotani et al., 1998; Standaert et al.,
2001)  in a PI3K- (Bandyopadhyay et al., 1999b; Kotani et al., 1998; Sajan et al.,
1999; Standaert et al., 2001; Standaert et al., 1999) and PDK1- (Chou et al., 1998; Le
Good et al., 1998) dependent manner in adipocytes. Furthermore, insulin stimulation
results in association of aPKC with GLUT4 vesicles (Braiman et al., 2001).
Recruitment of aPKC to the plasma membrane upon insulin stimulation has been
connected to its interaction with PDK1 (Balendran et al., 2000a; Le Good et al.,
1998), but more recently large caveolin-positive rosette structures at the plasma
membrane were assumed to be responsible for aPKC plasma membrane recruitment
(Kanzaki et al., 2004).
Regardless of the exact mode of activation, translocation of aPKC to the plasma
membrane and GLUT4 vesicles is well established (Braiman et al., 2001; Kanzaki et
al., 2004; Standaert et al., 1999). Additionally, a large amount of data from cell
culture experiments support a role for aPKC in insulin-regulated GLUT4
translocation. These include inhibition of aPKC activity with a pseudosubstrate
peptide (Bandyopadhyay et al., 1997a) and general PKC inhibitors (Bandyopadhyay
et al., 1997a; Bandyopadhyay et al., 1997b). In addition, expression of kinase-dead or
inactive aPKC inhibited GLUT4 translocation and glucose transport, whereas
expression of constitutively active aPKC promoted glucose transport (Bandyopadhyay
et al., 2000; Kotani et al., 1998). Impaired activity of aPKC is also associated with
insulin resistance and reduced glucose uptake in skeletal muscles of obese patients
(Vollenweider et al., 2002) as well as impaired GLUT4 translocation in fat-fed rats
(Tremblay et al., 2001). Only recently it has been shown that PKCλ knockout in ES
cells and adipocytes impairs insulin-stimulated glucose transport (Bandyopadhyay et
al., 2004), while earlier studies with siRNA-mediated gene silencing in 3T3-L1
adipocytes failed to show an effect of aPKC in glucose uptake (Zhou et al., 2004).
Thus, it is important to explore further the discrepancies observed so far.
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The connection between Akt2 and aPKC activation and GLUT4 translocation is still
unknown. After insulin- stimulation active Akt2 and aPKC were found to rapidly bind
to GLUT4-containing vesicles (Calera et al., 1998; Kupriyanova and Kandror, 1999;
Standaert et al., 1999) and to the plasma membrane (Andjelkovic et al., 1997; Chen et
al., 2003; Goransson et al., 1998; Standaert et al., 1999). However, the role of Akt2
and aPKC in the process of vesicle translocation is still largely unknown. Expression
of kinase-inactive Akt1 (Ducluzeau et al., 2002) or Akt2 (Chen et al., 2003) fused to
GLUT4 prevented GLUT4 translocation in response to insulin. This led to the
assumption that activation of the kinases either at or in close proximity to GSVs in
necessary for insulin to promote GLUT4 translocation (Chen et al., 2003; Ducluzeau
et al., 2002; Welsh et al., 2005).
However, these data are not in accordance with a considerable number of
translocation studies performed with inhibitors of PI3K and at low temperature (Bose
et al., 2004; Elmendorf et al., 1999; Thurmond et al., 1998; van Dam et al., 2005).
These results collectively suggest that Akt and PKCζ may play an important role at a
late stage in the GLUT4 translocation to the cell surface, presumably involving fusion
of GSVs to the plasma membrane. It is clear that more studies are necessary to fully
unravel the role of those kinases. Therefore it has been assumed recently that the
enzymes may impinge on more than one intracellular locus to exert their regulatory
action on GLUT4 (Thong et al., 2005).
In summary, therefore, both kinases most likely phosphorylate a key substrate (or
substrates) localized either close to the GLUT4 vesicles or the plasma membrane that
plays a central role in translocation. Although several candidate substrate have
emerged during the last years (Berwick et al., 2004; Hodgkinson et al., 2005a;
Imamura et al., 2003; Kane et al., 2002; Sano et al., 2003; Yamada et al., 2005) our
understanding of the kinase substrates and their role in GLUT4 translocation is yet far
from complete. Given the importance of Akt2 and aPKC in the insulin-dependent
GLUT4 translocation the detection of substrates of these kinases is of considerable
interest.
3.5.5 Fusion of GLUT4 with the plasma membrane
Insulin stimulation leads to the rapid translocation of GSVs to the plasma membrane
of muscle and adipose cells. A large number of results suggest an involvement of the
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PI3K- targets Akt2 and PKC at this late step. In the presence of PI3K inhibitors
GLUT4 vesicles accumulate in the vicinity of the plasma membrane (Bose et al.,
2004) and PI3K-dependent regulation of SNARE proteins regulates GLUT4-vesicle
docking and fusion to the plasma membrane (Min et al., 1999).
After translocation, the correct delivery of GLUT4-containing vesicles to the plasma
membrane and the recycling of GLUT4 through intracellular membrane
compartments relies, in part, on the recognition of target membranes by the vesicle
and on correct couplings of proteins that direct the fusogenic process. This is
performed by SNARE proteins - the soluble N-ethylmaleimide-sensitive factor (NSF)
attachment protein (SNAP) receptors - which play a critical role in a large variety of
vesicular transport processes by regulating membrane docking and fusion (Rothman,
1994; Sollner et al., 1993; Sudhof, 2004; Weber et al., 1998). The transport vesicles
contain proteins known as v-SNAREs, which form a class of coiled-coil proteins
associated with the fusing membrane. The v-SNAREs bind in a highly specific
manner to cognate membrane proteins, t-SNAREs, present in the appropriate target
membrane. A defining feature of v- and t-SNAREs is the presence of a conserved α-
helical SNARE domain. During SNARE-mediated membrane fusion, four of these
SNARE domains contribute to a parallel four-helical bundle arrangement (Poirier et
al., 1998; Sutton et al., 1998). In the case of the insulin-stimulated glucose transport in
adipocytes syntaxin 4 and SNAP-23 have been implicated in GLUT4 vesicle
trafficking as the required t-SNAREs (Foster and Klip, 2000; Watson et al., 2004).
Interestingly, the GLUT4 vesicles contain both v-SNAREs, VAMP2 and VAMP3, as
found by indirect immunofluorescence microscopy (Malide et al., 1997; Martin et al.,
1996). However, a number of studies indicate that VAMP2- and VAMP3-positive
GLUT4 vesicles may reside in different subcellular compartments. They further
indicate that VAMP2 is the v-SNARE located in the GSV compartment and
responsible for insulin-stimulated GLUT4 translocation (Cheatham et al., 1996;
Livingstone et al., 1996; Malide et al., 1997; Martin et al., 1998; Randhawa et al.,
2000; Sevilla et al., 1997; Volchuk et al., 1994; Yang et al., 2001).
Furthermore, there is accumulating evidence that, in addition to v- and t-SNAREs,
other proteins contribute to the membrane fusion process. Accessory molecules may
bind to the SNARE proteins and may, upon insulin stimulation, modulate the
SNARE-dependent fusion and docking events for GLUT4 surface externalization to
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the plasma membrane (Grusovin and Macaulay, 2003). It has also been assumed, as
described above, that the kinases Akt and aPKC may exert their main functions at this
step, possibly either by phosphorylation accessory proteins or by acting on SNARE
proteins by the aid of accessory proteins.
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3.6 Aim of this thesis
Despite significant progress during the last years, many key questions concerning
insulin-induced GLUT4 translocation still remain unsolved. Among the most exigent
ones is the question on how insulin stimulation, via activation of Akt2 and aPKC,
causes GLUT4 translocation to the plasma membrane and subsequent glucose uptake.
Thus, the identification of kinase substrates of Akt2 and aPKC is of high importance
and is ongoing at fast pace (Thong et al., 2005). However, these signal transduction
cascades are likely to be very complex and probably tightly controlled by accessory or
adaptor proteins to integrate kinases and substrates. Such adaptor molecules may play
a significant role in GLUT4 translocation and glucose transport into adipocytes. More
generally, Akt and aPKC are known to be involved in a numerous signaling events in
a plethora of cellular systems. Therefore, the elucidation of signaling complexes that
regulate activity, substrate phosphorylation or subcellular localization of these kinases
would be of high relevance for a large variety of cellular systems.
The aim of my thesis is the characterization of one such potential adaptor protein. The
WD-repeat propeller and FYVE-domain containing protein, designated as ProF, has
recently been identified by members of our institute by the aid of a yeast two-hybrid
screen using the kinase Akt as bait. The investigation of the role of Akt in cellular
systems has been of great interest for our institute, and has led to the discovery of a
crosstalk between Akt- and Raf- mediated signal transduction (Moelling et al., 2002;
Rommel et al., 1999; Zimmermann and Moelling, 1999).
For this thesis, the interaction of ProF with Akt was studied, as well as the binding to
the serine-threonine kinase PKCζ, both in overexpressed and endogenous systems.
Since the binding of WD-repeat proteins to interacting kinases and other signal
transduction-related proteins is often stimulation-dependent (Ron et al., 1994), special
attention was paid to binding of ProF to Akt and aPKC upon cellular stimulation. The
insulin-dependent translocation of GLUT4 vesicles in 3T3-L1 adipocytes was chosen
as a model system to further investigate the biological role of ProF. This was done
because of the key role of the ProF-interacting proteins Akt2 and PKCζ/λ in this
pathway, the vesicular nature of ProF due to its FYVE domain, and the high
expression levels of the protein in this cellular system. In adipocytes, the subcellular
localization of ProF, Akt, and PKCζ was investigated, depending on insulin
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stimulation. Overexpression or downregulation of ProF was performed in adipocytes
to check its role in insulin-dependent signaling events such as glucose uptake. Knock
down of ProF was also exploited to investigate the role of ProF in adipocyte
differentiation. The influence of ProF in adipogenesis and lipogenesis was analyzed
by various tools.
Furthermore, while this thesis was in progress, the v-SNARE protein VAMP2 was
found as a novel interaction partner of ProF by members of our institute. The
interaction of ProF with the v-SNARE VAMP2 and PKCζ was further investigated
and the role of ProF as adaptor protein was analyzed in the PKCζ- VAMP2- complex.
Additionally, the substrate phosphorylation of VAMP2 by PKCζ was investigated
upon stimulation. Furthermore, it was tested whether ProF can influence the
phosphorylation of VAMP2 in a PKCζ- and stimulation- dependent manner.
Although our knowledge on insulin-dependent GLUT4 translocation has
tremendously advanced during the last years, substantial effort is still needed in order
to understand the regulated trafficking of GLUT4. This accounts also for other
vesicular proteins in adipocytes and in a wider variety of cellular processes. Adaptor
proteins are likely to be of great importance in the adipocyte system (Kanzaki et al.,
2004) – as well as in other pathways - and clearly deserve great attention. In that way,
ProF might contribute as a potential adaptor protein to our understanding of signaling
pathways in general, and insulin signaling, leading to glucose uptake in adipocytes, in
particular.
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4 Results
4.1 WD-FYVE protein binds the kinases Akt and PKCζ/λ and regulates
glucose uptake in adipocytes
(submitted)
4.2 WD-FYVE protein binds VAMP2 and PKCζ and increases PKCζ-
dependent phosphorylation of VAMP2
(submitted)
4 . 3  WD-FYVE protein regultes differentiation of preadipocytes and
glucose uptake in adipocytes
(to be submitted)
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Summary
WD-repeat proteins offer a platform
for protein-protein interactions by folding
into a propeller- like structure. We
identified the propeller-FYVE protein,
ProF, consisting of seven WD-repeats and a
FYVE domain for binding to membranes.
ProF preferentially interacts with the
activated protein kinases Akt/PKB and
PKCζ/λ upon hormonal stimulation. Using
adipocytes as a model system to study ProF
function, we show that ProF translocates to
the plasma membrane in response to insulin
stimulation, parallel to the kinases Akt2 and
PKCζ/λ and the glucose transporter type 4.
Overexpression of ProF leads to increased
glucose uptake upon insulin stimulation,
while knockdown of ProF by small
interfering RNA leads to reduced glucose
uptake. Thus, we suggest that ProF
functions as an interaction partner of
kinases and regulates glucose transport into
adipocytes. The protein may be involved in
other inducible secretory systems.
Introduction
WD-repeat proteins belong to a large,
structurally conserved protein family.
Members of this family are characterised by
the presence of several partially conserved
sequence repeats of 40-60 amino acids. These
repeats typically end with a Trp- Asp dipeptide
(WD) at the C-terminus (1). The crystal
structure of the ß-subunit of the GTP-binding
protein transducin displays a highly
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symmetrical propeller-like structure of seven
folded WD-repeats (2) and all WD-repeat
proteins are speculated to fold into such
circularised ß-propellers. WD-repeat proteins
serve as a platform for protein-protein
interactions and are involved in a wide range
of cellular functions such as signal
transduction, RNA synthesis and processing,
vesicular trafficking, and apoptosis (for
reviews see (3)).
Well-characterised seven-bladed WD-
repeat proteins involved in signaling are the
receptors of activated C kinases (RACKs).
These proteins bind activated protein kinase C
(PKC) isoforms thereby enabling the
interaction with their substrates (4).
Most WD-repeats are found in a
multidomain context. Associated protein
domains can specify the subcellular
localisation of the molecule by binding to
particular intracellular compartments. There
the WD-repeats can bring together interacting
partners at their correct site of action.
The FYVE domain, which was
originally identified in Fab1p, YOTB, VAC1p,
and EEA1 (5), represents one such
compartment-specific targeting domain. FYVE
domains are conserved from yeast to man.
More than 30 FYVE domain-containing
proteins are known in humans. The domain
enables binding to phosphatidylinositol-3-
phosphate (PI3P), which is mainly
constitutively produced on endosomal
membranes by phosphoinositide-3-kinase
(PI3K). Most FYVE domain-containing
proteins serve as regulators of endocytotic
membrane trafficking, whereby a few proteins
have a role in signaling or cytoskeleton
remodelling (6). Their function is determined
by additional domains such as coiled-coil
domains in early endosomal antigen (EEA1),
ankyrin repeats in Smad associated receptor
antigen (SARA), or WD-repeats in the FYVE
domain protein localised to endosomes-1
(FENS-1). While the function of FENS-1 is
unknown, SARA presents mediators of the
transforming growth factor (TGF)-ß signaling
cascade to the TGF-ß receptor for
phosphorylation (7) and EEA1 plays an
important role in vesicle fusion during
endocytosis by controlling endosome docking
(8).
We identified ProF as interaction
partner of the serine/threonine kinase
Akt/PKB. Akt regulates multiple biological
processes including survival, proliferation, cell
cycle, and glycogen metabolism (9). We have
recently described a crosstalk between Akt-
and Raf- mediated signal transduction (10-12).
Akt has three isoforms, Akt1, Akt2, and Akt3,
each with overlapping but distinct cellular
function. Akt1 plays an important role in
growth and antiapoptosis, whereas Akt2
functions primarily as a regulator of glucose
metabolism (13-16). Akt is activated by
various growth factors and hormones such as
insulin-like growth factor (IGF-1) or insulin.
Activation occurs at the plasma membrane
after PI3K-dependent generation of
phosphatidylinositol-3,4,5-triphosphate (PIP3).
Thereby Akt is recruited to the plasma
membrane via its pleckstrin homology (PH)
domain and is activated by phosphorylation at
Thr 308 by phosphoinositide-dependent kinase
1 (PDK1), followed by phosphorylation at Ser
473 by a yet unknown kinase. In addition to
Akt, also atypical PKC isoforms, PKCζ/λ or
its human orthologues PKCζ/ι, were found
here to bind to the WD-FYVE protein. PDK1
also phosphorylates Thr 410/403 in the
activation loop of PKCζ /λ  in an insulin-
dependent mechanism (17). PKCζ shows 86%
overall amino acid sequence identity with
PKCλ, but only 45 – 55% to other PKC
i s o f o r m s  (18).  I n su l i n -med ia t ed
PKCζ /λ  activation has been reported in a
variety of cells, such as 3T3-L1 adipocytes
(19). PKCζ /λ  is involved in many signal
transduction pathways, including insulin-
dependent glucose uptake.
Both kinases have been shown to
localise on vesicles and to translocate to the
plasma membrane in response to insulin
stimulation in striated muscles and adipose
tissues (13,17,20). Insulin stimulates the
uptake of glucose by inducing the translocation
of vesicles containing the insulin-responsive
membrane-spanning glucose transporter type 4
(GLUT4) from intracellular pools to the
plasma membrane through a process of
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targeted exocytosis (21). The steps involved in
vesicle translocation are not fully resolved, but
Akt and PKCζ/λ have been shown to play a
key role in insulin-stimulated glucose uptake in
3T3-L1 adipocytes (22-24).
We describe here a new WD-repeat
FYVE protein, designated ProF. It is targeted
to internal vesicles and expressed in adipocytes
and other tissues. It preferentially binds the
activated kinases Akt and PKCζ/λ upon insulin
stimulation. Furthermore, in differentiated
adipocytes used here as a model system, ProF
is translocated to the plasma membrane in
response to insulin, similar to Akt, PKCζ/λ,
and GLUT4. Overexpression or knockdown of
ProF leads to increase or decrease of glucose
uptake in response to insulin, respectively.
Together, these data suggest a function of ProF
in glucose transport into adipocytes.
Experimental procedures
ProF antiserum - An anti-ProF antiserum was
raised in rabbits against a peptide
corresponding to the 15 amino acids at the C-
terminus of murine and human ProF. Some of
the antiserum was thereafter affinity-purified
to increase the specificity of binding
(Eurogentech Belgium). The same peptide was
used for competition.
Retroviral transduction and generation of
stably transduced 3T3-L1 fibroblasts -
Retroviruses containing the construct pRTP-
Myc-ProF or the empty pRTP vector as control
were produced using the BOSC-23 packaging
cell-line as described (25,26). Early passage
3T3-L1 fibroblasts were incubated in virus-
containing medium for 48 hours in the
presence of tetracycline (40 ng/ml) to suppress
ProF expression, yielding a pool of Myc-ProF
expressing cells. The cells were used in the
absence of tetracycline for subsequent glucose
uptake and immunofluorescence studies.
For siRNA downregulation the sequence used
was nucleotide (nt) 280 - 300 of ProF 3’-
untranslated region (5’- CCA CTG TTA CCG
CAA TCT A - 3’) for siProF1, and nt 1154 –
1172 of ProF open reading frame, targeted
against exon 11 (5’- GAA CTG ACA AGG
TAA TTA A- 3’) for siProF3. A 64-nt
oligonucleotide, containing the target both in
sense and antisense orientation was cloned into
pSUPER and then together with the H1
promoter into the lentiviral vector FUGW (27).
4 x 105 HEK 293T cells were transfected with
0.6 µg of the lentiviral expression construct,
0.6 µg of HCMV-G and 0.6 µg pCMVDR8.3
helper virus plasmids using Lipofectamine
2000 (Invitrogen), followed by medium change
after 24 h. The supernatant was used to infect 8
x 104 cells of low passage 3T3-L1 cells,
yielding a pool of siProF- expressing cells.
Immunofluorescence - COS-7 or HeLa cells
seeded on glass cover slips were transiently
transfected with Fugene-6 or Lipofectamin.
For inhibitor studies, cells were treated with
250 µM TPEN or 100 nM wortmannin (for 30
min). Cells were fixed with 3%
paraformaldehyde and permeabilised in PBS
containing 0.25% Triton X-100, incubated
with appropriate primary and secondary
antibodies and mounted in Mowiol (Hoechst
Pharmaceuticals). Secondary antibodies were
used at 1:100 dilution. The cells were
examined by sequential excitation at 488 nm
(FITC) and 568 nm (TRITC) using a confocal
laser microscope (Leica SP2) and a 40x1.25 oil
immersion objective (Leica). The images were
processed using IMARIS (Bitplane).
Fully differentiated 3T3-L1 adipocytes were
mildly trypsinised, replated on glass cover
slips, serum-starved for 2 hours and stimulated
with 100 nM insulin for the indicated time.
The cel ls  were f ixed with 4%
paraformaldehyde and permeabilised in PBS
containing 1% Triton X-100 before incubation
with appropriate first and secondary
antibodies.
Immunoprecipitation and Western blot
analysis - HEK 293T or HEK 293 cells were
transfected with expression vectors encoding
the indicated proteins and processed as
described (10). IGF-1 stimulation was
performed with 100 ng/ml IGF-1 for 15 min.
Murine tissues were extracted in a glycerol
buffer containing 150 mM NaCl, 20 mM Tris-
HCl, pH 7.5, 0.2% Nonidet NP40, 10%
glycerol, 1 mM EDTA using a tight-fitting
tissue blender. Complete homogenisation was
achieved after 6-10 strokes, 10 seconds each.
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Lysates were solubilised by shaking for 30
minutes at 4 °C.
Lysates of HEK 293T cells were
immunoprecipitated with 1 µg of the
appropriate antibody for at least 2 hours at 4
°C followed by additional 45 minutes with 10
µl of protein G-sepharose. Lysates and the
resulting immunoprecipitates were subjected to
SDS-polyacrylamide gel electrophoresis and
immunoblot analysis as described (10).
Mouse brain lysates (approximately 1.25 x 106
cells/ml lysate) were subjected to
immunoprecipitation with 1 µg of affinity-
purified antibody and incubated overnight at
4°C with or without a 100-fold molar excess of
the competing peptide. The endogenous ProF
protein was detected as 44 kDa form in direct
lysates and precipitates. A 40 kDa protein, also
competed by the peptide, was observed in
some cases with cultured cells and is likely to
be unspecific.
In 3T3-L1 cells, immunoprecipitation of
endogenous ProF was performed with anti-
ProF-antiserum, covalently coupled to protein
G-sepharose in order to avoid overlapping of
predominant signal of the IgG antibody heavy
chain. In brief, 10 µl of protein G-sepharose
(Amersham) were incubated with 2 µg of anti-
ProF antiserum in 500 µl of Washing-Binding
Buffer (all buffers from Pierce) for 30 minutes
at room temperature, afterwards washed twice
with this buffer and incubated in 260 µl of
Crosslinking Buffer with 850 µl of freshly
added dimethylpimelidate. Thereafter protein
G-sepharose was incubated for 1 hour at room
temperature and washed twice with
Crosslinking Buffer, incubated for 10 minutes
with Blocking Buffer at room temperature,
washed twice with Blocking Buffer, washed
three times with Elution Buffer, and then
equilibrated with Washing- Binding Buffer.
Lysate of 3T3-L1 cells was added to beads and
incubated overnight at 4°C.
Glucose uptake measurements  - For
experiment 6A, differentiated adipocytes were
starved for 20 hours in DMEM containing
0.5% FCS, and stimulated for 1 hour with
insulin in the presence of 1ml of 0.4 µCi/ml D-
(U-14C)-glucose (Amersham) with a specific
activity of 311 mCi/mmol. Cells were lysed in
radioimmunoprecipitation assay buffer (12)
and lysates were subjected to scintillation
counting analysis for measurement of 14C-
glucose uptake.
For experiment 6B, differentiated adipocytes
were starved for 20 hours in DMEM
containing 0.5% FCS, and glucose uptake
analysis was performed as described in (28)
with slight modifications. Briefly, cells were
incubated for 30 minutes at 37°C with 1 mL of
DMEM containing 100 nM insulin, washed
three-times with 2 ml of warm HEPES-
buffered Krebs- Ringer phosphate buffer (120
mM NaCl, 5 mM CaCl2, 1.2 mM MgSO4, 1.2
mM KH2PO4 and 30 mM HEPES, pH 7.2) and
incubated for 10 minutes in the same buffer in
the presence of 1ml of 1 µCi/ml 2-Deoxy-D-
(1-3H)-glucose (Amersham) with a specific
activity of 0.8 Ci/mmol. Cell were lysed in
radioimmunoprecipitation assay buffer (12)
and lysates were subjected to scintillation
counting analysis for measurement of 3H-
glucose uptake.
Reagents and antibodies - Cell culture media,
supplements and Novex® 8 – 16% and
10–20% Tris- Glycine gradient gels were
purchased from Invitrogen. N,N,N',N'-
tetrakis(2-pyridylmethyl)ethylenediamine
(TPEN), PKA inhibitor, and IGF-1 were
obtained from Calbiochem and insulin was
obtained from Novo Nordisk. Wortmannin,
isobutylmethylxanthin (IBMX), dexamethason,
and TRI Reagent were obtained from Sigma.
Restriction enzymes were purchased from New
England Biolabs and polymerases from
Promega. The Access RT-PCR system was
purchased from Promega, and the
QuikChangeTM Site-Directed Mutagenesis kit
from Stratagene. Unlabelled ATP for in vitro
kinase assay was obtained from Roche.
Oligonucleotides were purchased from
Microsynth (Balgach, Switzerland). The
transfection reagents Lipofectamin and Fugene
6 were purchased from Invitrogen and Roche,
respectively. Protease inhibitors were from
Roche, protein G sepharose beads, Redivue [γ-
32P] ATP, 2-Deoxy- D-(1-3H)-glucose, and D-
( U - 1 4 C)-glucose were obtained from
Amersham Pharmacia Biotech. Mouse
monoclonal antibody 9E10 against Myc and rat
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monoclonal 3F10 against HA were obtained
from Roche, rabbit polyclonal A14 against
Myc, rabbit polyclonal Y-11 against HA,
mouse monoclonal DF1513 against
CD71/Transferrin receptor, mouse monoclonal
F7 against human Akt2, goat polyclonal C-20
against GLUT4, rabbit polyclonal to PKC-
isoforms α/ß, γ, ε, η , and ζ /λ , and a goat
polyclonal against PKCζ/λ were obtained from
Santa Cruz Biotechnology, mouse monoclonal
262K against HA, rabbit polyclonal against
Akt, mouse monoclonal 5G3 against Akt,
rabbit polyclonal against phospho-Akt-Thr308
and rabbit polyclonal against phospho-Akt-
Ser473 from Cell Signaling Technology, sheep
polyclonal against Akt1, sheep polyclonal
against Akt2 and mouse monoclonal GD11
against c-Src and PKCsubstrate peptide from
Upstate Biotechnologies, mouse monoclonal
clone 14 against EEA1 from BD Transduction
Laboratories, the anti-rabbit IgG phycoerythrin
(PE) conjugate from Sigma and the mouse
monoclonal 1F8 against GLUT4 was from
Biogenesis. Fluorescein (FITC)-, rhodamine
(TRITC)- and Cy™5-conjugated anti-donkey
antibodies against mouse, rabbit or sheep were
purchased from Jackson Biologicals.
Cell culture - The human embryonic kidney
cell lines HEK 293 (ATCC number CRL-
1573), HEK 293T (ATCC number CRL-
11268), the human epithelial cell line HeLa
(ATCC number CCL-2), the simian kidney cell
line COS-7 (ATCC number CRL-1651) and
the murine fibroblastic cell line 3T3-L1
(ATCC number CL-173) were grown in
Dulbecco's modified Eagle's media (DMEM)
containing 10% fetal calf serum (FCS;
Seratec). Penicillin and Streptomycin were
added to cultures of 3T3-L1 cells.
Yeast two-hybrid screen - A yeast two-hybrid
screen was performed as described (29) using
full-length Akt1 as bait. A B cell-specific
cDNA library was obtained from S.J. Elledge
(Baylor College of Medicine, Houston, Texas)
(30). One of two cDNAs identified in the yeast
two-hybrid screen was subcloned into
pBluescriptKS (Stratagene).
Computational analysis of ProF protein -
Analysis of secondary structure elements were
performed using the Simple Modular
Architecture Research Tool (SMART; (31))
and a WD motif program (http://BMERC-
www-bu.edu/wdrepeat). The three-dimensional
model of ProF∆FYVE was generated by 3D-
PSSM program (32) with the WD-repeat
protein Tup1 (PDB 1ERJ) as structural
template  (33). The calculated fold-structure
had a certainty of fit better than 95%.
Recombinant DNA procedures - A ProF
fragment containing a double myc-tag 5’-prime
to the cDNA was generated by PCR and the
amplified fragment was cloned into pCMV5
generating pCMV5-myc-ProF.
The deletion mutant lacking the FYVE
domain,  ProF∆FYVE (pCMV5-myc-
ProF∆FYVE) was generated by introducing a
BspM1 restriction site between the FYVE
domain and the last WD repeat domain by site-
directed mutagenesis using pCMV5-myc-ProF
as a template and the following primers: 5’-
GGC CAT CAC AGA TGA AGA ACC TGC
ACC CAC AGC CAC CTT CC-3’ and the
complementary reverse primer. Subsequently
the plasmid was digested with Mun I and
BspM1 restriction enzymes to excise the
FYVE domain. The plasmid was annealed with
a short partially overlapping oligonucleotide
linker (forward primer: 5’-AAT TGA TCT
CCT GTG GCG GTG ATG GTG GGA TTG
TCG TCG GGA ACA TGG ACG TGG AGG
AAC GTG CAC CC-3’ and reverse primer 5’-
CTG TGG GTG CAC GTT CCT CCA CGT
CCA TGT TCC AGA CGA CAA TCC CAC
CAT CAC CGC CAC AGG AGAT C-3’) and
religated. The ProF mutants lacking blades 1 to
3 and blades 4 to 7 were generated by site
directed mutagenesis using pCMV5-myc-ProF
or pCMV5-myc-ProF∆FYVE as templates
generating pCMV5-myc-ProF∆FYVE∆4-
7(primers: 5’-GCA ATT TGC CTG GCA CTA
GTC TGA GAG TGG GCA GC-3’and reverse
complementary oligo) and pCMV5-myc-
ProF∆1-3 (primers: 5’-CGA ACA AAA ACT
TAT TTC TGA AGA AGA TCT GCT ATG
CTC TGA GAG TGG GCA GCG CCT GGG
AGG-3’) and -pCMV5-myc-ProF∆FYVE∆1-3,
respectively. A translational green fluorescent
protein (GFP)-ProF fusion was generated by
cloning myc-ProF into the BglII and Sa lI
digested plasmid pEGFP-C2 (Clontech). The
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retroviral vector pRTP-myc-ProF was
constructed by inserting the PCR amplified
fragment into the unique EcoRI site of pRTP
under control of a tetracycline repressible
promoter (25). HA-Bcr wildtype was cloned in
pCDNA3 (Invitrogen). The sequence of all
plasmids was verified by DNA sequencing.
Haemagglutinin tagged (HA)-Akt1 wild-type
(34), HA-Akt2 wild-type (35) and HA-m/p-
Akt1  (36) have been described previously. c-
Src wild-type cloned in pUSE plasmid was
purchased from Upstate Biotechnologies. HA-
PKCζ encoding plasmid was obtained from the
Fraunhofer Institute, Stuttgart, Germany.
RNA extraction, Reverse Transcription-PCR
(RT-PCR) and Real Time PCR - RNA was
extracted using TRI Reagent and RT-PCR was
performed with 1 µg of total RNA. Primers for
human and murine ProF were: forward (nt
658-678): GAT CAC TCT GTC ATC ATG
TGG; reverse (nt 894–915): CTT ACT GTC
CCA CAT TTG CTT G. Primers for murine ß-
actin as internal control were designed as
described (37), primers for human ß-actin
were: Forward (nt 607-629): ACG GCC GAG
CGG GAA ATC GTG CG, reverse (nt 987-
1009): ACT TGC GCT CAG GAG GAG CAA
TG. Primers for murine GLUT4 were: Forward
(nt 1220-1240): TTC ATT GTG GCA GAG
CTC TTC, reverse (nt 1352-1372): GAC GGC
AAA TAG AAG GAA GAC. First-strand
cDNA was synthesized at 48 ˚C for 45 min, 2
minutes at 94 ˚C and 22 cycles (for ß-actin) or
30 cycles (for ProF)  for 30 seconds at 94 ˚C,
1 minutes at 68 ˚C, and 2 minutes at 68 ˚C.
In vitro kinase assay - Myc-ProF∆FYVE
protein was expressed in HEK 293T cells and
immunoprecipitated with 1 µg of antibody as
previously described. Beads were washed three
times with ice-cold NETN buffer and twice
with kinase buffer containing 200 mM Tris-
HCl, pH 7.5, 200 mM MgCl2 and 10 mM
DTT, then resuspended in 40 µl of kinase
buffer, including 3 µM PKA inhibitor, 20 µM
unlabelled ATP, 10 mCi/ml [γ-32P] ATP with a
specific activity of 3000 Ci/mmol, and 0,45 µg
PKC subs t ra te  pep t ide  (Ups ta te
Biotechnologies). G-beads were incubated at
30°C for 30 minutes and subjected to SDS-
polyacrylamide gel electrophoresis and
immunoblot analysis. Autoradiography of
phosphorylated PKC substrate peptide was
performed using a STORM PhosphorImager
(Amersham Biotech) and evaluated with the
STORM Software.
Differentiation of adipocytes - For
differentiation, early passage 3T3-L1
fibroblasts, were grown in growth medium
(DMEM supplemented with 10% FCS) to
confluency followed by medium change. 72
hours later differentiation was induced by
growth medium supplemented with 166 nM
insulin, 0.1 µg/ml dexamethason, and 112
µg/ml 3-isobutyl-1-methylxanthine (IBMX).
Daily replacement of the hormonal
differentiation medium was performed for 3
days. Then, at day 0, the medium was replaced
by growth medium containing 166 nM insulin.
For insulin-stimulation experiments of pRTP-
Myc-ProF transduced cells, the cells were
starved in DMEM containing 0.5% FCS for 16
hours and stimulated for 1 hours as indicated in
Figh. 6A. Cells were used for experiments
within 20 days after removal of the hormonal
differentiation medium. Differentiation was
monitored by visual inspection or Oil Red O
staining.
Subcellular fractionation - Adipocytes were
stimulated with 100 nM insulin, homogenized
with eight passages through a 21 11/2 gauge
needle (Becton Dickinson Microlance-3) and
fractionated as described (38). The plasma
membrane (PM) pellet was resuspended in
400µl buffer and purified on a 1.12 M sucrose
cushion by centrifugation at 70,000 x g for 10
minutes. The PM-enriched interface (∼ 500 µl)
was thereafter diluted in homogenization
buffer without sucrose and pelleted at 200,000
x g for 4 minutes. The PM and the low-density
microsomal fraction (LDM) were resuspended
in NETN buffer described above and incubated
for 1 hour at 4°C to solubilise proteins,
followed by centrifugation at 13,000 x g and
4°C for 10 minutes.
Results
We performed a yeast two-hybrid
screen using a human B cell-specific cDNA
library and full-length Akt1 as bait (29). One
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of the identified clones encoded a novel
protein of 400 amino acids and a predicted
molecular mass of 44 kDa (accession number:
AAL04162), provisionally designated as WD-
FYVE protein 2 (WDFY2), (Fig. 1A).
Analysis of the secondary structure using the
specific WD motif search program BMERC,
(http://BMERC-www-bu.edu/wdrepeat),
identified seven WD-repeats. Database mining
using the Basic Local Alignment Search Tool,
BLAST, program (39) revealed a murine
homologue of unknown function (accession
number: NP-780755) with only 8 divergent
amino acids (Fig. 1A). Fig. 1B shows
alignments of some proteins with identical
domain structure. Homologues of the protein
were encountered in Drosophila melanogaster
and Caenorhabditis elegans, indicating a
conserved function of the protein in animals.
No homologues of the protein were found in
other eukaryotes or prokaryotes.
The individual WD-repeats of human
ProF are shown in Fig. 1C with the aberrations
compared to the consensus sequence (1)
highlighted in grey and their number indicated
in brackets. Analysis of the secondary structure
suggested that all seven repeats are able to
form four antiparallel ß-strands, A through D,
indicated as arrows on the top of Fig. 1C.
Seven WD-repeats can fold into a highly
symmetrical ß-propeller (2), whereby one
propeller blade contains the last three strands
of a repeat unit followed by the first strand of
the next repeat unit. Therefore, we used a
protein structure prediction approach to find
out whether ProF is able to fold into a seven
blade-containing propeller (Fig. 1D). As
template, we used the WD-repeat containing
protein Tup1, a corepressor of transcription in
yeast (33). Indeed, the amino acid sequence of
the protein without the FYVE domain could be
modeled into a seven blade-containing
propeller (Fig. 1D) arranged around a central
axis with a certainty of fit better than 95%.
Thus, the propeller-FYVE protein was
designated as ProF.
The FYVE domain of ProF is located
between WD-repeats 6 and 7 and comprises
two zinc ions coordinated by two times four
conserved cysteine residues to form zinc
fingers (6). To compare the FYVE domain of
ProF with that of other proteins, we aligned the
amino acid sequence of the FYVE domains of
ProF, the human ProF-homologue FENS-1,
and EEA1 in Fig. 1E. The predicted secondary
structure of the EEA-1 FYVE domain is shown
at the top. It contains four ß-strands and two a-
helices, as indicated by arrows and boxes (Fig.
1E). The FYVE domains of ProF and FENS-1
are highly conserved, with 80% amino acid
sequence identity, but both share only limited
identities with the FYVE domain of EEA1,
27% to 28%, respectively. ProF and FENS-1
share a change of an R to Q, R-Q-H-H-C-R in
the conserved R-(R/K)-H-H-C-R motif and an
11 amino acid insert between a2 and ß1 (Fig. 1
E, highlighted in yellow). These two
characteristics are unique among all FYVE
domain proteins (40,41). They may account for
a higher affinity towards PI3P and may make
the binding of a second protein, usually
important for membrane targeting (42),
obsolete.
To detect mRNA expression of
endogenous ProF we performed reverse-
transcription polymerase chain reaction (RT-
PCR) using primers that recognise both the
murine as well as the human ProF (m/h ProF).
Endogenous ProF mRNA was detectable in
murine brain extract, 3T3-L1 adipocytes, NIH-
3T3 cells, and in human embryonic kidney
HEK 293T cells, but undetectable in HeLa
cells (Fig. 2A). We raised an antiserum against
a peptide corresponding to the 15 C-terminal
amino acids of mouse and human ProF. The
antibody recognised a band at 44 kDa height,
corresponding to ProF as demonstrated with
the detection of overexpressed untagged ProF,
(Fig. 2B, lane 4) and the downregulation of the
band by a siRNA targeted against ProF (Fig.
2B, lane 2). We tested a number of additional
cell lines and found the highest expression
levels of ProF protein in 3T3-L1 cells
(unpublished data). In a number of cell lines an
additional band was detected at 40 kDa height
(Fig. 2B, lanes 1 –3), which was not related to
ProF as demonstrated by siRNA (Fig. 2B, lane
2).
Because FYVE domains bind to PI3P
present on vesicles, we investigated the
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subcellular localisation of ProF. For that
purpose, we transiently transfected HeLa cells,
which are devoid of endogenous ProF, with a
Myc-tagged ProF construct and performed
confocal immunofluorescence microscopy.
Myc-ProF partially colocalised with EEA1, a
marker for early endosomes, and to a lesser
extent with the transferrin receptor (TfR), a
marker for recycling endosomes (Fig. 2C). To
analyse the role of the FYVE domain we
compared the localisation of Myc-ProF and
Myc-ProF∆FYVE lacking the FYVE domain
in COS-7 cells. The vesicular localisation was
dependent on the FYVE domain (Fig. 2D).
Myc-ProF∆FYVE was distributed in the
cytoplasm and the punctuated staining was
strongly reduced in comparison to the full-
length protein. Furthermore, the vesicular
localisation of Myc-ProF was lost in the
presence of the Zn2+-chelator TPEN, which
destroys zinc finger configurations.
Additionally, the vesicular staining of a GFP-
ProF fusion protein was abolished in the
presence of wortmannin (Fig. 2D). The PI3K-
inhibitor wortmannin prevented the formation
of PI3P and PIP3, which is required for the
binding of FYVE domains to vesicles. These
findings indicate that the FYVE domain indeed
targets the protein to PI3P-containing vesicles.
The ability to dimerise is a property of
a number of FYVE domain proteins and
important for their affinity to endosomal
membranes. Dimerisation of EEA1 is assumed
to enhance the avidity to PI3P.
Homodimerisation also takes place in the
FYVE domain-containing protein SARA (43)
and this plays an important role for its
endosomal localisation. To demonstrate the
oligomerisation of ProF we performed
coimmunoprecipitation assays with Myc- and
Flag-tagged ProF (Fig. 2E). Indeed, the
interaction was clearly detectable. Since the
dimerisation motif of EEA1 and SARA is
localised in the FYVE domain (41) we tested
the interaction of the ProF mutant
ProF∆FYVE. The interaction also took place
when only one of the interaction partners
contained a FYVE domain. This suggests that
sequences outside of the FYVE domain
contribute to the interaction (Fig. 2E). This had
consequences for our effort to design
dominant-negative mutants of ProF. Putative
dominant-negative ProF mutants deleted for
the FYVE domain can still heterodimerise with
the wild-type and can therefore behave
similarly to the wild-type protein.
ProF was identified as an interaction
partner of Akt1, which we wanted to confirm
by coimmunoprecipitation assays. We tested
the binding to other kinases, known to interact
with WD-repeat proteins such as members of
the PKC family (4) and the Src kinase family
(44). Additionally, the multidomain protein
break point cluster region, (Bcr) was tested,
since it contains a PH domain and various PH
domain-containing proteins are known to bind
to WD-repeat proteins (45). We tested the
kinases HA-Akt1, HA-PKCζ, and HA-Bcr as
well as untagged Src by using transiently
transfected HEK 293T cells and antibodies
against the HA-tag or Src (Fig. 3A). Myc-ProF
coimmunoprecipitated HA-Akt1 and HA-
PKCζ, but not HA-Bcr or untagged Src. HA-
Akt1 and HA-Akt2 interacted equally well
with ProF (unpublished data). Furthermore
overexpressed ProF coprecipitated endogenous
atypical PKC isoforms PKCζ/λ in HEK 293T
cells, but not the classical PKC isoforms
PKCα /ß or the novel PKC isoform PKCε
(unpublished data). These results suggest a
specificity of ProF for particular kinases and
even isoforms within a kinase family.
To further characterise the interaction
of Akt and PKCζ with the ProF protein we
mapped their interaction sites. Various mutants
of ProF were constructed. However, deletion
of single amino acids, fragments, or individual
blades did not show reduced binding
(unpublished data). Two other mutants
comprised the blades 1 to 3 of ProF (Myc-
ProF∆4-7∆FYVE), and blades 4 to 7 of ProF
(Myc-ProF∆1-3∆FYVE). Furthermore, in both
of these mutants the FYVE domain was
deleted. They were tested by cotransfection
with HA-Akt and HA-PKCζ  (Fig. 3B). Akt
was coprecipitated by both mutants, but bound
more strongly to blades 1 to 3 (mutant Myc-
ProF∆4-7∆F Y V E ) ,  w h e r e b y  P K Cζ
predominantly bound to blades 1 to 3. Akt
truncation mutants containing either the PH
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domain or the kinase and regulatory domains
were found to still bind Myc-ProF
(unpublished data). These results suggest that
several binding sites contribute to the
interaction between the kinases and ProF.
Nevertheless, they indicate a specific binding
of Akt1, Akt2, and PKCζ to ProF involving
mainly blades 1 to 3.
The binding of kinases to WD-repeat
proteins, involved in signal transduction, is
often regulated through phosphorylation of the
binding kinases (45). Therefore, HEK 293T
cells  were st imulated by IGF-1.
Immunoprecipitates of overexpressed Myc-
ProF from stimulated cells indeed contained
both, more total Akt and more phosphorylated
Akt in comparison to non-stimulated cells (Fig.
4A). Even in unstimulated cells, which
contained only a low amount of activated Akt,
phosphorylated Akt was preferentially
recruited to ProF, indicating a very efficient
selection. Likewise, immunoprecipitates of
overexpressed Myc-ProF contained more
PKCζ/ι, the human orthologue of murine
PKCζ/λ , in stimulated cells (Fig. 4A). The
coimmunoprecipitated PKCζ/ι is catalytically
active, since it was able to phosphorylate a
PKC substrate peptide in an in vitro kinase
assay. These results suggest a stronger
interaction of ProF with the active kinases and
confirm the interaction of ProF with both
kinases in a semi-endogenous system.
Endogenous ProF also interacted with
endogenous Akt and PKCζ/λ, as shown by
coimmunoprecipitation of the kinase- adaptor
complexes in mouse brain lysates (Fig. 4B).
Furthermore, the interaction of endogenous
ProF with endogenous PKCζ/λ is shown by
coimmunoprecipitation of PKCζ/λ in 3T3-L1
cells (Fig. 4C). A 40 kDa protein recognised
by the anti-ProF antiserum in the direct lysate
(Fig. 4C, lane 2) is of unknown origin. Thus,
ProF interacts with PKCζ/λ in brain and 3T3-
L1 cells (Fig. 4B and C).
The interaction of ProF with Akt was
further demonstrated by a dragging experiment
in which a membrane- targeted myristoylated
and palmitoylated (m/p)-Akt1 was co-
expressed with ProF in COS-7 cells. ProF was
able to drag m/p-Akt1 from the plasma
membrane to vesicular intracellular structures.
(Fig. 5A top, left and right).
Deletion of the FYVE domain induced the
opposite effect, namely dragging of
ProF∆FYVE by m/p-Akt1 to the plasma
membrane (Fig. 5A, bottom, arrow). This
experiment further substantiates our finding
that the FYVE domain is essential for targeting
ProF to internal vesicles. It also shows that the
binding of ProF to Akt is sufficient to
overcome anchoring of m/p-Akt to the cell
surface membrane.
Is has been published previously that
insulin stimulation in adipocytes leads to
activation of Akt2 and PKCζ /λ  and to
translocation of GLUT4 vesicles to the plasma
membrane (21). We used these cells as model
system to study the role of ProF. For that
purpose we stably transduced 3T3-L1 cells
with a retroviral vector encoding Myc-ProF
(pRTP-MycProF) for expression of Myc-
tagged ProF in addition to endogenous ProF.
These cells were differentiated into adipocytes
and analysed by confocal immunofluorescence
microscopy. We tested whether Myc-ProF
colocalised with Akt2, PKCζ/λ, or GLUT4
without and with insulin stimulation. Without
insulin stimulation Akt2 and PKCζ/λ were
detected mainly in the cytoplasm, and showed
some colocalisation with ProF on punctuate
structures (Fig. 5B, C, D).  After insulin
stimulation for 15 minutes we detected Myc-
ProF, the kinases and GLUT4 also at the
plasma membrane (Fig. 5B, C, D). These
results indicate that ProF is translocated to the
plasma membrane in response to insulin,
parallel to PKCζ/λ, Akt, and GLUT4.
In order to verify these observations
we used a cell fractionation analysis to test the
insulin-dependent distribution of endogenous
ProF in response to insulin. Unstimulated and
insulin-treated differentiated adipocytes were
lysed and the localisation of ProF was analysed
using differential centrifugation. ProF was
detected in the low density microsomal (LDM)
fraction in unstimulated cells (Fig. 5E),
whereas in stimulated cells it was found in the
plasma membrane (PM) fraction. Furthermore,
in response to insulin PKCζ/λ and activated
Akt were enriched at the PM, and GLUT4
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accumulated in the PM. In the cytoplasmic
fraction the recruitment of PKCζ/λ to LDMs
and PM upon stimulation was reflected by the
reduction of the kinase level. This was not
observed for activated Akt and total Akt, most
likely because the levels of Akt were too high
to allow observation of decreased protein
levels in the cytoplasmic fraction. GLUT4 was
not detected in the cytoplasm and ProF was
observed only in very small amounts after
stimulation. In conclusion, these results
confirm that ProF, PKCζ/λ, activated Akt and
GLUT4 move from the vesicle- containing
LDM fraction to the plasma membrane upon
insulin stimulation.
To further investigate the biological
role of ProF, we investigated glucose uptake in
3T3-L1 adipocytes as a model system using
overexpressed ProF. Viral transduction of early
passage 3T3-L1 cells yielded a pool of Myc-
tagged ProF expressing cells, therefore
excluding the possibility of clonal variation.
The transduced cells were differentiated into
adipocytes and glucose uptake was determined
after 20 hours of serum- starvation. Glucose
uptake was increased by 53% due to
overexpression of ProF in the absence of
insulin. Using increasing concentrations of
insulin for stimulation, presence of Myc-ProF
caused an increase of glucose uptake from
48% to 100% (Fig. 6A). Protein levels of
endogenous ProF or the unrelated kinase Erk2
were not affected by Myc-ProF as shown by
Western Blot (Fig. 6A, bottom). These results
demonstrate the contribution of overexpressed
ProF to glucose uptake.
To substantiate these results, we performed
knock down of Prof. We stably transfected
3T3-L1 cells with lentiviral vectors expressing
various siRNAs targeting ProF. siProF1 was
targeted against a sequence in the 3’-
untranslated region of ProF mRNA, siProF3
against exon 11 of the ProF open reading
frame. siProF3 led to almost complete
downregulation of endogenous ProF protein
levels, whereas siProF1 downregulated the
protein only partially (Fig. 6B, top lane). None
of the siRNAs affected expression levels of the
unrelated protein tubulin (Fig. 6B, bottom
lane). Transduction efficiencies were around
95% of the cells. To investigate the role of
ProF in adipocytes, we used untransduced,
parental 3T3-L1 cells (-), and pools of stably
lentivirus- transduced 3T3-L1 cells expressing
siProF1 and siProF3, as well as an unrelated
siRNA against luciferase (siGL2) as control.
At day four after removal of the differentiation
cocktail, all cells displayed comparable levels
of differentiation, as shown by cell
morphology and lipid droplet appearance (Fig.
6B, bottom) and expression of adipocyte-
related marker proteins (data not shown). To
measure glucose uptake, cells were serum-
starved for 20 hours, insulin was added for 30
minutes and then radioactive deoxyglucose
was added for 10 minutes. Cells were
afterwards lysed and subjected to scintillation
counting analysis. The data show that insulin-
dependent deoxyglucose uptake was reduced
by 55% in siProF3- expressing adipocytes and
siProF1 reduced the glucose uptake by 30% in
comparison to non-transduced cells, whereas
the control siRNA decreased glucose uptake by
only 7.5%. The reduction of glucose uptake
was dependent on ProF-levels, since more
efficient knockdown led to more decreased
glucose uptake. These results are in good
agreement with the increased insulin-
stimulated glucose uptake observed in
adipocytes with overexpressed Myc- ProF
(Fig. 6A).
Discussion
We have identified a WD-repeat
protein containing a FYVE domain, which
interacts specifically with the kinases Akt and
PKCζ/λ . The putative propeller structure,
formed by the WD-repeats, preferentially binds
to the activated kinases. This is in accordance
with the function of several WD-repeat
proteins that also favour binding of activated
kinases such as RACK1 and RACK2. RACK1
selectively binds activated PKCβII to enable
the interaction of the kinase with its substrates
(4). Furthermore, RACK1 is found to associate
with integrins, where it regulates focal
adhesion and migration by recruiting Src (44).
RACK2 recruits activated PKCε to Golgi
membranes to control secretion and vesicular
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trafficking (46). These examples show that
WD-repeat proteins can bring together various
kinases as well as kinases and their substrates
to integrate signaling pathways. Due to
localisation motifs present on WD-repeat
proteins, these events can be targeted to
specific compartments in the cell.
ProF contains a unique FYVE domain, which
was described as a high-affinity PI3P-binding
site in the homologous protein FENS-1 (41).
We showed that this domain is responsible for
the localisation of ProF to internal vesicles.
Tissue expression data showed that ProF is
expressed in various tissues with high
secretory activity such as brain and pancreas
(unpublished data). However, in these tissues
the involvement of Akt and PKCζ regarding
secretory processes is unclear. In ß-pancreatic
cells glucose-dependent secretion of insular
granules is linked to other PKC isoforms,
which do not interact with ProF (unpublished
observation), while PKCζ  migrates to the
nucleus in response to glucose stimulation
(47). In the brain, PKC-mediated vesicular
trafficking, leading to neurotransmitter release,
plays an important role, but the contribution of
Akt and PKCζ is unclear.
In contrast, adipocytes have a vesicular
trafficking system for insulin-dependent
glucose uptake that has been shown to depend
on the activation of Akt and PKCζ/λ  (for
review see (21)). Due to the vesicular
localisation of ProF, the binding of kinases Akt
and PKCζ, and the high protein expression
levels of ProF in these cells (Fig. 2B) we chose
adipocytes as a model system to further
characterise the role of ProF. Confocal
immunofluorescence analysis and cell
fractionation revealed that upon insulin
stimulation ProF, Akt2, PKCζ/λ, and GLUT4
translocate to the plasma membrane in
differentiated 3T3-L1 cells. Overexpression of
ProF led to increased and knockdown to
decreased glucose uptake in adipocytes. These
data suggest that ProF plays a role in general
GLUT4 vesicle trafficking. Interestingly, ProF
does not only positively influence insulin-
stimulated, but also basal glucose uptake. This
might be directly connected with the capability
of ProF to selectively bind activated Akt and
PKCζ/λ. Basal levels of activated kinases exist
in unstimulated cells. Furthermore, ProF
contains a high-affinity PI3P-binding FYVE
site (41) and low levels of PI3P are found at
the plasma membrane of unstimulated
adipocytes (48), which may be sufficient to
recruit some ProF to the plasma membrane in
the absence of a stimulus. Under basal
conditions a minority of GLUT4 (around 5%)
is also found at the plasma membrane of
adipose and muscle cells. Thus, basal levels of
activated kinases and PI3P in unstimulated
cells might be sufficient for ProF to maintain
some glucose uptake in 3T3-L1 cells.
Confocal  immunofluorescence
analysis and cell fractionation revealed that
upon insulin stimulation ProF, Akt2, PKCζ/λ,
and GLUT4 accumulate at the plasma
membrane. The translocation of ProF may be
mediated by the FYVE domain, which binds
PI3P. PI3P has recently been described to be
generated at the plasma membrane of
adipocytes upon insulin stimulation (48) and to
play a role in translocation of GLUT4-
containing vesicles to the plasma membrane.
The GLUT4 translocation to the plasma
membrane upon incubation of cells with PI3P
did not result in fusion of GLUT4 vesicles with
the plasma membrane, suggesting that
important activation steps leading to vesicle
fusion and subsequently to glucose uptake
seemed to be missing (49). We have
preliminary data supporting this (unpublished
observation). It is possible that kinases are
required for the missing step, the fusion of the
GLUT4 vesicle to the plasma membrane.
These kinases may be Akt2, and PKCζ/λ.
Thus, ProF may bind via its FYVE- domain in
the proximity to the plasma membrane and the
kinases may contribute to the next steps.
An important task in respect to the
function of ProF as interaction partner for
kinases involved in vesicular trafficking would
be to determine the substrates of these kinases.
A putative PKCζ substrate involved in insulin
dependent glucose uptake is the SNARE
protein, the vesicle-associated membrane
protein 2 (VAMP2), responsible for docking of
GLUT4 vesicles at the plasma membrane (50)
and the protein 80K-H, which has been
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suggested to regulate the fusion of SNARE
proteins (51). Akt substrates are AS160, a Rab-
GTPase activating protein, which participates
in the translocation of GLUT4-containing
vesicles to the plasma membrane (52-54) and
PIKfyve, which has been implicated in insulin-
dependent GLUT4 translocation (55).
Presently, we are investigating the role of ProF
for the phosphorylation of possible substrates
of Akt and PKCζ.
Tissue expression data indicate that
ProF might participate in other vesicular
trafficking systems. For example the protein
PIKfyve, which regulates GLUT4 trafficking
in adipocytes (55), is also known to play a role
in sorting cargo molecules between the late
endosome and the lysosome (56). ProF may be
involved in the brain and the pancreas, and it
will be interesting to analyse the role of ProF
and the kinases involved in these vesicular
systems.
In summary, we demonstrated that the
WD-FYVE protein ProF serves as a binding
platform for the activated kinases Akt and
PKCζ . The FYVE domain targets the
interacting proteins to vesicular membranes.
Our data show that in adipocytes ProF, Akt,
PKCζ/λ, and GLUT4 are detected on internal
vesicles and after insulin stimulation all
proteins accumulate at the plasma membrane.
Overexpression of ProF led to increased
glucose uptake, while knockdown of ProF by
siRNA led to reduced glucose uptake.
Furthermore, ProF may be more generally
involved in a variety of vesicular trafficking
processes in adipocytes or other tissues and
may bind to other signaling proteins.
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Figure legends
Fig. 1. Characterisation of ProF. (A) Deduced amino acid sequences of human (h) ProF (accession
number (AC): AAL04162) and the murine (m) homologue (AC: NP_780755), differing in eight
indicated amino acids, are shown. The protein contains seven WD-repeats (WD 1–7), indicated as
coloured boxes, and one FYVE domain, indicated as black dashed box. (B) The domain structure of
ProF is shown, with the FYVE domain and seven WD domains (WD1-7) indicated. Molecules
structurally related to human ProF are found in human (FENS-1, AC: XP_018197), mouse (mProF;
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AC: NP_780755; mFENS-1, AC: AAH25226.1), Drosophila (AC: AAF52946.1), and C. elegans
(AC: NP_495983.1). Their amino acid sequence identity with human ProF is given in percent. Scale
bar indicates 100 amino acids. (C) The amino acid sequences of the WD-repeats 1 through 7 of ProF
are listed. A typical WD-repeat unit contains four ß-strands ßD ßA ßB and ßC (arrows) and consists of
about 40 amino acids. Mismatches to a postulated WD-repeat consensus sequence are grey-shaded and
their numbers are listed in brackets. The FYVE domain is located between WD6 and WD7 and is
indicated by ∆. (D) A model of the three-dimensional structure of ProF without the FYVE domain was
generated by the 3D-PSSM program with the yeast protein Tup1 as template. The resulting ß-propeller
consists of seven blades formed by the WD-repeats (1-7), whereby the D-strand of each WD-repeat is
part of the previous blade (colours are matching Fig. 1A). The FYVE domain is located between the ß-
strands 6C and 7D (arrow). (E) The amino acid sequences of the FYVE domains of ProF, FENS-1,
and EEA1 are aligned and compared with the predicted secondary structure of EEA1 containing four
ß-strands and two α-helices α2 and α3 (top). Highly conserved sequences are R-R-H-H-C-R, W-X-X-
D, C-G, R-V-C, and the eight cysteines. The FYVE domains of ProF and FENS-1 have a homologous
insert of 11 amino acids and a R to Q mutation in the conserved R-R-H-H-C-R region, indicated in
yellow.
Fig. 2. Expression and subcellular localisation of ProF. (A) mRNA expression levels in different cells
were analysed by RT-PCR from total RNA with primers specific for murine and human (m/h) ProF as
indicated. ß-actin expression was used as control. (B) ProF protein expression levels in different cell
lines were analysed by Western blot with an peptide antibody raised against the 15 C-terminal amino
acids of ProF and recognising human and mouse ProF. siProF (lane 2) shows downregulation of the
ProF protein in 3T3-L1 cells using a siRNA targeted against ProF. Positive (pos.) control (lane 4)
indicates a lysate of HEK 293T cells overexpressing untagged ProF. In the case of lane 4, only 1/20 of
the protein content of lanes 1 – 3 was loaded to avoid excess signal strength by detection. (C) HeLa
cells were transiently transfected with Myc-ProF and subjected to confocal immunofluorescence
microscopy with antibodies against the Myc epitope, EEA1, and TfR. Colocalisation of Myc-tagged
ProF (red) with endogenous EEA1 (green) on early endosomes and with endogenous TfR (green) on
recycling endosomes was visualised in yellow in the merged pictures. Scale bar indicates 20 µm. (D)
Immunofluorescence microscopy analysis of COS-7 cells transiently transfected with plasmid DNA
encoding Myc-ProF, Myc-ProF∆FYVE, and GFP-ProF. Cells were treated for 30 minutes with 250
µM TPEN or 100 nM wortmannin. Scale bars indicate 20 µm. (E) Oligomerisation: Lysates prepared
from HEK 293T cells transiently transfected with the indicated constructs were subjected to
immunoprecipitation (IP) with an antibody against the Myc epitope tag. Dimerisation capabilities of
ProF and ProF∆FYVE were assessed by immunoblotting (IB) with an antibody against the Flag
epitope and by SDS-PAGE (upper panel). The two lower panels show controls for protein expression
levels of Myc- and Flag- tagged proteins.
Fig. 3. Interaction of ProF with overexpressed Akt and PKCζ. (A) HEK 293T cells were transiently
transfected with HA-Akt1, HA-Bcr, HA-PKCζ, and Src in the presence or absence of Myc-ProF.
Interaction of ProF with HA-Akt1, HA-Bcr, HA-PKCζ, and Src was analysed by IP with an antibody
to Myc-tag followed by IB with antibodies against Src-, HA-, and Myc-epitopes. Direct lysates are
shown as expression controls (bottom). (B) For mapping of the interaction sites of PKCζ and Akt on
ProF, HEK 293T cells were transiently transfected with the indicated Myc-ProF constructs and HA-
PKCζ (left) and HA-Akt1 (right). The interaction of ProF deletion mutants with PKCζ and Akt was
analysed by IP with an antibody to the Myc-tag, followed by IB with antibodies against HA- and Myc-
epitopes. The two upper panels show the interaction, the two lower ones show direct lysates as
expression controls.
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Fig. 4. Half-endogenous and endogenous interactions of ProF with Akt and PKCζ/λ. (A) HEK 293T
cells transiently expressing Myc-ProF were stimulated with 100 ng/ml IGF-1 and subjected to IP with
an antibody towards the Myc- epitope. Association of Myc-ProF with endogenous Akt1/2 was
detected by an anti-Akt antibody and phosphorylation of Akt by an antibody to phospho-Ser 473,
indicating increased coimmunoprecipitation of activated ProF after stimulation by IB analysis.
Detection of coimmunoprecipitated PKCζ/ι with an antibody against PKCζ /ι shows that the
interaction of ProF with PKCζ/ι is increased upon IGF-1 stimulation. The kinase activity of the
coprecipitated PKCζ/ι was tested with a PKC substrate peptide. Expression and immunoprecipitation
of Myc-ProF was verified by IB of direct lysates and IP with an antibody against the Myc epitope. (B)
Mouse brain extract was incubated with anti-ProF antibody in the absence or presence of an excess of
ProF peptide to compete for the antibody followed by IB. IB against ProF shows competition of the
ProF protein (lane 2). (C) 3T3-L1 pre- adipocyte cells were subjected to IP with an antibody against
ProF, crosslinked to sepharose beads with dimethylpimelimidate (lane 3, bottom). Association of
endogenous PKCζ/λ with ProF was detected by IB (lane 3, top). Lane 1 shows the position of
PKCζ/λ and ProF, using a lysate of HEK 293T cells overexpressing untagged ProF. Lane 2 shows the
direct lysate of 3T3-L1 preadipocytes.
Fig. 5. Trafficking and cotranslocation. (A) Dragging. COS-7 cells were transiently transfected with
HA-m/p-Akt1 alone and together with Myc-ProF or Myc-ProF∆FYVE. Confocal microscopy analysis
with HA- or Myc-specific antibodies revealed areas of colocalisation as visualised in yellow on the
merged pictures. Arrow heads indicate colocalisation at the plasma membrane. Scale bar indicates
20 µm. (B, C, D) Colocalisation of ProF with Akt2 (B), PKCζ/λ (C) and GLUT4 (D) Differentiated
3T3-L1 adipocytes (day 15 after removal of hormonal differentiation medium) stably transduced with
a retroviral vector encoding Myc-ProF were serum-starved for 2 hours and stimulated with 100 nM
insulin as indicated. Cells were subjected to confocal immunofluorescence microscopy using Akt2-,
PKCζ/λ-, or GLUT4- (green) and Myc- (red) specific antibodies. Scale bars indicate 20 µm. (E)
Differentiated adipocytes (day 15) were serum-starved for 4 hours, stimulated with 100 nM insulin as
indicated and fractionated by differential centrifugation. Equal amounts of proteins of cytoplasmic,
low density microsomal (LDM), and plasma membrane (PM) fractions were analysed by SDS-PAGE
and IB with antibodies against ProF, PKCζ/λ, phospho-Akt1/2, Akt1/2, and GLUT4.
Fig. 6. Effects of ProF overexpression and knock- down on GLUT4 translocation and glucose uptake.
(A) Differentiated adipocytes (day 15 after removal of hormonal differentiation medium)
overexpressing Myc-ProF (filled columns) or empty vector control (open columns) were starved for
20 hours and stimulated for 1 hour with insulin in the presence of 14C-glucose. Data are mean values ±
s.d. of 3 experiments. *P < 0.05, **P < 0.01 of cells overexpressing Myc-ProF relative to empty
vector control (top). Expression of endogenous ProF- protein and overexpressed Myc-ProF protein
was analysed by IB (bottom). (B) 3T3-L1 adipocytes were untransduced (-), transduced with the
retroviral vector FUGW with insert for expression of siRNA against firefly luciferase as control
(siGL2), or with two different inserts for expression of different siRNAs targeted against ProF mRNA
(siProF1, siProF3). Adipocytes (day four after removal of hormonal differentiation medium) were
starved for 20 hours and stimulated for 30 minutes without (open columns) or with 100 nM insulin
(filled columns) before incubation with deoxyglucose for 10 min. Data are mean values ± s.d. of 3
experiments. *P < 0.05, **P < 0.01 relative to siGL2 cells (top panel). Different levels of ProF
expression were analysed by IB (top lane), total protein levels were standardised to tubulin (middle
lane). Morphology of the adipocytes was analysed by light microscopy (bottom lane).
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Summary
We have recently identified and
characterized a protein, consisting of seven
WD-repeats, presumably forming a β -
propeller, and a FYVE domain (ProF),
which targets the protein to vesicular
membranes. ProF bound the activated
kinases Akt and protein kinase Cζ/λ 
(PKCζ/λ) upon stimulation with insulin-like
growth factor-1 (IGF-1) (1). Here we
describe the vesicle-associated membrane
protein 2 (VAMP2) as interaction partner
of ProF. The interaction was demonstrated
with the ectopically expressed and the
endogenous proteins in mammalian cells.
ProF and VAMP2 colocalized on vesicular
structures with PKCζ  and the three
proteins formed a ternary complex. IGF-1
stimulation of HEK293T cells activated
PKCζ, which in turn led to phosphorylation
of VAMP2. ProF recruited activated PKCζ
t o  V A M P 2 ,  w h i c h  i n c r e a s e d
phosphorylation of VAMP2 in vitro. By
binding PKCζ  and VAMP2, ProF can
integrate the kinase with its substrate.
VAMP2 is known to regulate docking and
fusion of vesicles and to play a role in
targeting vesicles to the plasma membrane.
Thus, ProF may act as adaptor protein for
PKCζ  and VAMP2 and by this may
regulate vesicle cycling. The ternary
complex of ProF, VAMP2, and PKCζ may
also be involved in other secretory
pathways.
Introduction
We have recently identified the
propeller-FYVE protein (ProF) as a binding
partner for Akt and protein kinase
Cζ/λ (PKCζ/λ) (1). ProF contains seven WD-
repeats, which form a propeller-like structure
providing a protein binding-platform (2).
Furthermore, ProF harbors a FYVE domain
tha t  spec i f i ca l ly  in te rac t s  wi th
phosphatidylinositol-3-phosphate (PI3P) (3)
and targets ProF to internal vesicles. Deletion
of the FYVE domain or inhibition of PI3P-
formation by a phosphoinositide-3-kinase-
inhibitor resulted in loss of vesicular
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localization. ProF preferentially bound to the
activated kinases Akt and PKCζ/λ  upon
stimulation with insulin-like growth factor-1
(IGF-1) (1).
In adipocytes ProF translocated with
the kinases and glucose transporter 4 (GLUT4)
to the plasma membrane in response to insulin
stimulation. Akt and PKCζ/λ are known to
play a key role in insulin-dependent
translocation of GLUT4 from internal storage
vesicles to the plasma membrane in adipose
tissues (4). We recently demonstrated that
overexpression of ProF led to increased
glucose uptake upon insulin stimulation, while
knock-down of ProF by small interfering RNA
(siRNA) led to reduced glucose uptake. This
suggests a role of ProF in glucose metabolism
and possibly in other secretory pathways,
because of its broad tissue expression (1).
In order to better understand the role
of ProF in regulated vesicle trafficking, we
searched for substrates of Akt and PKCζ on
vesicles. While this work was in progress, the
Akt substrate of 160 kDa (AS160) has been
found to be located on GLUT4-containing
vesicles in adipocytes (5) where it affects
vesicle trafficking upon Akt phosphorylation
(6-8). Several PKCζ  substrates have been
described previously. The vesicle-associated
membrane protein 2 (VAMP2) may be one of
them (9). VAMP2 belongs to the vesicular
soluble N-ethylmaleimide-sensitive fusion
protein (NSF)-attachment protein receptors (v-
SNARE). This protein family comprises eight
members involved in secretory pathways (10).
VAMP2 is widely expressed in a large variety
of tissues such as brain, kidney, adrenal gland,
liver and pancreas (11). VAMP2 is crucial for
stimulus-dependent secretion in various cell-
types including insulin-stimulated GLUT4
translocation in adipocytes and muscle cells
(12-14), general fusion of early and sorting
endosomes (15,16), and synaptic vesicle
fusion with the plasma membrane in neurons
(17-20). The fusion of VAMP2-containing
vesicles with the plasma membrane is
mediated by complex formation of the v-
SNARE with the target-(t) SNAREs, which
are the synaptosome-associated protein
(SNAP) and syntaxin (21). VAMP2 has
previously been shown to be phosphorylated
in myotubes overexpressing PKCζ , which
correlated with increased GLUT4
translocation and glucose uptake (9). GLUT4
consists of twelve transmembrane spanning α-
helix segments forming a central pore for
diffusion of glucose molecules into the cell
(22).
ProF has been shown in our previous
analysis to be a binding partner of PKCζ (1).
In the present study we show that ProF also
interacts with VAMP2 in vitro and in vivo. We
furthermore demonstrate that all three proteins
form a ternary complex. In this complex ProF
brings PKCζ  in proximity to its substrate
VAMP2 and leads to  increased
phosphorylation of VAMP2 by activated
PKCζ. Thus, ProF is an adaptor protein, which
integrates kinases and their substrates such as
VAMP2, which, upon phosphorylation, may
contribute to the regulation of exocytotic
processes.
Experimental procedures
Antibodies and reagents - Antibodies against
Myc-epitope (A14, rabbit polyclonal and
9E10, mouse monoclonal),  against
hemagglutinin (HA) (Y-11, rabbit polyclonal),
and PKCζ (C-20, rabbit and goat polyclonal),
were obtained from Santa Cruz
Biotechnology. The mouse monoclonal and
the rabbit polyclonal antibody to VAMP2
were from Synaptic Systems and Calbiochem,
respectively. The antibody to Flag-epitope
(M2, mouse monoclonal) was from SIGMA. A
polyclonal peptide antibody directed against
the 15 C-terminal amino acids of ProF was
raised in rabbits and affinity purified on the
peptide used for immunization (1). This
peptide was also used for peptide competition
in endogenous interaction analysis. All
secondary antibodies for immunoblotting and
indirect immunofluorescence staining were
from Pharmacia Amersham and Jackson
Immuno Research, respectively.
Yeast two-hybrid analysis - A human B cell-
specific cDNA library was obtained from S.J.
Elledge (Baylor College of Medicine,
Houston, Texas) (23). The yeast two-hybrid
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analysis was performed essentially as
described using ProF as a bait (24). The
plasmid encoding Flag-VAMP2 has
previously been described (25) and was kindly
provided by Dr. Mitsunori Fukuda (RIKEN,
Japan).
Recombinant DNA manipulation and plasmid
constructs - Serine to alanine point mutations
were inserted into the coding sequence of
Flag-VAMP2 using the Quick Change
Mutagenesis Kit (Stratagene). Plasmid pEF-
Flag-VAMP2 was used as template. The
primers for mutagenesis were obtained from
Microsynth (Balgach, Switzerland), mutation
1 (S28A): forward, cca aac ctt act gct aac agg
aga ctg, reverse, cag tct cct gtt agc agt aag gtt
tgg; mutation 2 (S61A): forward, gac cag aag
ttg gcg gag ctg gat gac, reverse: gtc atc cag ctc
cgc caa ctt ctg gtc, mutation 3 (S75A):
forward, gca ggg gcc gcc cag ttt gaa, reverse:
ttc aaa ctg ggc ggc ccc tgc, mutation 4 (S80A):
forward, cag ttt gaa aca gct gca gcc aag ctc,
reverse, gag ctt ggc tgc agc tgt ttc aaa ctg. The
inserted mutation is highlighted in bold in the
forward primer. Mutants containing four
single and one mutant harboring all four
mutations were constructed. All mutations
were verified by DNA sequencing.
N-terminally Myc-tagged human ProF
encoding constructs were used (1): Myc-ProF,
Myc-ProF∆FYVE lacking the FYVE domain
for PI3P binding, Myc-ProF∆1-3∆FYVE
lacking blades 1 to 3 and the FYVE domain,
Myc-ProF∆4-7∆FYVE lacking blades 4 to 7
and the FYVE domain and Myc-ProF∆4-7
lacking blades 4 to 7 were used in this study.
A HA-tagged PKCζ construct was obtained
from F. J. Johannes.
Retroviral transduction and generation of
stably transduced 3T3-L1 fibroblasts
Retroviruses containing the construct pRTP-
Myc-ProF or the empty pRTP vector as
control were produced using the BOSC-23
packaging cell-line as described (26,27). Early
passage 3T3-L1 fibroblasts were incubated in
virus-containing medium for 48 h. The cells
were used for immunofluorescence studies.
Immunoprecipitation -  For  t rans ient
expression the human embryonic kidney cell
line (HEK) 293T was transfected with
expression vectors encoding the indicated
proteins using calcium phosphate (28). Cells
were lysed using a lysis buffer, containing 100
m M  N a C l ,  1  m M  e t h y l e n e -
diaminetetraaceticacid (EDTA), 20 mM Tris-
HCl, and 0.5 % NP-40 (NETN) (28) including
complete EDTA-free protease inhibitor tablets
(Roche Medicals) and cleared by
centrifugation at 16.000g and 4°C.
Interactions of endogenous proteins were
analyzed in mouse brain extracts. Proteins
were extracted in an extraction buffer
containing 20 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1mM EDTA, 0.2% NP-40 and
supplemented with protease inhibitor tablets,
by incubating the lysates at 4°C for 30 minutes
at vigorous shaking. Glycerol was added to a
final concentration of 10% after clearing of
lysates. Protein concentrations were
determined by Bradford assay in a
microtiterplate reader at 595 nm using Bovine
serum albumin (BSA) as standard.
Lysates were precleared for 1 hr using 30 µl
Protein-A-Sepharose (Amersham Pharmacia
Bio tech) .  C lea red  lysa te s  were
immunoprecipitated with 1 µg of the
appropriate antibody for at least 3 h at 4°C and
then 1 h in the presence of 10 µl of protein G-
sepharose (Amersham Pharmacia Biotech).
Immunoprecipitation of ProF  was conducted
overnight at 4°C. For competition studies 1 µg
anti-ProF antibody was preincubated with 10
µg peptide on ice for 30 minutes. Elution of
overexpressed Flag-VAMP2 was performed
by vigorous shaking for 1 hr at 24°C, followed
by two rounds of shaking for 1hr at 4°C in 120
µl of NETN- buffer containing 900 µg/µl of
Flag-peptide (Sigma).
Lysates and the resulting immunoprecipitates
were resolved on commercial 10-20% SDS-
polyacrylamide gradient gels (Invitrogen). The
primary and secondary antibodies were used at
a dilution of 1:10.000. Immunoblotting of
endogenous ProF was performed overnight at
4°C with a 1:1.000 dilution of the antibody.
All incubation and wash steps were performed
in 1% non-fat dry milk in Tris- buffered saline
(TBS) containing 0.1% Tween-20. Detection
was performed using a chemoluminescence
detection kit (Amersham Pharmacia Biotech).
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Confocal microscopy - The simian kidney
derived cell line COS-7 was grown on glass
cover slips and was transiently transfected
with Fugene-6 (Roche Medicals) according to
the manufacturers` instructions. Twenty hrs
after transfection, cells were washed with
phosphate-buffered saline (PBS), fixed with
3% paraformaldehyde and permeabilized in
PBS containing 0.25% Triton X-100. Cover
slips were successively incubated with
appropriate primary and secondary antibodies
before they were mounted in Mowiol (Hoechst
Pharmaceuticals). The cells were examined by
sequential excitation at 488 nm (fluorescein
iso th iocyanate  (FITC)) ,  568  nm
(tetramethylrhodamine isothiocyanate
(TRITC)) and 633 nm (cyanine-5 (CY5))
using a confocal microscope (SP2, Leica) and
a 40x1.25 oil objective (Leica). The images
were processed by using Photoshop (Adobe
Systems).
In vitro kinase assay - Flag-VAMP2 was
transiently expressed in the presence or
absence of Myc-ProF in HEK 293T cells.
Cells were lysed as described above and
lysates were immunoprecipitated using an
anti-Flag antibody. Immunocomplexes were
washed in a kinase reaction buffer (20 mM
Tris-HCl, pH 7.5, 20 mM CaCl2, 1 mM DTT).
For the kinase reaction the buffer was
supplemented with 3 µM protein kinase A
inhibitor, 20 µM ATP, and 10 µCi γ-32P-ATP
with a specific activity of 3.000 mCi/mole
(Amersham Pharmacia). To start the reaction
0.2 µg recombinant PKCζ  (Upstate) was
added to the samples. The phosphorylation
reaction was conducted at 30°C for 30 min
and was stopped by boiling the samples in
sodium dodecyl sulfate -polyacrylamide gel
electrophoresis (SDS-PAGE) loading buffer.
Samples were resolved on 10-20% SDS-
polyacrylamide gradient gels. Expression of
Flag-VAMP2 and Myc-ProF was verified by
immunoblotting and phosphorylation was
visualized using a Storm 840 Phosphoimager
(Molecular Dynamics).
Results
We have recently identified a protein,
consisting of seven WD-repeats, presumably
folding into a β-propeller-type structure, and a
FYVE domain (Fig. 1A), designated as ProF.
ProF interacted via its WD-repeats with the
serine/ threonine kinases Akt and PKCζ/λ and
was located on internal vesicles via its FYVE
domain (1). These two kinases preferentially
bound to ProF in their activated,
phosphorylated forms upon IGF-1 stimulation.
We furthermore showed that ProF is required
for glucose uptake in differentiated adipocytes.
Therefore, the question arose whether ProF at
the same time interacted also with putative
kinase substrate.
In order to identify such candidates,
we performed a yeast two-hybrid screen using
ProF as a bait and identified VAMP2 as a
putative interaction partner. VAMP2 is a v-
SNARE protein associated with vesicular
membranes via its C-terminal transmembrane
domain. Its central SNARE domain of
approximately 60 amino acids allows the
interaction of VAMP2 with its cognate t-
SNARE proteins (Fig. 1A) (10).
To verify these results, we first
analyzed the interaction of VAMP2 with ProF
by coimmunoprecipitation of overexpressed
proteins. For that purpose, Myc-tagged ProF
and Flag-tagged VAMP2-expression
constructs were cotransfected into HEK 293T
cells. Cell lysates were treated with an anti-
Flag antibody and the precipitates were
analyzed by immunoblotting for the presence
of coprecipitating proteins. As can be seen,
Myc-tagged ProF indeed coprecipitated with
Flag-tagged VAMP2 (Fig. 1B), validating the
results from yeast two-hybrid screen.
Further indications for the interaction
of both proteins were obtained by confocal
immunofluorescence analysis showing their
subcellular distribution. For that, Flag-tagged
VAMP2 and Myc-tagged ProF were co-
expressed in COS-7 cells and analyzed by
confocal microscopy. As can be seen, a partial
colocalization of VAMP2 (green signal) and
ProF (red signal) on vesicular structures was
detectable (Fig. 1C). Colocalization of the two
proteins is indicated by the orange color,
detectable in the merged picture, showing the
superposition of the two signals.
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We further characterized the
interaction between ProF and VAMP2 with
deletion mutants of ProF. We designed Myc-
tagged mutant ProF proteins, lacking either the
FYVE domain or the FYVE domain in
conjunction with blades 1 to 3 or blades 4 to 7
of the β-propeller (indicated in Fig. 1D). We
coexpressed these proteins together with Flag-
tagged VAMP2 in HEK 293T cells and tested
the interaction by coimmunoprecipitation
assays. As can be seen, all ProF-mutants
interacted equally well with VAMP2 (Fig.
1D ). This result suggested that multiple
binding sites on ProF are involved in the
binding of VAMP2.
We have previously shown that ProF
binds PKCζ (1) and show here the interaction
between ProF and VAMP2. Furthermore,
overexpression of PKCζ has been reported to
result in an increased phosphorylation of
VAMP2 (9). This raised the question whether
ProF would affect the interaction between
VAMP2 and PKCζ. In order to test that, we
expressed Flag-VAMP2 and HA-PKCζ in the
presence or absence of Myc-ProF in HEK
293T cells (Fig. 2A ). As can be seen,
coexpression of Myc-ProF led to the
coprecipitation of large amounts of HA-PKCζ
by Flag-VAMP2 (Fig 2A , lane 6). In the
absence of Myc-ProF only small amounts of
HA-PKCζ were coprecipitated, indicating a
weak interaction (Fig. 2A, lane 5), which may
be due to endogenous Prof. Furthermore, in
the absence of HA-PKCζ only small amounts
of Myc-ProF were coprecipitated, indicating
that the presence of all three proteins might
stabilize the ternary complex. Thus, ProF
could serve as an adaptor protein that mediates
the binding of PKCζ and VAMP2.
The ternary complex formation was
further confirmed by a sequential precipitation
procedure. For that purpose, we overexpressed
the epitope-tagged forms of all three proteins
in  HEK 293T cel ls .  Fi rs t  we
immunoprecipitated Flag-VAMP2 and showed
coprecipitation of Myc-ProF and HA-PKCζ
by Western Blotting analysis of an aliquot of
the immunoprecipitate (Fig. 2B, lane 2). The
precipitated complex was thereafter eluted
with a Flag-peptide and Myc-ProF was
immunoprecipitated. As can be seen,
coimmunoprecipitation of HA-PKCζ  was
demonstrated by immunoblotting (Fig. 2B,
lane 3). Coimmunoprecipitation of Flag-
VAMP2 was not detectable, possibly because
VAMP2 dissociated from the complex after
elution. Thus, Myc-ProF binds both proteins,
Flag-VAMP2 and HA-PKCζ, simultaneously.
To demonstrate the colocalization of
all three proteins, we performed confocal
microscopy analysis. For that, Flag-tagged
VAMP2, HA-tagged PKCζ and Myc-tagged
ProF were transiently expressed in COS-7
cells and analyzed by confocal microscopy. As
can be seen, a partial colocalization of the
three proteins on intracellular vesicles was
detected (Fig. 2C). Colocalization of the three
proteins is indicated by white color in the
merged picture, showing the superposition of
the three signals.
So far we analyzed overexpressed
proteins and now wanted to confirm our
results with endogenous proteins. ProF and
VAMP2 have been shown to be expressed in
the brain (1,29). Therefore, we tested mouse
brain lysates for the interaction between
endogenous ProF and VAMP2. For that, brain
lysates were treated with an anti-ProF
antibody with and without peptide competition
(1). The peptide competition demonstrated the
specificity of the reaction. The precipitates
were analyzed by Western Blotting. As can be
seen, coprecipitation of VAMP2 with ProF
was detectable. As ProF was not precipitated
in the presence of the peptide, the loss of the
VAMP2 signal in the immunoprecipiate
indicates an interaction between ProF and
VAMP2 (Fig. 3A). Thus, we confirmed the
interaction not only for overexpressed ProF
and VAMP2, but also for endogenous proteins
in brain tissue.
In order to further characterize the
interaction of the endogenous proteins, we
immunoprecipitated all three endogenous
proteins, ProF, VAMP2, and PKCζ  from
mouse brain lysates. The lysates were treated
with antibodies against the individual proteins
and the precipitates were analyzed by Western
Blotting with antibodies against ProF,
VAMP2, and PKCζ . As can be seen, only
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after precipitation with anti-ProF antibodies all
three proteins were present in the
immunoprecipitates (Fig. 3B ). PKCζ
precipitated small amounts of VAMP2, but did
not precipitate detectable amounts of ProF,
and VAMP2 precipitated small amounts of
ProF, but did not precipitate detectable
amounts of PKCζ. This result confirms the
role of ProF as binding partner for VAMP2
and PKCζ  not only in the overexpression
system, but also for the endogenous proteins
as demonstrated in brain tissue.
We confirmed these biochemical
results by confocal microscopy studies with
3T3-L1 cells. For that, 3T3-L1 pre-adipocytes,
stably expressing Myc-ProF, were subjected to
immunofluorescence analysis. As can be seen,
Myc-ProF, endogenous VAMP2, and
endogenous PKCζ colocalized on perinuclear
vesicular structures (Fig. 3C). These results
are in agreement with the previous findings
that ProF is located on internal vesicles in
various cell lines and e.g. in unstimulated 3T3-
L1 adipocytes, where it colocalized with
endogenous PKCζ (1).
Next we asked whether activated
PKCζ  was able to directly phosphorylate
VAMP2. We considered this as likely, because
it had been shown by Braiman and coworkers,
that overexpression of wild-type PKCζ in
myotubes accelerated insulin-dependent serine
phosphorylation of VAMP2, while
overexpression of dominant negative PKCζ
c o m p l e t e l y  a b o l i s h e d  V A M P 2
phosphorylation even in the presence of
insulin. Thus, these authors supplied some
evidence for phosphorylation of VAMP2 by
PKCζ  (9). We addressed this question by
transient overexpression of Flag-VAMP2 with
and without HA-PKCζ in HEK 293T cells.
Cells were stimulated with 100 ng/ml IGF-1 in
order to activate PKCζ, or left unstimulated.
15 min later cells were lysed and Flag-
VAMP2 and associated proteins were
immunoprecipitated using an anti-Flag
antibody. The precipitates were subjected to
an in vitro kinase assay. Phosphorylation was
initiated by adding γ-32P-ATP. Subsequently
the precipitates were separated by SDS-PAGE
and analyzed for radioactive signals using the
PhosphoImager. As can be seen, IGF-1-
stimulation led to substrate phosphorylation of
the immunoprecipitated VAMP2 and to
phosphorylation of the coimmunoprecipitated
PKCζ  (Fig, 4A ) .  Thus ,  VAMP2
phosphorylation depends on IGF-1 stimulation
and activated PKCζ.
After having confirmed the
phosphorylation of VAMP2 by IGF-1-
s t imula ted  PKCζ , we mapped the
phosphorylation site on VAMP2. For that, we
generated mutants of VAMP2, in which
different serine residues were mutated to
alanine. Out of the six serine residues
conserved in mouse and rat VAMP2 (S2, S28,
S61, S75, S80, S115) (Fig. 1A), we excluded
S2 from mutation because of its position at the
very N-terminus and S115, because of its C-
terminal position and its location inside the
vesicle, which seemed to be an unlikely target
for phosphorylation. The four remaining serine
residues were mutated to alanine. Three of
these sites are located within the SNARE
motif (S61, S75 and S80). The fourth one is
located in the N-terminal sequence (S28) and
has previously been reported to represent a
PKC phosphorylation site in vitro (30). The
only mutant that showed a markedly reduced
32P-phosphorylation by about 70% reduction
after PKCζ  treatment was the Flag-
VAMP2mt(1-4) mutant, in which all four
possible PKC targets were converted into
alanine (data not shown). Residual 32P-
phosphorylation could be due to
phosphorylation of threonine residues by
PKCζ . This indicated that all four serine
residues of VAMP2 could be PKCζ-dependent
phosphorylation sites
So far we have shown that VAMP2 is
a substrate of PKCζ in HEK 293T cells upon
IGF-1 stimulation (Fig. 4A ). In a final
experiment we wanted to include the analysis
of ProF and its effects. Instead of using IGF-1-
s t i m u l a t e d  c e l l s  w e  t r e a t e d
coimmunoprecipitates of VAMP2 and ProF
with active recombinant PKCζ, because we
have shown above that ProF can lead to
increased binding of PKCζ to VAMP2 (Fig.
2A). Therefore, it appeared likely that this
in teract ion resul ted in  increased
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phosphorylation of VAMP2. In order to test
this, Flag-VAMP2 wild-type (wt) and the
Flag-VAMP2 mutant with the four S to A
mutations, designated as Flag-VAMP2mt(1-
4), were transiently expressed with and
without Myc-ProF in HEK 293T cells. Flag-
VAMP2 was immunoprecipitated with an anti-
Flag antibody. The precipitates were subjected
to an in vitro kinase assay using recombinant
active PKCζ and subsequently analyzed for
the presence of 32P-phosphorylation. As
expected, phosphorylation of Flag-VAMP2 by
PKCζ was increased in the presence of Myc-
ProF (Fig. 4B). Flag-VAMP2mt(1-4) did not
show in vitro 32P-phosphorylation (Fig. 4B,
lane 3), proving the specificity of the
interaction. In summary, these data revealed
that the presence of Myc-ProF increases the in
vitro phosphorylation of Flag-VAMP2 by
activated PKCζ.
Discussion
We have previously identified ProF as
an adaptor molecule, which is located on
internal vesicles and binds to activated Akt
and PKCζ upon IGF-1-stimulation (1). This
raised the question on putative kinase
substrates, which might also interact with
ProF. We addressed this question using
different experimental approaches. An initial
yeast two-hybrid screen indicated the
possibility of VAMP2 being a binding partner
of ProF. We confirmed the physical
interaction of VAMP2 and ProF by
coimmunoprecipitation of overexpressed and
endogenous proteins. VAMP2 is known to be
anchored via its transmembrane domain to
secretory vesicles in e.g. adipocytes where it
represents the v-SNARE protein responsible
for mediating fusion of vesicles, such as the
insulin-induced fusion of GLUT4–containing
vesicles with the plasma membrane (13,31). In
adipocytes and skeletal muscle cells, VAMP2
has been described to bind to the t-SNARE
proteins syntaxin-4 and SNAP-23, found at the
plasma membrane (32,33), whereas in neurons
VAMP2 interacts with syntaxin-1 and SNAP-
25 at the plasma membrane for
neurotransmitter release (17-20). These
findings demonstrate the general role of
VAMP2 in a number of secretory systems.
Many vesicle cycling events rely on
the interaction of v-SNARE and t-SNARE
proteins, which allows docking of vesicles to
their target membranes. SNARE complex
formation is thought to bring the opposing
membranes close enough for fusion (34).
These SNARE-dependent fusion events
include a number of secretory processes such
as insulin release from pancreatic β-cells (35-
37), synaptic vesicle exocytosis (38), granule
release in hematopoetic cells (39), and
aquaporin- (40), or GLUT4-translocation to
the plasma membrane (14,41). In general,
exocytotic events are regulated by a variety of
mechanisms including phosphorylation of
SNARE and accessory proteins (38).
In this study we show that ProF can
mediate the interaction between PKCζ  and
VAMP2. ProF, VAMP2, and PKCζ
colocalized on vesicular structures and formed
a ternary complex. Therefore, we
hypothesized that the presence of ProF may
improve phosphorylation of VAMP2. Indeed,
PKCζ-dependent phosphorylation of VAMP2
in vitro was enhanced in the presence of ProF.
Furthermore, IGF-1 stimulation induced
activation of PKCζ and phosphorylation of
VAMP2 in vitro. It is currently unknown how
t h e  P K Cζ-dependent phosphorylation
influences the interaction of VAMP2 with its
cognate t-SNAREs or with accessory proteins.
Whether the PKCζ-dependent phosphorylation
of VAMP2 decreases or increases the
interaction between the v-SNARE and t-
SNARE proteins and how it regulates vesicle
cycling should be investigated in future
studies.
We specified four serine residues
within the VAMP2 molecule, which represent
potential phosphorylation sites and mutated
them to alanine. Three of the four mutated
serine residues were found within the highly
conserved SNARE motif of VAMP2. This
motif fits to the SNARE motifs of syntaxin-4
and SNAP-23 and would allow a twisted,
parallel 4-helical bundle (18). Since the
driving forces for the generation of the helical
bundle are mostly hydrophobic interactions,
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one or several highly polar phosphorylated
serine residues could disturb the formation of
the bundle. However, several reports showed
that decreased binding of SNARE proteins to
each other could lead to an increased fusion of
vesicles. For example, SNAP-25 is
phosphorylated by PKC at S187, which lies
within the C-terminal SNARE motif (42-44).
Activation of PKC by various agents resulted
in phosphorylation of SNAP-25 (43). This
phosphorylation decreased binding of SNAP-
25 to  syntaxin-1 and increased
neurotransmitter release, possibly by
accelerating the SNARE complex dissociation
and thus enhancing the efficiency of
exocytosis (43). Similar results have been
obtained in the case of PKC-dependent
phosphorylation of syntaxin-4 and SNAP-23
( 4 5 , 4 6 ) .  T h u s ,  P K Cζ-mediated
phosphorylation of VAMP2 in response to
stimulation as shown here may interfere with
the interaction of the v-SNARE protein
VAMP2 with t-SNARE proteins and may
thereby lead to reduced affinity – possibly
promoting disassembly and therefore
accelerating vesicle trafficking as described
for the SNARE proteins above.
Another possibility would be that the
phosphorylation of VAMP2 by PKCζ
influences its interaction with accessory
proteins. Such proteins can up- or
downregulate SNARE- to SNARE-protein
interactions. For example Munc18c inhibits
SNARE- to SNARE-protein interaction and
thus negatively regulates insulin-stimulated
translocation of GLUT4 to the plasma
membrane in adipocytes (47,48). Recently,
several interaction partners of VAMP2 such as
prenylated Rab acceptor 1 (PRA1) (49), a
VAMP2 associated protein of 33 kDa (VAP-
33) (50,51), and pantophysin (52) were found
in 3T3-L1 cells, however their precise role in
vesicle fusion is not yet understood.
Without knowledge of the precise
mechanism of action, our results demonstrate
that ProF stimulates phosphorylation of the
SNARE protein by PKCζ. This could be a
possible mechanism by which PKCζ
influences vesicle trafficking. Recruitment of
PKCζ to VAMP2 by means of ProF enhanced
the substrate phosphorylation of the SNARE
protein (as depicted in Fig. 5). IGF-1
stimulation increased the phosphorylation of
PKCζ and VAMP2. Furthermore, a role of
ProF in insulin metabolism can be envisaged.
We showed previously in adipocytes that ProF
translocates upon insulin- stimulation to the
plasma membrane, parallel to GLUT4, and
increases glucose uptake (1). At which time
point VAMP2 gets phosphorylated by PKCζ
we do not know.
The expression profile of ProF
suggested a broad tissue distribution. Thus, the
ternary complex of ProF, VAMP2 and PKCζ
may occur in other tissues as well, possibly
involved in other secretory pathways.
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VAMP2, vesicle-associated membrane protein 2; VAP-33, VAMP associated protein of 33 kDa;
v-SNAREs, vesicular-SNARE
Figure legends
Fig.1. VAMP2, a new interaction partner of ProF. A, Domain structure of ProF and VAMP2.
ProF consists of 7 WD-repeat motifs (WD1-7, indicated as blue boxes) for binding to proteins
and a FYVE domain (indicated as black box), which enables binding to PI3P on vesicular
membranes (top panel). VAMP2 is anchored to vesicular membranes through its C-terminal
transmembrane domain (TM). Furthermore, it possesses a central SNARE motif essential for the
interaction with its target SNARE proteins on the plasma membrane. Serine residues, which are
potential PKCζ-phosphorylation sites are indicated below (bottom panel). B ,
Coimmunoprecipitation assay of transiently overexpressed Myc-tagged ProF and Flag-tagged
VAMP2 in HEK 293T cells. Immunoprecipitates were analyzed by immunoblotting (IB) with
antibodies against Flag- and Myc-epitopes. The upper panel shows the interaction. C ,
Colocalization of Myc-ProF and Flag-VAMP2. Myc-ProF and Flag-VAMP2 were transiently
overexpressed in COS-7 cells. Confocal microscopy analysis with Flag-specific and Myc-specific
antibodies revealed areas of colocalization as visualized in yellow on the merged picture
(bottom). D, Characterization of the interaction between ProF and VAMP2. Myc-ProF wild-type
(wt), ProF lacking the FYVE domain (Myc-ProF∆FYVE), and in addition lacking blades 1-3
(Myc-ProF∆1-3∆FYVE) or lacking blades 4-7 (Myc-ProF∆4-7∆FYVE) were transiently
overexpressed together with Flag-VAMP2 in HEK 293T cells. Interaction of ProF with VAMP2
was analyzed by immunoprecipitation (IP) with an antibody to the Flag-tag followed by
immunoblotting (IB) with antibodies against Flag- and Myc-epitopes.
Fig. 2. Interaction of ProF and VAMP2 with PKCζ . A, Myc-ProF increases the interaction of
PKCζ and VAMP2. HA-PKCζ, Flag-VAMP2 and Myc-ProF were transiently overexpressed in
HEK 293T cells. Interaction of VAMP2 with ProF and PKCζ  was analyzed by
immunoprecipitation (IP) with an antibody to the Flag-epitope followed by immunoblotting (IB)
with antibodies against HA-, Myc- and Flag-epitopes. B, HA-PKCζ, Flag-VAMP2 and Myc-ProF
form a ternary complex. HA-PKCζ, Flag-VAMP2 and Myc-ProF were transiently coexpressed in
HEK 293T cells. The ternary complex comprising HA-PKCζ, Flag-VAMP2 and Myc-ProF was
immunoprecipitated with an anti Flag-antibody. The complex was eluted from the antibody by
addition of an excess of a competing Flag-peptide followed by an immunoprecipitation using an
antibody directed against the Myc-epitope. Immunoprecipitates of the different steps were
analyzed by immunoblotting against HA-, Myc- and Flag-epitope. Lane 1, Direct lysate (DL) of
HEK 293T cells expressing HA-PKCζ, Flag-VAMP2 and Myc-ProF; Lane 2, Complex after
immunoprecipitation with anti Flag-antibody; Lane 3, Complex after peptide competition with
Flag-peptide and subsequent immunoprecipitation with anti-Myc-antibody. C , COS-7 cells
transiently expressing HA-PKCζ (green), Flag-VAMP2 (red) and Myc-ProF (magenta) were
analyzed by confocal microscopy using antibodies against HA-, Flag- and Myc-epitopes. A
partial colocalization on cytoplasmic punctuate structures (white) is observed (merged).
Fig. 3. Interaction and colocalization of endogenous PKCζ, VAMP2 and ProF. A, Murine brain
lysates were treated with an anti-ProF antibody in the presence and absence of an excess of
competing peptide used as antigen to raise the anti-ProF antibody. The precipitates were analyzed
by immunoblotting for the presence of VAMP2 and ProF. B, Immunoprecipitation analysis using
antibodies directed against PKCζ, ProF, and VAMP2. Precipitates were immunoblotted against
PKCζ, ProF, and VAMP2. C , For confocal immunofluorescence analysis of 3T3-L1 pre-
adipocytes were serum-starved for 2 hrs prior to staining for endogenous PKCζ/λ (green),
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endogenous VAMP2 (red), and Myc-tagged ProF (magenta). A partial colocalization on
cytoplasmic punctuate structures (white) is observed (merged and merged, zoomed).
Fig. 4. Phosphorylation of Flag-VAMP2 by PKCζ is increased in vitro by ProF. A, Flag-VAMP2
was overexpressed in the presence (lane 2 – 3) and absence (lane 1) of HA-PKCζ in HEK 293T
cells. Cells were stimulated with 100 ng/ml IGF-1 for 15 min (lanes 1, 3). Flag-VAMP2 and
Flag-VAMP2 - HA-PKCζ complexes were immunoprecipitated with an antibody directed against
the Flag-epitope. Immunoprecipitates were subjected to a in vitro kinase assay (IVKA) with γ-
32P-ATP. VAMP2 phosphorylation and PKCζ autophosphorylation were analyzed using a
Phosphoimager (panels 1 and 2). Expression of proteins was analyzed by immunoblotting against
Flag-epitope (panels 3 and 5) and HA-epitope (panels 4 and 6). The panels 1 – 4 show the
immunoprecipitates (IP), panels 5 – 6 the direct lysates (DL). B, Flag-VAMP2 wild-type (wt) and
VAMP2 serine to alanine mutant (mt(1-4)) were overexpressed in the presence and absence of
Myc-ProF in HEK 293T cells. Flag-VAMP2 and Flag-VAMP2 - Myc-ProF complexes were
obtained by immunoprecipitation with an antibody directed against the Flag-epitope.
Immunoprecipitates were phosphorylated by addition of recombinant PKCζ  and γ -32P-ATP.
VAMP2 phosphorylation and PKCζ autophosphorylation was analyzed using a Phosphoimager
(panel 1 and 2) and expression of proteins by immunoblotting against Flag-epitope (panel 3 and
4) and Myc-epitope (panel 5 and 6).
Fig. 5. Model of the general role of ProF in secretory systems. Stimulation of the cells induces a
signal transduction cascade, which leads to activation of a kinase, such as the atypical protein
kinase PKCζ. PKCζ is recruited to VAMP2-containing vesicles through the protein ProF. ProF
enables the interaction between activated PKCζ and v-SNARE VAMP2, leading to the
phosphorylation of VAMP2 by activated PKCζ. The vesicle then translocates to the plasma
membrane, where the interaction of VAMP2 with its cognate target t-SNARE induces
incorporation of the vesicle membrane into the plasma membrane.
82
A.
Flag-VAMP2
Myc-ProF
IB: anti- Myc
IP: anti-Flag
IB: anti-Myc
IP: anti-Flag
IB: anti-Flag
Myc-ProF
Flag-VAMP2
Myc-ProF
1 2 3
+
-
-
+
+
+B.
Flag-VAMP2
Myc-ProF
merged
C.
S25 S80S75S61
WD3 WD6 FYVE WD7WD5WD1 WD4WD2
SNARE
1 116
1 400
30 90 94
52 96 141 183 227 270 352
D.
IP:anti-Flag
IB:anti-Flag
IB:anti-Flag
Myc-ProF wt
Myc-ProF∆FYVE
Myc-ProF∆4-7∆FYVE
Myc-ProF∆1-3∆FYVE
Flag-VAMP2
IB:anti-Myc
Flag- VAMP2
Myc-ProF wt
Myc-ProF∆FYVE
Myc-ProF∆1-3∆FYVEV
Myc-ProF∆4-7∆FYVE
Flag- VAMP2
IP:anti-Flag
IB:anti-Myc
Myc-ProF wt
Myc-ProF∆FYVE
Myc-ProF∆1-3∆FYVE
Myc-ProF∆4-7∆FYVE
-
-
-
-
+
1
+
-
-
-
-
2
-
+
-
-
-
3
-
-
+
-
-
4
-
-
-
+
-
5
+
-
-
-
+
6 7
-
+
-
-
+
8
-
-
+
-
+
9
-
-
-
+
+
FYVE5
3
6
72
4
1
VAMP2
ProF
S2 S115
TM
Figure 1
IP: anti-Flag
IB: anti-Myc
IP: anti-Flag
IB: anti-HA
IB: anti-HA
HA-PKCζ
Myc-ProF
Flag-VAMP2
IB: anti-Myc
IP: anti-Flag
IB: anti-Flag
HA-PKCζ
Myc-ProF
Flag-VAMP2
HA-PKCζ
Myc-ProF
Flag-VAMP2IB: anti-Flag
+
-
-
-
-
+
-
+
-
-
+
+
+
-
+
+
+
+
A.
C.
Myc-ProF mergedHA-PKCζ Flag-VAMP2
Figure 2
IB:anti-Myc
IB:anti-Flag
IB:anti-HA HA-PKCζ
Myc-ProF
Flag-VAMP2
1 2 3 4 5 6
B.
1 2 3
D
L
IP
: a
nt
i- 
Fl
ag
IP
: a
nt
i- 
M
yc
83
B.
IB:anti-ProF
IB:anti-VAMP2 VAMP2
ProF
A.
VAMP2PKCζ/λ mergedMyc-ProF
C.
+ --
VAMP2
ProF
PKCζ/λ
IB:anti-ProF
IB:anti-VAMP2
IB:anti-PKCζ/λ
DL
- -+
- +-
IP: anti-PKCζ
IP: anti-ProF
IP: anti-VAMP2
+ +
- +
IP: anti-ProF
Competing peptide
IgG
Figure 3
84
+ - +
A.
Flag-VAMP2 wt + + -
Myc-ProF - + +
Flag-VAMP2 mt(1-4) - - +
32P-VAMP2
32P-PKCζ
Flag-VAMP2 wt/mt(1-4)
Myc-ProF
Myc-ProF
Phospho-Blot
IB:anti-Flag
IB:anti-Myc
Phospho-Blot
IP:anti-Flag
IP:anti-Flag
IB:anti-Myc
Flag-VAMP2 wt/mt(1-4)IB:anti-Flag
B.
1 2 3
Flag-VAMP2
HA-PKCζ
32P-VAMP2
32P- PKCζ 
IP: α-Flag
IP: α-Flag
IP:α-Flag, IVKA
IP:α-Flag, IVKA
IB: α-Flag
IB: α-HA
IGF-1 stimulation:
- + +HA-PKCζ:
+ + +Flag-VAMP2:
IB: α-Flag
IB: α-HA
Flag-VAMP2
HA-PKCζ
1 2 3
IP
DL
1 2 3
Figure 4
85
Stimulus
PKCζ
ProF
VAMP2
t-SNARE
VAMP2 P
PKCζ
P
P
Figure 5
86
87
4.3 WD-FYVE PROTEIN REGULATES DIFFERENTIATION
OF PREADIPOCYTES AND GLUCOSE UPTAKE IN
ADIPOCYTES
(manuscript to be submitted)
Thorsten Fritzius, Jochen Heinrich and Karin Moelling*
From the Institute of Medical Virology, University of Zurich, Gloriastrasse 30, CH-8006
Zurich, Switzerland
Running Title: Role of WD-FYVE protein in adipogenesis
*Address correspondence to: Karin Moelling, Institute of Medical Virology, University of Zurich
Gloriastr. 30 CH-8006 Zurich, Switzerland. Phone: ++41 44 634 26 52; Fax: ++41 44 634 49 67; E-
mail: moelling@immv.unizh.ch
Summary
We have recently identified a
protein, consisting of seven WD-repeats,
presumably forming a β-propeller, and a
FYVE domain, ProF, which binds the
activated kinases Akt and protein kinase
Cζ /λ  (PKCζ /λ ) upon stimulation and is
involved in glucose uptake in 3T3-L1
adipocytes. Overexpression of ProF led to
increased glucose uptake, while its knock
down by small interfering RNA (siRNA)
caused reduced glucose uptake (1). Here we
describe that ProF also influences
differentiation of 3T3-L1 preadipocytes into
adipocytes. Protein and lipid droplet
accumulation was delayed in 3T3-L1 cells
with ProF knock down. The effect of
downregulation of ProF on protein
accumulation and glucose uptake was
effective during the onset of differentiation.
ProF influenced the expression of several
adipocyte differentiation- related proteins,
but did not influence the growth rate of the
cells. Use of two different siRNAs targeted
against the ProF mRNA revealed that
complete down regulation of ProF strongly
influenced glucose uptake and adipogenesis
in a concentration-dependent manner, since
partial downregulation had a much weaker
effect. Thus, we propose that ProF affects
both, early differentiation and glucose
uptake of differentiated cells.
Introduction
We have recently identified the
propeller- FYVE protein (ProF) as binding
partner for Akt and protein kinase Cζ /λ
(PKCζ/λ) (1). In adipocytes, ProF translocated
together with the kinases and the glucose
transporter 4 (GLUT4) to the plasma
membrane in response to insulin. As the two
kinases play a major role in insulin-dependent
GLUT4 translocation from internal vesicles to
the plasma membrane in adipocytes (2), we
investigated the role of ProF in this process
and recently demonstrated that the protein
regulates glucose uptake in adipocytes as
shown by overexpression as well as
downregulation of ProF. In order to better
understand the role of ProF in the adipocyte
system, we expanded our investigation to the
process of adipogenesis, the generation of
adipose tissue from fibroblast-like precursor
cells. Adipogenesis controls the number of
adipocytes present in an organism (3) and
strongly increased number and size of
adipocytes can result in obesity (4).
Obesity has become a health problem
of epidemic proportion both in the developed
and the developing world (5). It serves as a
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significant risk factor for many diseases such
as diabetes type II, cancer, heart disease and
hypertension (6-8). Therefore, the investigation
of adipogenesis is of high relevance to obesity
research.
To address this question, we decided
to investigate the role of ProF in the 3T3-L1-
cell line, which provides a well-characterized
model for the study of adipocyte specific
terminal differentiation and adipogenesis (9-
12).  3 T 3 - L 1  p r e a d i p o c y t e s  a r e
morphologically similar to fibroblasts and
grow exponentially until they reach
confluence. This leads to cell-cycle arrest at
the G0/G1 cell cycle boundary, arrest of
proliferation and the expression of early
adipocyte differentiation markers, including
low density lipoprotein (LDL) (13-15).
Exposure of the cells to hormonal agents such
as insulin, dexamethasone (DMX) and 3-
isobutyl-1-methylxanthine (IBMX) causes the
synchronous re-entry of all preadipocytes into
the cell cycle by traversing the G1/S
checkpoint, followed by a limited number
(approximately two rounds) of mitotic cell
divisions. This period is called the mitotic
clonal expansion phase (16). DNA synthesis
during this period probably alters accessibility
of promoter control elements to transcription
factors. During this phase intermediate
differentiation markers, such as CAATT-
enhancer-binding protein (C/EBP)β  and
C/EBPδ , are expressed, which prime the
different iat ion pathway (17) b y
transcriptionally activating the peroxisome
proliferator-activated receptor (PPAR)γ and
C/EBPα genes (18-21).
The phase of clonal amplification is
followed by an unique cell-cycle stage of
permanent growth-arrest, called GD (22,23),
which is probably the result of the antimitotic
activity of PPARγ and C/EBPα . (24-28). In
this phase expression of late differentiation
markers occurs. Examples are GLUT4 and the
insulin receptor (IR), but also C/EBPα, which
is important for maintenance of the terminally
differentiated state. Expression of these
proteins also leads to downregulation of the
extracellular matrix and reorganization of the
cytoskeleton (12). Together, this results in
differentiation of the cells into mature, fully
differentiated adipocytes, as seen by rounding
up of cells into a spherical shape and
accumulation of large cytosolic lipid vacuoles
– the triacylglycerol droplets. After an
extended period in culture the vacuoles
coalesce and become unilocar, causing the
typical signet ring appearance of mature white
adipocytes (11).
Adipocyte differentiation is controlled
by complex actions involving gene expression
and signal transduction. It is mediated by
several transcription factors identified as
master regulators for adipogenesis. However,
the mechanisms underlying the steps, which
trigger the initiation of differentiation, remain
unknown up to date.
ProF has been shown to be involved in
glucose metabolism of 3T3-L1 cells in our
previous analysis (1). In the present study we
demonstrate that ProF influences both,
differentiation of preadipocytes and glucose
uptake in mature adipocytes. ProF knock down
led to delayed protein and lipid droplet
accumulation during the initial phase of
differentiation. ProF further influenced the
expression of several adipocyte differentiation-
related proteins. Use of two different siRNAs
targeted against ProF revealed that both, the
glucose uptake and the onset of differentiation
were dependent on expression levels of ProF.
Results
We have recently identified and
characterized a protein, consisting of seven
WD-repeats, presumably forming a β-
propeller, and a FYVE domain, which we
designated as ProF (1). While the WD-repeats
of ProF form a protein- protein interaction
platform (29), the FYVE domain specifically
interacts with phosphatidylinositol-3-
phosphate, found on vesicular membranes
(30). ProF preferentially bound the activated
kinases Akt and PKCζ/λ upon stimulation with
insulin-like growth factor 1 (IGF-1). Using
adipocytes as model system to understand the
role of ProF, we found that the protein
translocated with the kinases and glucose
transporter 4, GLUT4, to the plasma
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membrane in response to insulin stimulation.
We also showed that overexpression of ProF
led to increased glucose uptake upon insulin
stimulation, while knock down of ProF by
siRNA led to reduced glucose uptake. This
suggested a role of ProF in adipocytes (1).
In order to better understand the
function of ProF in this system we analyzed
the role of ProF during adipocyte
differentiation. To that end, we transduced
3T3-L1 cells with a lentiviral vector expressing
a siRNA targeted to ProF mRNA (siProF3), an
empty lentiviral vector control (FUGW) or
used untransduced (parental) cells. Cells were
thereafter subjected to differentiation using a
hormonal induction medium (Fig. 1) and
monitored by visual inspection using light
microscopy. This method is warranted,
because the drastic alterations in the
morphology of the cell during conversion to
spherical shape are highly important for the
regulation of adipogenesis. For example, the
proteolytic degradation of the extracellular
matrix has been reported to promote the
expression of critical adipocyte differentiation
factors such as C/EBPα  and PPARγ (31).
Indeed, visual observation of the cells revealed
that ProF affects adipocyte differentiation. The
differentiation of adipocytes is a multi-step
process that successively requires 1.) growth
inhibition by cell-cell contact, 2.) hormonal
induction, causing mitotic clonal expansion,
and 3.) ultimative growth arrest, followed by
terminal differentiation – as shown i.e. by
rounding up of the cells - and the accumulation
of triacylglycerol storage vacuoles – as shown
by accumulation of lipid droplets (Fig. 1).
While parental and FUGW- transduced 3T3-
L1 cells differentiated as expected, we found
that siProF3 cells behaved radically different
during the phase of mitotic clonal expansion
and terminal differentiation. Cells with ProF
knock down retained for a longer period a
fibroblast-like morphology, and started to
round up at least 24 hours later than the control
cells (Fig. 2A). However, at the stage of
terminal differentiation (day +7) the cells with
ProF knock down showed a morphology that
was undistinguishable from the appearance of
the parental and FUGW- transduced 3T3-L1
cells (Fig. 2A, right). Furthermore, Oil Red O
staining of the lipid droplets of the cells
demonstrated a delay in lipid accumulation
(data not shown).
Because adipocyte differentiation is
accompanied by a massive increase in protein
content during mitotic clonal expansion
(32,33), we decided to investigate protein
levels of the cells during adipocyte
differentiation by Bradford method. We found
that cells transduced with siProF3 showed a
clear delay in protein accumulation during
mitotic clonal expansion, which is most
prominent at day +1. In terminally
differentiated cells protein levels of siProF3-
expressing cells are indistinguishable from
untransduced and control cells. Furthermore,
we investigated the cell number of both,
untransduced and transduced cells during
adipogenesis, because a hallmark of the mitotic
clonal expansion phase is a limited number –
approximately one to two rounds - of mitotic
cell divisions (16). Interestingly, we could not
find a difference between siProF3-transduced
and untransduced cells, leading us to the
assumption that ProF does not influence the
clonal expansion as such. In summary, these
data show that ProF leads to a delay in both,
protein synthesis and lipogenesis, the
accumulation of lipid droplets.
Next, we wanted to know whether
ProF affected the expression of marker
proteins, which regulate adipogenesis. We
performed a time course experiment, in which
we lysed 3T3-L1 cells at different stages of
adipogenesis and subjected the lysates to SDS-
PAGE analysis (Fig. 3). First, we investigated
the expression levels of ProF. Expression of
siProF3 led to the downregulation of ProF3
below detection level, while expression of the
empty control vector did not influence ProF
expression. Furthermore, we found that
expression of the ProF protein increased during
hormonal induction, which peaked in the
mitotic clonal expansion phase (day –1 to day
0), and gradually declined during terminal
differentiation (Figure 3, lane 1). The
expression of the PPARγ protein, which is
known to be induced at –1 and peaks at day +1
(34), was slightly reduced during mitotic
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clonal expansion but was unaffected during
terminal differentiation (Figure 3, lane 2).
Similarly, the expression of the late
differentiation marker GLUT4 was slightly
reduced at early time points (day  +1), but
unaffected during terminal differentiation
(Figure 3, lane 4). The expression of Akt2,
which is known to be upregulated during
adipogenesis (35,36), was slightly affected by
ProF knock down (Figure 3, lane 3) at day +0.
However, ProF knock down did not alter the
expression of the loading control Erk2 (Figure
3, lane 5). These results suggest that ProF
affects the expression of a number of marker
proteins of adipogenesis.
We further wanted to characterize the
role of ProF in adipogenesis by determining
the uptake of glucose in siProF3- transduced
and control cells. For that purpose, we
differentiated 3T3-L1 preadipocytes and
measured the uptake of radioactive glucose at
different time points during differentiation. At
day +1, the insulin-stimulated glucose uptake
of siProF3 cells was 50% of the insulin-
dependent glucose incorporation of the control
cells after standardized for total protein
amounts (Fig. 4A and Fig. 4B, left), while the
total protein levels were 60% of the control, as
determined by Bradford method. At day +4,
the insulin-stimulated glucose uptake of
siProF3-expressing cells was still only 60% of
that obtained for the control cells, whereas the
total protein level was already 85% of the
control (Fig. 4A and Fig. 4B, middle). At day
+7, total protein levels were comparable to
those at day +4, but the glucose uptake of
siProF3 cells was undistinguishable from that
in the untransduced and FUGW-control vector
transduced cells (Fig. 4A and Fig. 4B, right).
In summary, these data demonstrate that ProF
affects glucose uptake in adipocytes, but this
effect is limited to the initial phase of
differentiation. Furthermore, ProF still
influenced glucose uptake at day +4, where
total protein levels and cellular morphology
(not shown) were almost indistinguishable
from the controls.
Next, we wanted to confirm this
results by testing if ProF influenced
adipogenesis indirectly by increasing the
growth or proliferation rate of the cells. If
knock down of ProF would slow down the
growth of the preadipocyte cells, it would
cause a delay of adipogenesis, because
adipogenesis is dependent on the confluent
state of the cells, which causes cell-cycle arrest
at the G0/G1 cell cycle boundary, the arrest of
proliferation and expression of early adipocyte
differentiation markers, including the low
density lipoprotein (LDL) (13-15). To test that,
3T3-L1 cells, which were untransduced
(parental), transduced with empty vector
(FUGW), or transduced with an siRNA-
expressing lentiviral vector targeting ProF
(siProF3) were seeded for differentiation into
adipocytes. In the case of siProF3, cells were
seeded in three different concentrations (6x104
cells, 9x 104 cells, and 1,2 x 105 cells) to
eliminate the possibility of an effect of ProF on
cell growth. At day 1 of the differentiation, all
cells were subjected to glucose uptake analysis
and measured for total protein levels by
Bradford method. As can be seen, knock down
of ProF led to decreased glucose uptake (Fig.
5A), as well as total decreased protein content
(Fig. 5B), and fibroblast-like cell morphology,
independent from the initial number of cells. In
summary, ProF does not influence glucose
uptake in adipocytes by affecting the growth
rate of cells, thereby delaying the mitotic
clonal expansion.
To gain further insight into the role of
ProF in adipocyte differentiation, we
introduced a second siRNA against a different
sequence of the ProF mRNA. While the
siProF3, that was used so far, targets the
nucleotides 1.154 – 1.172 of the open reading
frame of ProF, the siProF1 is targeted against
nucleotides 280 - 300 of the 3’-untranslated
region (Fig. 6A). The expression levels of ProF
were analyzed by SDS-PAGE analysis. As can
be seen, we found that siProF3 led to a
downregulation of ProF protein expression
below detection levels, whereas siProF1 only
caused a partial downregulation of ProF. None
of the two siRNAs affected the expression of
the tubulin control (Fig. 6B). Next, we
compared the influence of ProF knock down
on cell morphology and total protein content
(Fig. 6C, D). As can be seen, the accumulation
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of lipid droplets was markedly delayed in
siProF3- transduced cells, but similar to
parental cells in siProF1- transduced cells.
Also the protein content of siProF1 cells was
only slightly decreased in siProF1-, but
markedly decreased in siProF3- transduced
cells during mitotic clonal expansion, when
compared to the untransduced control. Taken
together, these data indicate that only complete
downregulation of ProF influenced
adipogenesis, whereas partial downregulation
of ProF3 affected adipogenesis only
marginally.
To further strengthen this hypothesis,
we performed a glucose uptake with both
siProF- cells, compared to untransduced and
control- transduced cells (siGL2), in which the
siRNA is targeted against firefly luciferase. To
better evaluate the role of ProF in
adipogenesis, the glucose uptake was measured
at two different time points during adipocyte
differentiation - day +1(Fig. 7, top) and day +4
(Fig. 7, bottom). As can be seen, glucose
uptake was insignificantly decreased in
siProF1 cells (35% at day +1, and 30% at day
+4), but significantly decreased in siProF3
cells, both at day +1 (70% in comparison to
untransduced control) and day +4 (50% in
comparison to untransduced control) of
adipocyte differentiation (Fig. 7A, B).
Interestingly, analysis of the cell morphology
(Fig. 7C) and the total protein content (Fig.
7D) revealed that siProF3 influences both
markers for adipogenesis noticeably at day +1,
but only slightly at day +4, while siProF1
showed only little effect on adipocyte
differentiation at both time points. In summary,
these data show that both, reduced glucose
uptake and delayed adipogenesis, are
dependent on ProF- protein levels, since a
more efficient knock down led to decreased
glucose uptake and delayed adipogenesis. The
results furthermore demonstrate that ProF
affects glucose uptake independently from its
influence on adipogenesis, since glucose
uptake was still markedly reduced at day +4,
when cel ls  were morphological ly
indist inguishable from siGL2 and
untransduced control cells.
Discussion
We have previously identified ProF as an
adaptor molecule, which regulates glucose
uptake in adipocytes (1). Overexpression of
ProF led to increased glucose uptake, while
knock down of ProF by siRNA led to reduced
glucose uptake. This raised the question
whether ProF might also influence
adipogenesis, the differentiation of
preadipocytes into adipocytes (1). We
addressed this question by using different
experimental approaches. The effect of ProF
on adipogenesis was determined by
observation of the morphology, determination
of protein content, cell number, expression of
marker proteins by measuring the glucose
uptake. For our experiments we used the
murine 3T3-L1 cell line as an established and
reliable model for studying adipocyte
development including growth, metabolism
and differentiation. (8,37).
We found that ProF influences differentiation
of 3T3-L1 preadipocytes into adipocytes.
Protein and lipid droplet accumulation was
delayed in 3T3-L1 cells with ProF knock
down. The effect of ProF- knock down on
protein accumulation and glucose uptake was
limited to the first days of differentiation. ProF
did not influence the growth rate of the cells,
but influenced the expression of several
adipocyte differentiation- related proteins. Use
of two different siRNAs targeted against ProF
revealed that complete downregulation of ProF
strongly influenced glucose uptake and
adipogenesis, whereas partial downregulation
had much weaker effects. Based on these
results we conclude that ProF affects both,
glucose uptake in adipocytes and adipogenesis
of preadipocytes.
The clarification of how ProF is able to
influence both processes will be of great
interest in future studies. We recently found
that ProF binds activated Akt upon growth
factor- stimulation and that insulin stimulation
leads to a localization of both, ProF and Akt, at
the plasma membrane of adipocytes (1).
Insulin is well known to play a critical role in
adipocyte differentiation (38-41) and the
importance of insulin and Akt for adipogenesis
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is supported by several Akt-, phosphatidyl
inositol-3-kinase-, and insulin receptor- knock
out mice (39-47). Furthermore, overexpression
of a constitutively active form of Akt induces
adipocyte differentiation (48). However, the
molecular pathways downstream of Akt are not
clearly understood (48,49). One could envisage
that ProF acts as an interaction partner of Akt
and, thus, could be involved in bringing
together the kinase with a substrate molecule,
involved in adipocyte differentiation.
In the last years, a number of Akt targets,
which play a role in this process, have been
uncovered. One target of Akt, implicated in
adipogenesis is the protein mammalian target
of rapamycin (mTOR), a serine/threonine
kinase (50,51), which is highly upregulated
during adipocyte differentiation (52). mTOR
phosphorylation causes changes in the
phosphorylation of p70 ribosomal protein S6
kinase (p70S6K) and eukaryotic initiation factor
4E binding protein 1, (eIF4E-BP1) (53).
Phosphorylation of p70S6K leads for example to
phosphorylation of the cAMP response
element binding protein (CREB), a
transcription factor that promotes adipogenesis
(54,55), while eIF4E-BP1 phosphorylation
allows activation of protein translation (56).
The immunosuppressant drug rapamycin,
which inhibits the function of mTOR (53,57-
59), represses adipocyte differentiation and
lipogenesis in 3T3-L1 cells (60-62).
Interestingly, mTOR is found predominantly
on internal vesicles of mammalian cells (52).
We have recently found that in unstimulated
adipocytes ProF is also located at internal
vesicles (1).
Another target of Akt are the Foxo
transcription factors (63). Phosphorylation by
Akt causes inhibition of their transcriptional
activity (64,65). Foxo1, the most abundant
Foxo isoform in adipocytes is induced in the
early stages of adipocyte differentiation, but its
activation is delayed by Akt phosphorylation
until the end of the clonal expansion phase
(66). Akt phosphorylation of other
transcription factors, such as GATA2, has also
recently been found to promote adipocyte
differentiation (67).
More recently, Akt activity was found to be
required to induce expression of the key
regulator of adipogenesis PPARγ, because
Akt1/2 double knock-out resulted in impaired
PPARγ induction (68). Interestingly, we found
that knock down of ProF leads to delayed
expression of PPARγ during mitotic clonal
expansion phase (Fig. 3). Furthermore, we
have shown earlier that ProF is able to interact
with both isoforms, Akt1 as well as Akt2 (1). It
will also be interesting to see in further
experiments if ProF downregulation by siRNA
influences C/EBPβ and C/EBPδ expression, as
this has not been found in Akt1/2 double knock
out mice.
Taken together, our data support the idea, that
ProF could be a positive regulator of both,
adipogenesis and insulin-dependent glucose
uptake in adipocytes. It is worth noting, that
rapamycin, a negative regulator of adipocyte
differentiation has been proposed to suppress
both, adipogenesis in preadipocytes as well as
glucose uptake – and other insulin actions - in
fully differentiated adipocytes (69). ProF could
have the opposite effect on adipocytes.
Experimental procedures
Reagents and antibodies - Cell culture media,
supplements and Novex® 8–16% and 10–20%
Tris- Glycine gradient gels were purchased
from Invitrogen. Insulin was obtained from
Novo Nordisk. Isobutylmethylxanthin (IBMX)
and dexamethason were obtained from Sigma.
The transfection reagent Lipofectamin 2000
was purchased from Invitrogen. Protease
inhibitors were from Roche, 2-Deoxy- D-(1-
3H)-glucose, and D-(U-14C)-glucose were
obtained from Amersham Pharmacia Biotech.
Rabbit polyclonal (C-14) against Erk2, mouse
monoclonal (B-7) against tubulin, rabbit
polyclonal (H-100) against PPARγ, and goat
polyclonal C-20 against GLUT4, were
obtained from Santa Cruz Biotechnology,
sheep polyclonal against Akt2 from Upstate
Biotechnologies.
ProF antiserum - An anti-ProF antiserum was
raised in rabbits against a peptide
corresponding to the 15 amino acids at the C-
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terminus of murine and human ProF. Some of
the antiserum was thereafter affinity-purified
to increase the specificity of binding
(Eurogentech Belgium). Competition
experiments were performed with the same
peptide to verify the specificity (data not
shown).
Cell culture - The murine fibroblastic cell line
3T3-L1 (ATCC number CL-173) was grown in
Dulbecco's modified Eagle's media (DMEM)
containing 10% fetal calf serum (FCS;
Seratec). Penicillin and Streptomycin were
added to cultures of 3T3-L1 cells.
Differentiat ion of  adipocytes  - For
differentiation, early passage 3T3-L1
fibroblasts, were grown in growth medium
(DMEM supplemented with 10% FCS) to
confluency followed by medium change. 72 h
later differentiation was induced by growth
medium supplemented with 166 nM insulin,
0.1 µg/ml dexamethason, and 112 µg/ml
IBMX. Daily replacement of the hormonal
differentiation medium was performed for 3
days. Then, at day 0, the medium was replaced
by growth medium containing 166 nM insulin.
For insulin-stimulation experiments the cells
were starved in DMEM containing 0.5% FCS
for 20 h and stimulated for 1 h as indicated.
Cells were used for experiments within 20
days after removal of the hormonal
differentiation medium. Differentiation was
monitored by visual inspection or Oil Red O
staining (not shown).
Retroviral transduction and generation of
stably transduced 3T3-L1 cells - Retroviruses
containing the construct pRTP-Myc-ProF or
the empty pRTP vector as control were
produced using the BOSC-23 packaging cell-
line as described (70,71). Early passage 3T3-
L1 fibroblasts were incubated in virus-
containing medium for 48 h in the presence of
tetracycline (40 ng/ml) to suppress ProF
expression. The cells were used in the absence
of tetracycline for immunofluorescence
studies.
For siRNA downregulation the sequence used
was nt 280 - 300 of ProF 3’-UTR, (5’- CCA
CTG TTA CCG CAA TCT A - 3’) for siProF1,
and nt 1154 – 1172 of ProF open reading
frame, targeted against exon 11 (5’- GAA CTG
ACA AGG TAA TTA A- 3’) for siProF3. A
64-nt oligonucleotide, containing the target
both in sense and antisense orientation was
cloned into pSUPER and then together with
the H1 promoter into the lentiviral vector
FUGW (72). 4 x 105  HEK293T cells were
transfected with 0.6 µg of the lentiviral
expression construct, 0.6 µg of HCMV-G and
0.6 µg pCMVDR8.3 helper virus plasmids
using Lipofectamine 2000 (Invitrogen),
followed by medium change after 24 h. The
supernatant was used to infect 8 x 104 cells of
low passage 3T3-L1 cells.
Immunoprecipitation and Western blot
analysis - 3T3-L1 cells were extracted in
NETN- buffer containing 100 mM NaCl, 20
mM Tris-HCl, pH 7.5, 0.5% Nonidet NP-40, 1
mM EDTA using a tight-fitting tissue blender.
Complete homogenization was achieved after
6-10 strokes, 10 s each. Lysates were
solubilized by shaking for 30 min at 4 °C. The
endogenous ProF protein was detected as 44
kD form in direct lysates and precipitates. A 40
kD protein, also competed by the peptide, was
observed in some cases with cultured cells and
is likely to be unspecific.
Glucose uptake measurements - For Figure 4
and 5, differentiated adipocytes were starved
for 20 h in DMEM containing 0.5% FCS, and
stimulated for 1 h with insulin in the presence
of 1ml of 0.4 µCi/ml D-(U-14C)-glucose
(Amersham) with a specific activity of 311
mCi/mmol.  Cel ls  were  lysed in
radioimmunoprecipitation assay buffer (73)
and lysates were subjected to scintillation
counting analysis for measurement of 14C-
glucose uptake.
For Figure 6, differentiated adipocytes were
starved for 20 h in DMEM containing 0.5%
FCS, and glucose uptake analysis was
performed as described in (74) with slight
modifications. Briefly, cells were incubated for
30 min at 37°C with 1 mL of DMEM
containing 100 nM insulin, washed three-times
with 2 ml of warm HEPES- buffered Krebs-
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Ringer phosphate buffer (120 mM NaCl, 5 mM
CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4 and
30 mM HEPES, pH 7.2) and incubated for 10
min in the same buffer in the presence of 1ml
of 1 µCi/ml 2-Deoxy-D-(1-3H)-glucose
(Amersham) with a specific activity of 0.8
Ci /mmol .  Ce l l s  were  lysed  in
radioimmunoprecipitation assay buffer (73)
and lysates were subjected to scintillation
counting analysis for measurement of 3H-
glucose uptake.
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Figure legends
Figure 1: Timeline of adipocyte differentiation. The major hallmarks in adipogenesis, the process of
preadipocyte differentiation into adipocytes, are schematically indicated by arrows (top). Day + 0 in
the time line corresponds to the day of removal of the hormonal induction medium (indicated by a red
bar). The pictures below show the general morphology of the 3T3-L1 cells during cell cycle arrest,
hormonal induction, growth arrest and terminal differentiation.
Figure 2: Role of ProF on glucose uptake during adipocyte differentiation. A, Levels of protein
expression were analyzed in untransduced, parental (par.), empty vector transduced (FUGW) and cells
transduced with an siRNA-expressing lentiviral vector targeting ProF (siProF). Levels of ProF protein
expression were analyzed by IB (top lane), total protein levels were standardized to Erk2 (bottom
lane). B, (top, left) 3T3-L1 cells, which were untransduced (parental), transduced with empty vector
(FUGW), or transduced by a siRNA targeted against ProF (siProF3) were analyzed by light
microscopy during different time points of adipocyte differentiation. Day + 0 corresponds to the day of
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removal of the hormonal induction medium. (right) The number of lipid droplets in randomly selected
areas during adipogenesis is depicted (right). The accumulation of protein during adipogenesis was
analyzed by Bradford method (bottom). C, the number of living cells during different time points of
adipogenesis was analyzed by Trypan Blue staining.
Figure 3: ProF influences expression of adipogenesis- related genes. 3T3-L1 cells, which were
untransduced (p), transduced with empty vector (F), or transduced by a siRNA-expressing lentiviral
vector targeting ProF (si) were lysed at different time points of adipocytes differentiation. Time-course
analysis of expression of adipocyte differentiation markers was performed by Western blot with
antibodies against ProF, PPARγ, Akt2, GLUT4, and Erk2 (from top to bottom).
Figure 4: Effect of ProF knock down is limited to the first days of adipocyte differentiation. A, (top)
3T3-L1 cells, which were untransduced (p), transduced with FUGW empty vector (F), or transduced
by a siRNA-expressing lentiviral vector targeting ProF (si) were subjected to glucose uptake analysis
during different time points of adipocyte differentiation. For that, cells were starved for 20 h and
stimulated for 1 h with insulin in the presence of 14C-glucose (filled column) or left unstimulated
(open column). Data are mean values ± SD of 3 points. Asterisk indicate statistically significant
difference in glucose uptake (Student’s t-test, ** = P ≤ 0.01). B, Levels of total protein expression
during adipocyte differentiation were analyzed by Bradford method (bottom).
Figure 5: ProF does not influence glucose uptake in adipocytes by affecting the growth rate of cells. A,
3T3-L1 cells, which were untransduced (parental), transduced with empty vector (FUGW), or
transduced by a siRNA-expressing lentiviral vector targeting ProF (siProF3) were seeded for
differentiation into adipocytes. In the case of siProF3 cells were seeded in three different
concentrations (6x104 cells, 9x 104 cells, and 1,2 x 105 cells) to eliminate the effect of ProF on cell
growth. At day 1 of the differentiation, all cells were subjected to glucose uptake analysis (top). B, C.
Simultaneously total protein levels of the cell were determined by Bradford method (B) and
morphology of the cells was analyzed by light microscopy (C).
Figure 6: Use of different siRNA to evaluate the role of ProF. A, Levels of ProF expression were
analyzed by IB (top lane), total protein levels were standardized to tubulin (bottom lane). 1 is  direct
lysate from untransduced cells, 2 is direct lysate from siGL2 transduced cells, 3 is siProF1-expressing
cells, 4 is siProF3-expressing cells. B, 3T3-L1 cells, which were untransduced (parental), or
transduced with siRNAs targeted against ProF (siProF1 and siProF3) were analyzed by light
microscopy during different time points of adipocyte differentiation. Day + 0 corresponds to the day of
removal of the hormonal induction medium. C, Accumulation of protein during adipogenesis was
analyzed by Bradford method.
Figure 7: ProF influences glucose uptake and adipogenesis. A, B, 3T3-L1 cells, which were
untransduced (parental), transduced with a control siRNA against firefly luciferase (siGL2), or
transduced by siRNAs targeted against ProF (siProF1 and siProF3) were subjected to glucose uptake
analysis at day +1 of adipocyte differentiation (A) or day +4 of adipocyte differentiation (B). For that,
cells were starved for 20 h and stimulated for 30 min with insulin (filled column) or left unstimulated
(open column). Afterwards cells were incubated with 2-Deoxy-D-(1-3H)-glucose. Data are mean
values ± SD of 3 points. Asterisk indicate statistically significant difference in glucose uptake
(Student’s t-test, * = P≤ 0.05, ** = P ≤ 0.01). C, D. Morphology of the cells was analyzed by light
microscopy (C), while total protein content at day +1 (left) and day +4 (right) was determined by
Bradford method (D). For (D), 1 is  untransduced cells, 2 is siGL2 transduced cells, 3 is siProF1-
expressing cells, 4 is siProF3-expressing cells.
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Figure 8: Model for the role of Akt and ProF in adipogenesis. Stimulation of cells by glucocorticoids
such as IBMX and DMX leads to elevated cAMP levels and expression of transcription factors, while
insulin triggers a signal transduction cascade, which causes activation of Akt. Akt itself, targets
several proteins, implicated in adipogenesis such as mTOR (bottom) and Foxo (right). ProF, as
adaptor protein that binds Akt and potentially recruits Akt substrates, might influence glucose uptake
in such a way.
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5 Discussion
The topic of my thesis was to study a newly found propeller FYVE- protein, which
we designated as ProF. Since the more specific aspects of this thesis have been
covered in the manuscripts, the aim of this discussion is to integrate all results in order
to obtain a general picture of the role of ProF in adipocytes.
In this PhD thesis, a new protein was characterized, which interacts with several
proteins as demonstrated in preadipocytes and other cellular systems, such as brain
tissue. Among these interaction partners are two kinases, Akt and PKCζ, and
VAMP2, a protein involved in vesicular trafficking.  Binding of these proteins is
mediated by the WD-repeats of ProF. Indeed, WD-repeat proteins are known to
coordinate the complex multiprotein assembly in many different cellular systems by
specifically binding to one or more partner proteins (Li and Roberts, 2001; Smith et
al., 1999).
The FYVE domain, the second structural motif on the ProF protein, is responsible for
its interaction with cellular membranes by membrane lipid recognition. Several
membrane-targeting domains have been identified in the last decade, however only
FYVE domains were found to bind exclusively and with high specificity to PI3P
(Stenmark and Aasland, 1999). Yet, a typical FYVE domain shows only a weak
binding capacity towards PI3P due to its shallow PI3P-binding pocket and a single
phosphate interaction. Therefore, most isolated FYVE domains are insufficient for
membrane binding and require further interaction domains for efficient membrane
recruitment (Dumas et al., 2001; Lawe et al., 2000). However, there is a small number
of FYVE-containing proteins that, when overexpressed, translocate to endosomal
membranes by themselves (Ridley et al., 2001; Seet and Hong, 2001; Tsukazaki et al.,
1998). It should be noted that there is not one conserved motif within the FYVE
domain that allows this higher binding affinity, but several individual deviations
(Blatner et al., 2004). The FYVE domain of the protein FENS-1 is exceptional by
showing the highest binding capacity of all FYVE domains investigated so far
(Blatner et al., 2004; Ridley et al., 2001). FENS-1 is also interesting because it shows
60% sequence identity with ProF and a very similar domain structure. The sequence
identity of the FYVE domain of ProF and FENS-1 is with 80% even higher than the
overall sequence identity. This is not so surprising since the FYVE domain is
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comparatively well conserved among all species (Stenmark et al., 2002), whereas the
WD-repeats show very little sequence conservation among species (Li and Roberts,
2001). The structural feature that determines the high membrane affinity of the FYVE
domain of FENS-1 is an 11-amino acid insertion next to the conserved (R/K)-(R/K-
)H-H-C-R sequence, which is rich in aromatic amino acids and was found exclusively
in the proteins ProF and FENS-1. Structure prediction analysis suggests that this motif
forms an extended turret loop (Blatner et al., 2004). This exceptionally long
hydrophobic protrusion has been shown to cause the high membrane penetration
power and strong membrane affinity of the FYVE domain (Blatner et al., 2004).
Deletion of the unique 11-amino acid insertion caused a dramatically (around 80-fold)
decreased membrane affinity of the mutant compared with the wild type FENS-1.
Furthermore, mutants of conventional FYVE domain proteins such as Hrs with an
insertion of the FENS-1 motif exhibited an 11-fold higher membrane affinity than the
wild-type protein. This clearly underscores the critical role of the hydrophobic
insertion of FENS-1 in membrane binding.
Our data support this finding. Overexpressed ProF was found to localize to
intracellular vesicles. This binding was clearly dependent on the FYVE domain
binding to PI3P, because deletion of the FYVE domain and inhibition of PI3P-
production by wortmannin led to loss of vesicular staining and to distribution of the
protein in the cytoplasm. Similarly to FENS-1 (Blatner et al., 2004; Ridley et al.,
2001), a single FYVE domain was sufficient for membrane localization of ProF. This
demonstrates the high PI3P- binding capacity of ProF.
A key role of the phosphoinositide PI3P in the cell is the regulation of vesicular
trafficking in the early endocytic pathway (Corvera, 2000) as well as in Golgi/
vacuole sorting (Odorizzi et al., 1998). Normally, PI3P is exclusively found at
endosomes, where it is constitutively produced by the phosphatidylinositol kinase
PI3K class III (Gillooly et al., 2001). More recently, it has been found that PI3P is
also generated in a stimulus-dependent fashion (Razzini et al., 2000; Vieira et al.,
2001; Zhang et al., 1998). One especially interesting aspect is the insulin-mediated
formation of PI3P at the plasma membrane of adipocytes (Maffucci et al., 2003). This
finding deserves a more in-depth discussion, because ProF plays a role in adipocytes
and contains a FYVE domain for binding to PI3P.
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As mentioned earlier, insulin activates class I PI3K, which produces PIP2 and PIP3,
and which is required for insulin-dependent translocation of the glucose transporter
GLUT4 (Cheatham et al., 1994; Tengholm and Meyer, 2002; Tsakiridis et al., 1995;
Wang et al., 1999). In fat and muscle cells insulin also activates class II PI3K (Brown
et al., 1999) to produce PI3P at the plasma membrane (Maffucci et al., 2003). To
demonstrate the production of PI3P at this location Maffucci and coworkers
transfected fat and muscle cells with plasmid constructs expressing a GFP-tagged
tandem FYVE domain of Hrs. The GFP-FYVE fusion protein translocated to the
plasma membrane upon insulin stimulation (Maffucci et al., 2003). This underscores
the capability of adipocytes to recruit FYVE domain proteins to the plasma membrane
after insulin stimulation. We found that the FYVE domain of ProF is capable of high-
affinity binding to PI3P. Furthermore, our data showed that ProF partially
translocated to the plasma membrane of adipocytes after insulin stimulation. This
could be due to PI3P- production at this location.
After Maffucci and coworkers found insulin-induced PI3P-formation at the plasma
membrane of fat and muscle cells, they wanted to know whether the generation of this
phosphoinositide played a role in trafficking events. To investigate this possibility
they decided to focus on the major trafficking event in adipocytes downstream of the
insulin receptor: the translocation of GLUT4 from intracellular storage sites to the
plasma membrane. To check whether the plasma membrane pool of PI3P was
involved in this process, exogenous PI3P was targeted to the plasma membrane of fat
and muscle cells via lipid carriers. Interestingly, PI3P at the plasma membrane led to
the accumulation of GLUT4 vesicles close to the plasma membrane, but did not result
in fusion of GLUT4 with the plasma membrane and, thus, did not cause increased
glucose transport into the cells (Maffucci et al., 2003). These results were confirmed
by overexpression of myotubularin, a PI3P phosphatase, which caused impaired
insulin- induced GLUT4 translocation to the plasma membrane. This presumably
happened because of reduced PI3P production in 3T3-L1 adipocytes upon insulin
stimulation (Chaussade et al., 2003). Further studies showed that after PI3P- delivery
the GLUT4 vesicles accumulated in a docked but unfused state close to the plasma
membrane (Ishiki et al., 2005). Similar results were found when the cells were treated
with inhibitors that inactivate class I PI3K, which produces PIP3 to activate Akt2 and
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PKCζ/λ, but do not inactivate class II PI3K, which produces PI3P. This was found
both in fat (Bose et al., 2004) and muscle cells (Ishiki et al., 2005).
In summary, these results show that insulin- induced GLUT4 translocation is a two-
step process. The first step consists of class I PI3K- independent accumulation of
GLUT4 vesicles close to the plasma membrane (van Dam et al., 2005), which will be
called GLUT4 plasma membrane accumulation from now on.
The second step in insulin-induced GLUT4 translocation is the fusion of the GLUT4
vesicles with the plasma membrane. This leads to the externalization of the glucose
transporter, which allows the uptake of glucose into the cell. For clarity this part of
the process will be called GLUT4 vesicle fusion from now on. The whole insulin-
dependent process, which includes both GLUT4 plasma membrane accumulation and
GLUT4 vesicle fusion, will be referred to as GLUT4 translocation.
The GLUT4 vesicle fusion step is dependent on class I PI3K, and probably also Akt2-
and PKCζ/λ (Bose et al., 2004; Min et al., 1999). These data are in accordance with
the report that activation of Akt2 and PKCζ/λ through class I PI3K-mediated
production of PIP3 is for the most part required at a late stage of insulin-dependent
GLUT4 translocation and correlates with the GLUT4 vesicle fusion rather than
GLUT4 plasma membrane accumulation (van Dam et al., 2005).
What does this mean for the adaptor protein ProF and its role in insulin-induced
GLUT4 translocation? As mentioned before, ProF translocates to the plasma
membrane upon insulin stimulation, possibly because of PI3P production at this
location. Our experiments showed the translocation of ProF both in
immunofluorescence studies and in cell fractionation experiments. Furthermore, we
showed that Akt2 and PKCζ/λ translocated to the plasma membrane upon insulin
stimulation (Fig. 6). Our latter finding is in accordance with numerous data from other
groups (Braiman et al., 2001; Hanada et al., 2004; Kanzaki et al., 2004; Standaert et
al., 1999).
One possible interpretation of our results is that ProF, which binds to PI3P, mediates
the translocation of the kinases to the plasma membrane, where they can exert their
role on GLUT4 vesicle fusion. A second possibility is that the kinases, which are
activated by PIP3 and PDK1 at the plasma membrane, recruit ProF to this location. In
that case, ProF would bind to the activated kinases and PI3P at the plasma membrane
might facilitate the recruitment. As a third possibility ProF and the kinases translocate
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to the plasma membrane independently. In that case ProF would bind to PI3P, while
the kinases would bind to PIP3 and would be activated by PDK1. At this subcellular
location ProF could preferentially bind to activated Akt2 and PKCζ/λ to integrate the
kinases with their substrate proteins. At the moment we do not yet have the data to
determine which one of these three possibilities is correct.
Regardless of the exact mechanism involved, all three proteins, ProF, Akt2, and
PKCζ/λ translocate to the plasma membrane of adipocytes upon insulin stimulation.
What could be the function of ProF at this location? As mentioned earlier, activated
Akt2 and PKCζ/λ play a key role in GLUT4 vesicle fusion. Most probably they exert
their function by phosphorylating target proteins that regulate docking and fusion of
GLUT4 vesicles with the plasma membrane. At this step, ProF could bring together
the kinases and their substrates by binding both proteins at the appropriate subcellular
location.
What are these kinase substrates? Recently, several possible targets of Akt2 and
PKCζ/λ involved in GLUT4 vesicle fusion have emerged. Many of these proteins
appear to be involved in the regulation of the SNARE complex. In the process of
insulin-dependent GLUT4 translocation, this SNARE complex consists of the t-
SNAREs syntaxin 4 and SNAP-23 at the plasma membrane (Foster and Klip, 2000;
Watson et al., 2004) and the v-SNARE VAMP2 on the GLUT4-containing vesicles
(Martin et al., 1998), but it also includes numerous associated proteins (Grusovin and
Macaulay, 2003). The SNARE complex formation by binding of VAMP2 to SNAP-
23 and syntaxin 4 is crucial for fusion of GLUT4 vesicles with the plasma membrane.
Akt and PKCζ/λ could either indirectly regulate the SNARE complex formation by
phosphorylating regulators of SNARE proteins, or directly by phosphorylating the
SNARE proteins themselves.
Recent results obtained from fat and muscle cells point to the fact that Akt2 and
PKCζ/λ can indeed phosphorylate regulators of SNARE complex formation.
Akt2 appears to phosphorylate the protein Synip (Yamada et al., 2005), which is
bound to the t-SNARE syntaxin 4 in unstimulated adipocytes to prevent it from
binding to the v-SNARE VAMP2 (Foster and Klip, 2000; Min et al., 1999). In
stimulated adipocytes, Synip dissociates from syntaxin 4 to allow SNARE-SNARE-
interaction and GLUT4 vesicle fusion (Foster and Klip, 2000; Min et al., 1999).
Results from Yamada and coworkers indicate that Akt2 can directly phosphorylate
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Synip in vitro and that this phosphorylation decreases the binding of Synip to syntaxin
4 for GLUT4 vesicle fusion (Yamada et al., 2005), although these data have recently
been questioned (Sano et al., 2005). Therefore, the exact role of Akt at the plasma
membrane is still unclear.
One interesting but indirect target of the kinase PKCζ is the protein Munc18c, a
binding partner for syntaxin 4 in adipocytes (Halachmi and Lev, 1996; Tellam et al.,
1997; Tellam et al., 1995). Munc18c has been implicated in regulation of GLUT4
externalization, similar to Synip (Tamori et al., 1998; Tellam et al., 1997; Thurmond
et al., 1998; Thurmond et al., 2000). The kinases Akt2 and PKCζ/λ appear to play an
important role in Munc18c-dependent GLUT4 externalization. This has been recently
demonstrated in adipocytes from Munc18c knock out mice, in which the action of
PI3K-dependent kinases affected GLUT4 externalization in wild type, but not in
Munc18c knock out mice (Kanda et al., 2005). This indicates that kinases downstream
of PI3K – most likely Akt2 or PKCζ/λ - are involved in insulin-stimulated GLUT4
externalization and that one of their targets is the disruption of the syntaxin 4-
Munc18c interaction. A recent publication shows that upon insulin stimulation PKCζ
preferentially interacts with Munc18c in fat and muscle cells (Hodgkinson et al.,
2005b). Furthermore, disruption of the PKCζ-Munc18c binding by overexpression of
deletion mutants impaired insulin-stimulated GLUT4 translocation. However,
Munc18c appears not to be a direct target of PKCζ (Hodgkinson et al., 2005b). It is
possible that active PCKζ directly recruits another kinase to the plasma membrane.
However, it is also conceivable that an adaptor protein is responsible for this
recruitment. This protein could bind both, PKCζ and another kinase, at the correct
subcellular location. ProF could be envisaged as such a protein, which allows the
phosphorylation of regulators of SNARE protein interaction.
Furthermore, SNARE protein interaction leading to GLUT4 vesicle fusion could also
be regulated by direct phosphorylation of the SNARE proteins. One publication by
Braiman and coworkers showed evidence for such a direct SNARE phosphorylation
involved in GLUT4 translocation to the plasma membrane (Braiman et al., 2001).
Braiman and coworkers found that either insulin or overexpression of PKCζ induced
serine phosphorylation of VAMP2. We confirmed and extended this knowledge by
verifying the stimulation- and PKCζ-dependent phosphorylation of VAMP2.
Furthermore, we found that the adaptor protein ProF binds to both proteins and forms
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a ternary complex with PKCζ and VAMP2. Our in vitro studies also demonstrated
that ProF increases the binding of PKCζ to VAMP2 and the PKCζ- dependent
phosphorylation of VAMP2 (Fig.6). This underscores the role of ProF as adaptor
protein. Additionally, it provides evidence that ProF promotes the phosphorylation of
SNARE proteins by PKCζ and, thus, may play a role in the regulation of GLUT4
vesicle fusion to the plasma membrane.
What could be the effect of ProF-mediated VAMP2 phosphorylation by PKCζ? We
found that PKCζ can phosphorylate more than one serine residue on VAMP2 in vitro
and that three of the four potential phosphorylation sites are within the SNARE motif
of VAMP2. This motif binds to the SNARE-motifs of syntaxin 4 and SNAP-23 to
allow the formation of a twisted, parallel four-helical bundle (Sutton et al., 1998).
Because the formation of this helical bundle of SNARE motifs is dependent on
hydrophobic interactions and because several highly polar phosphoserine residues
could disturb the formation of the bundle, one would expect a negative effect of
Fig. 6: Schematic model of the role of ProF insulin-dependent signaling events, which lead to plasma
membrane translocation of GLUT4. Binding of insulin activates the insulin receptor, which stimulates
class I PI3K (left arrow), leading to PIP3 production at the plasma membrane, and class II PI3K (left
arrow), leading to PI3P production at the plasma membrane. PIP3 allows the activation of the kinases
Akt2 and PKCζ/λ at the plasma membrane (left). ProF also translocates to the plasma membrane upon
insulin stimulation, possibly via binding of the FYVE domain of ProF to PI3P (top). The model shows
binding of ProF (center) to Akt2 and PKCζ/λ. Furthermore, ProF binds the SNARE protein VAMP2
(right), an in vitro substrate of PKCζ, which is located on GLUT4-containing vesicles. By interacting
with both proteins, ProF increases VAMP2 substrate phosphorylation by PKCζ (black arrow) and
might thereby regulate the GLUT4 vesicle fusion with the plasma membrane and glucose uptake (top,
right). Proteins investigated in these studies are highlighted in black, other key proteins involved in
plasma membrane translocation of GLUT4 are depicted in gray. For further details see text.
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VAMP2 phosphorylation on SNARE formation and GLUT4 vesicle fusion. However,
several reports showed that decreased binding between v-SNARE and t-SNARE
proteins could lead to an increased fusion of vesicles. For example, as discussed
earlier, SNAP-25, the SNAP-23 homolog expressed in neurons, is phosphorylated by
PKC at S187, which lies within the C-terminal SNARE motif (Gonelle-Gispert et al.,
2002; Kataoka et al., 2000; Shimazaki et al., 1996). Unfortunately, all experiments
were performed with a mixture of PKC isoforms or with PKC inhibitors, which
exhibit little isoform specificity. Therefore it is not possible to distinct which PKC
isoforms were responsible for the phosphorylation. Nevertheless, PKC-dependent
phosphorylation of SNAP-25 caused decreased binding of SNAP-25 to syntaxin1 and
increased neurotransmitter release, possibly by accelerating the SNARE complex
dissociation and thus enhancing the efficiency of exocytosis (Shimazaki et al., 1996).
More recently, similar results were obtained with syntaxin 4 and SNAP-23, the t-
SNARE implicated in GLUT4 externalization (Foster and Klip, 2000; Watson et al.,
2004). In the case of SNAP-23 it was found that stimulation of platelet cells caused
PKC- dependent phosphorylation of syntaxin 4 at a so far undetermined position. This
led to a decreased interaction of the protein with SNAP-23 and increased granule
exocytosis (Chung et al., 2000). Likewise, PKC- mediated phosphorylation of SNAP-
23 at S23 and T24 led to reduced syntaxin 4 binding and increased granule exocytosis
(Polgar et al., 2003). In the case of syntaxin 4 it was suggested by Chung and
coworkers that PKC- phosphorylation increased the exocytosis of alpha and dense
granules by promoting disassembly of the SNARE complex. Thus, PKCζ-mediated
phosphorylation of VAMP2 after stimulation may decrease the interaction of the v-
SNARE protein VAMP2 with t-SNARE proteins. This may promote disassembly of
the SNARE complex and thus may accelerate vesicle trafficking and glucose uptake
as described for the SNARE proteins above. This hypothesis would be in accordance
with the data from Kotani and coworkers, who showed that expression of
constitutively active aPKC in adipocytes indeed promoted glucose transport (Kotani
et al., 1998). We found that overexpression of ProF, which acts as adaptor for PKCζ
and VAMP2 in vitro, also promotes glucose uptake in adipocytes. It is therefore
possible that ProF might affect vesicle trafficking by increasing the PKCζ- mediated
dissociation of the SNARE complex upon phosphorylation. It will be interesting to
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test this hypothesis by analysis of t-SNARE association with PKCζ- phosphorylated
or unphosphorylated VAMP2.
In summary, our results show that ProF mediates the binding of VAMP2 to PKCζ and
the phosphorylation of VAMP2 by activated PKCζ, which could play a role in
adipocytes, but possibly also in muscle cells and in a multitude of other cellular
systems. Indeed, the process of SNARE-dependent fusion of vesicles with the plasma
membrane upon stimulation is crucial not only for GLUT4 plasma membrane
translocation, but also for many other vesicular trafficking systems, such as insulin
release from pancreatic β-cells upon elevated glucose levels (Regazzi et al., 1995;
Sadoul et al., 1995; Wheeler et al., 1996), zymogen granule release from pancreatic
acinal cells upon stimulation (Wang et al., 2004), and synaptic vesicle exocytosis
(Burgoyne and Morgan, 2003), including the constitutive cycling of several neuronal
transmembrane proteins, which serve as ion channels (Bobanovic et al., 2002; Sheng
and Lee, 2001; Wan et al., 1997). Furthermore, it includes secretory granule release in
platelet cells upon stimulation by thrombin (Flaumenhaft et al., 1999; Reed, 2004)
and plasma membrane translocation of the aquaporin transporter in kidney duct cells
upon vasopressin stimulation (Gouraud et al., 2002; Nielsen et al., 2002) or of the H+-
K+-ATPase proton transporter in gastric parietal cells  upon stimulation by histamin
or gastrin (Okamoto and Forte, 2001; Peng et al., 1997). Additionally, SNARE
proteins have emerged as major players in numerous intracellular vesicle trafficking
events, such as transport from endosomes to lysosomes or the trans-Golgi network
(summarized in (Hong, 2005)). It is possible that ProF is also involved in a subset of
those trafficking events. In summary, our results point to a possible role of ProF in
GLUT4 vesicle fusion as binding partner of the kinases Akt and PKCζ/λ, although in
vivo studies in adipocytes clearly would be needed to confirm this role.
The question arises if the kinase Akt2 and PKCζ/λ and the adaptor protein ProF also
play a role in the first step of insulin-dependent glucose uptake, the GLUT4 plasma
membrane accumulation.
Some data point to an involvement of the kinases in this first step. Expression of
kinase-inactive Akt1 (Ducluzeau et al., 2002) or Akt2 (Chen et al., 2003) fused to
GLUT4 prevented GLUT4 plasma membrane accumulation in response to insulin.
Furthermore, two targets of Akt have been implicated in vesicle cycling upstream of
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the GLUT4 vesicle fusion. The Akt substrate of 160 kDa (AS160) has been reported
to regulate the translocation of GLUT4 vesicles from intracellular storage sites (Kane
et al., 2002; Sano et al., 2003; Zeigerer et al., 2004), while the FYVE domain
containing protein PIKfyve is implicated in vesicular sorting, and thereby in
influencing the translocation of GLUT4 vesicles (Berwick et al., 2004). Additionally,
some groups have shown a translocation of Akt2 (Calera et al., 1998; Kupriyanova
and Kandror, 1999) and PKCζ/λ (Standaert et al., 1999) to internal vesicles directly
after insulin stimulation before the accumulation of GLUT4 vesicles close to the
plasma membrane, although these data have been questioned by other groups (Hill et
al., 1999). Therefore, Akt2 and PKCζ/λ could as well play a role in GLUT4 plasma
membrane accumulation.
ProF is a vesicular protein and interacts with active Akt and PKCζ/λ. Thus, ProF
could potentially also be located on the insulin-responsive GLUT4 storage
compartment vesicles, termed GSVs. Our fractionation data show that ProF is found
in the low density microsomal (LDM) fraction of unstimulated adipocytes. The LDM
fraction contains all small vesicles, including the GSVs, but also Golgi membranes,
endosomes and other intracellular membranes (Piper et al., 1991). In unstimulated
adipocytes, ProF is likely to be located on endosomes, which contain constitutive
levels of PI3P (Gillooly et al., 2001). Our immunofluorescence pictures show a
punctuate staining of overexpressed Myc-tagged ProF in adipocytes, however the
resolution of the immunofluorescence data is not sufficient to detect a colocalization
of ProF with GLUT4 on vesicles. Furthermore, around 50% of total GLUT4 is found
on non-insulin-responsive vesicles, such as endosomes (Hah et al., 2002; Martin et al.,
1996; Ramm et al., 2000; Zeigerer et al., 2002), while the remainder of GLUT4 is
located in the GSV compartment. Therefore, even a colocalization of ProF with
GLUT4 could not demonstrate that ProF is located in the highly insulin-responsible
GSV pool. It is possible that ProF binds to GSVs by interacting with the protein
VAMP2. This v-SNARE is an important component of the GSVs (Malide et al., 1997;
Sevilla et al., 1997; Volchuk et al., 1994), but is also found on other intracellular
vesicles (Hong, 2005). Interestingly, Maffucci and coworkers showed a translocation
of overexpressed FYVE proteins from endosomes to the plasma membrane of
adipocytes upon insulin stimulation. This is similar to the translocation of ProF from
intracellular vesicles to the plasma membrane after treatment of the cells with insulin.
117
Thus, it is likely that these internal vesicles, on which ProF resides, are endosomes
and not GSVs (Maffucci et al., 2003).
Furthermore, most data suggest that the second step in GLUT4 translocation – the
GLUT4 vesicle fusion - likely plays the main role in the overall process. The first step
– the GLUT4 plasma membrane accumulation - may play a more permissive role,
perhaps by facilitating the efficient delivery of GSVs to the plasma membrane (van
Dam et al., 2005). Additionally, most data indicate that Akt or PKCζ/λ exert their role
predominantly at the level of GLUT4 vesicle fusion (Bose et al., 2004; Elmendorf et
al., 1999; Thurmond et al., 1998; van Dam et al., 2005). Therefore, the role of ProF as
adaptor for Akt and PKCζ in insulin-dependent glucose uptake is more likely to be
found at the plasma membrane than in intracellular storage sites.
Interestingly, we found that ProF does not only influence GLUT4 translocation and
glucose uptake in adipocytes, but also the process of adipogenesis, the generation of
new adipocytes by differentiation of precursor cells. The efficient knock down of
ProF by siRNA delayed both, protein and lipid droplet accumulation in preadipocytes.
We used two different siRNAs targeted against ProF and found that complete
downregulation of ProF strongly influenced glucose uptake and adipogenesis,
whereas partial downregulation had much weaker effects. The two adipocyte-specific
aspects, adipogenesis in undifferentiated preadipocytes and GLUT4 translocation in
differentiated adipocytes, are closely related, as many signaling enzymes of the
GLUT4 translocation such as insulin, PI3K and Akt play an important role in this
pathway (Accili and Taylor, 1991; Arribas et al., 2003; Bluher et al., 2002; Bluher et
al., 2004a; Bluher et al., 2004b; Cinti et al., 1998; Garofalo et al., 2003; Miki et al.,
2001; Valverde et al., 1999). For example, overexpression of a constitutively active
form of Akt induces adipocyte differentiation while Akt knockout impeded
adipogenesis (Kohn et al., 1996; Peng et al., 2003). Similarly, expression of
constitutively active Akt increased glucose uptake and GLUT4 translocation to the
plasma membrane, while dominant-negative Akt resulted in inhibition of glucose
uptake (Czech and Corvera, 1999; Kohn et al., 1998; Kohn et al., 1996). Since ProF
acts as interaction partner for Akt, and may in that way play a role in GLUT4
translocation, it is conceivable that ProF also acts on adipogenesis as adaptor protein
of Akt. ProF can also interact with activated PKCζ/λ, however evidence for a role of
PKCζ/λ in adipocyte differentiation is limited (Lacasa et al., 1995). In summary, it
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appears that PKCζ/λ does not play an important role during adipocyte differentiation.
It is very much possible that ProF acts as a adaptor to bring Akt into close proximity
of target proteins involved in adipogenesis, very similar to its proposed role in
GLUT4 translocation. However, the molecular pathways downstream of Akt are not
clearly understood (Kohn et al., 1996; Magun et al., 1996). One of the most
interesting proteins in respect to ProF and Akt is the serine-threonine kinase mTOR
(Sakaue et al., 1998; Scott et al., 1998), which is highly upregulated during adipocyte
differentiation (Withers et al., 1997) and probably affects adipogenesis by activating
protein translation (Isotani et al., 1999). This is in accordance with the finding that the
increase of total protein levels during adipogenesis is delayed in cells with knock
down of ProF by siRNA. mTOR is also interesting, because it is found predominantly
on internal vesicles of mammalian cells (Withers et al., 1997), which appears to be
similar to ProF. Therefore, ProF could use its FYVE domain as membrane anchor to
bind to mTOR- containing vesicles and bring activated Akt into close proximity of its
substrate. Most other targets of Akt implicated in adipogenesis are nuclear
transcription factors such as Foxo1 (Nakae et al., 2003) or GATA2 (Menghini et al.,
2005), which are negatively regulated by Akt phosphorylation to promote adipocyte
differentiation. However, since Akt has to translocate to the nucleus to phosporylate
its targets (Andjelkovic et al., 1997; Meier et al., 1997), the vesicular protein ProF is
unlikely to play a role as adaptor in that respect.
Clearly, more data are needed to unravel the role of Akt and its adaptor protein ProF
in adipogenesis.  Likewise, it is apparent that more studies are required to understand
GLUT4 translocation in its full complexity. In both cases, the most important question
to answer is the identification of substrates of Akt and PKCζ in vivo and to clarify
their role in the system of GLUT4 translocation or adipogenesis. The analysis of a
membrane-localized adaptor protein that interacts with key kinases of GLUT4
translocation at their target subcellular localization may provide important insights
into how these kinases are brought at their correct subcellular localization and how
the substrate phosphorylation of their key targets is achieved and regulated. This is
especially important considering the worldwide prevalence of disorders connected
with insulin-dependent glucose uptake into fat and muscle cells, but also with
adipogenesis that regulates fat cell formation  in the organism (Feve, 2005). The most
important among these diseases is the non-insulin-dependent diabetes mellitus type 2
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(type 2 diabetes), which has reached epidemic proportions in the past decade. Indeed,
numerous studies report that impaired GLUT4 translocation in fat and muscle cells
may represent a primary defect leading to the development of type 2 diabetes (Kahn,
1998; Mora and Pessin, 2002; Mueckler, 2001; Saltiel, 2001; Saltiel and Kahn, 2001;
Shepherd and Kahn, 1999). This disease is known to affect large numbers of people
from all ethnic groups and at all social and economic levels throughout the world
(Zimmet et al., 2001). At the present time it is estimated that 190 million people
worldwide have diabetes and that this will increase to 320 million by 2025. This
epidemic may even cause a decline in life expectancy in several nations, including the
United States in the 21st century (Olshansky et al., 2005).
In summary, these data emphasize the necessity to investigate type 2 diabetes and the
molecular mechanisms related to this disease in depth. For that a comprehensive
analysis of the signaling pathways leading to insulin-dependent GLUT4 translocation
in fat and muscle cells is essential. Furthermore, a detailed investigation of the
molecular components that regulate these pathways is of great importance to
understand the molecular mechanisms of glucose uptake and the related diseases.
In this thesis I characterized one such adaptor protein that plays a role in insulin-
stimulated glucose uptake. The further investigation of ProF as connector of kinases
and substrates might allow a better understanding of many important questions of
GLUT4 translocation, including signaling pathways and their regulation.
Furthermore, ProF may also be more generally involved in a variety of vesicular
trafficking processes in adipocytes as well as in other tissues. For example ProF may
also play a role in exocytotic or secretory pathways or the constitutive cycling of
vesicles and their proteins from intracellular sites to the plasma membrane
(summarized in (Royle and Murrell-Lagnado, 2003)). A similar role has been
proposed for other vesicular proteins involved in GLUT4 translocation, namely for
AS160 and PIKfyve (Welsh et al., 2005). Discerning the role of ProF in these
trafficking processes will be a main focus of further study on this protein.
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7 Appendix
7.1 Abbreviations
AGC PKA, PKG, and PKC family serine-threonine kinases
Akt Oncogene causing AKR mouse thymoma
aPKC atypical PKC
APS Adaptor protein containing PH and SH2 domain
ASK Apoptosis signal-regulating kinase
AS160 Akt substrate of 160 kDa
BAD Bcl-XL-antagonist, causing cell death
Bcl B-cell leukemia
bFGF basic fibroblast growth factor
COP coatomer protein
cPKC conventional PKC
CTMP carboxyl-terminal modulator protein
DAG diacylglycerol
type 2 diabetes non-insulin-dependent diabetes mellitus type 2
DL direct lysate
EEA1 early endosomal antigen 1
EGF epidermal growth factor
eNOS endothelial nitric oxide synthetase
ErbB2 avian erythroblastic leukaemia viral oncogene homologue 2
FENS-1 FYVE domain protein localized to endosomes-1
FoxO Forkhead box class O transcription factor
FYVE domain identified in Fab1p, YOTB, VAC1p, and EEA1
GAP GTPase-activating protein
GLUT Glucose transporter
G-protein trimeric GTP-binding protein
GS glycogen synthase
GSK glycogen synthase kinase
GSV GLUT4 storage vesicle
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IB Immunoblot
IGF-I insulin-like growth factor I
IKK IκB kinase
IL Interleukin
ILK integrin-linked kinase
IP Immunoprecipitation
IRS-1 insulin receptor substrate 1
IκB inhibitor of NF-κB
JIP1 JNK interacting protein 1
JNK c-Jun N-terminal kinase
LDM Low density microsomal fraction
m/p-Akt1 myristoylated and palmitoylated Akt1
MAP kinase mitogen-activated protein kinase
MAPKAP-K2 mitogen-activated protein kinase-activated protein kinase 2
MDM2 murine double minute 2
MLK mixed lineage kinase
MSK1 mitogen- and stress-activated protein kinase 1
mTOR mammalian target of rapamycin
NFκB nuclear factor-κB
NGF nerve growth factor
NPKC novel PKC
OPCA OPR/PC/AID motif
P70S6K p70 S6 kinase
P70S6K p70 S6 kinase
P90RSK p90 ribosomal S6 kinase
PAK p21 activated kinase
PAR-6 Partitioning defective homolog-6
PB1 Phox and Bem-1 domain
PDGF platelet derived growth factor
PDK1 phosphoinositide-dependent kinase 1
PH Pleckstrin homology
PI3K phosphoinositide-3-kinase
PI3P phosphatidylinositol-3-phosphate
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PIKfyve PI3P kinase containing a FYVE domain
PIP2 phosphatidylinositol-(3,4)-bisphosphate
PIP3 phosphatidylinositol-(3,4,5)-trisphosphate
PI(3,5)P2 phosphatidylinositol-(3,4)-biphosphate
PKA cAMP-dependent protein kinase
PKB Protein kinase B
PKG cyclic GMP-dependent kinase
PKG cGMP-dependent protein kinase
ProF Protein containing a WD-repeat propeller and a FYVE domain
PS Pseudosubstrate
PTEN Phosphatase and tensin homolog deleted on chromosome 10
RAC Protein related to protein kinase A and protein kinase C
RACK Receptor for activated C kinase
RD Regulatory domain
SARA Smad anchor for receptor activation
SH2 Src homology 2
SH3 Src homology 3
siRNA small interfering RNA
SNARE soluble N-ethylmaleimide–sensitive factor attachment protein
receptor
SOS son of sevenless
Tcl T-cell leukemia
TGF transforming growth factor
TNF tumor necrosis factor
TSC tuberous sclerosis complex
VAMP2 vesicle-associated membrane protein 2.
VEGF Vascular endothelial growth factor
WD-repeat repetitive motif containing a weakly conserved C-terminal Trp
(W) -Asp (D) dipeptide
XIAP X-linked inhibitor of apoptosis protein
YAP Yes-associated protein
ZIP PKC zeta-interacting protein
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